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Lumpsuckers (Cyclopterus lumpus L.) have gained popularity as a cleaner fish to 
biologically control salmon lice infestations in farmed Atlantic salmon in Norway. 
Starting in 2012, most producers in Norway have been raising lumpsuckers in 
captivity from milt and eggs collected from wild-caught fish. Since then, this 
industry has grown exponentially to meet the demands of Atlantic salmon 
producers. However, this growth was not without its issues. A number of bacterial 
diseases have been recorded from farmed lumpsuckers, with Pasteurella atlantica 
being one of the most concerning to farmers, given it is an emerging pathogen first 
diagnosed in Norwegian lumpsuckers in 2012.  
The main objectives of this project were to characterise P. atlantica, investigate the 
pathogenicity and the resulting immune responses in lumpsuckers, develop and 
test vaccines, and identify vaccine targets for future vaccine development.  
The first milestone was the establishment of P. atlantica culture in liquid medium. 
Through this work, bacterial growth was achieved in tryptic soy broth 
supplemented with foetal calf serum. This meant that bacteria could be produced 
in large volumes as required for experiments and vaccine development.  
Subsequently, a variety of challenge models were tested to study pathogenesis of 
P. atlantica in lumpsuckers. The bath challenge model was identified as the most 
reliable model, which could be further used during vaccine testing. Through these 
experiments, it was found that an asymptomatic carrier status occurs following 
exposure to the bacteria, highlighting the importance of fish health screening 
programs. 
To that end, whole cell inactivated vaccines were developed against P. atlantica to 
investigate their protection potential. However, only limited protection was 
conferred following experimental challenge of vaccinated lumpsuckers despite 
serology following vaccination showing high specific antibody levels. Additionally, 




lumpsucker head kidney leucocytes demonstrated potential intracellular 
behaviour, as well as auto-aggregation and adherence of the bacteria to host cells. 
Whole genome sequencing was then used to investigate the genome of P. atlantica 
to shed light on virulence factors that may be involved in disease and may be 
suitable as vaccine targets, paving the way for further work in reverse vaccinology. 
Furthermore, as the pathogen was still unclassified taxonomically at this point, 
phylogenetic analysis was additionally carried out which suggested the taxonomic 
position of P. atlantica within the Family Pasteurellaceae.   
In silico analysis subsequently identified a putative uncharacterised adhesin 
protein as being a major virulence factor and potential vaccine target and 
possessed similarities to the adhesins YadA and Hia found in Yersinia spp. and 
Haemophilus influenzae, respectively.  
Gene expression analysis was then used to assess the regulation of this adhesin in 
the presence and absence of lumpsucker head kidney leucocytes. It was observed 
that the gene encoding the putative adhesin is upregulated significantly, both 
during bacterial culture as well as when bacterial cells are exposed to lumpsucker 
head kidney leucocytes in vitro, complementing the in silico analysis. 
The knowledge gained from this work has significant implications for vaccine 
development. Through reverse vaccinology, a potential vaccine target has been 
identified that, through further research, could be used to develop subunit vaccines 
such as recombinant or DNA/mRNA vaccines. These promising results provide 
grounds for further research against a serious emerging disease in aquaculture 
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1.  Introduction 
Lumpsucker (Cyclopterus lumpus L.) is a new farmed species introduced to 
Norwegian aquaculture in 2012. Lumpsucker production was initially 
straightforward and successful due to their ability to eat food pellets and fast 
growth rates, adaptability to the cold Nordic climate, and efficiency as cleaner fish. 
However, as with most new farmed species, a number of difficulties were 
encountered related to welfare, nutrition, and diseases and vaccine development. 
These issues have garnered significant attention, with research efforts making 
progress to improve the sustainability of lumpsucker production.  
1.1 Lumpsuckers in aquaculture 
Background 
The lumpsucker is a morphologically unique fish species belonging to the Order 
Scorpaeniformes, Family Cyclopteridae and is the only member of the genus 
Cyclopterus. The body is rounded and compressed anteriorly and posteriorly, with 
the front dorsal fin forming a crested hump, and the pectoral fins having evolved 
to form the characteristic muscular sucker used for attachment to substrates (Fig. 
1). In the wild, they seem to prefer smooth substrates, such as floating kelp (fry and 
young juveniles), mussels and stones (older fish). As they grow older, they become 
more pelagic and tend to use the entire water column (Jonassen et al., 2018). The 
skin is scaleless, tough, and covered with pointed tubercules along defined ridges 
(Powell et al., 2018a). Coloration is an additional identifying feature, with 
immature fish ranging from blue to green to grey while sexually mature males can 






Figure 1. Morphology and coloration variability in lumpsuckers. A: juvenile lumpsuckers. B: 
ventral muscular sucker (arrow), C and D: sexually mature males. 
Geographically, lumpsuckers are native to the northeast and northwest Atlantic 
Ocean, Greenland, Iceland, over most of the North Sea, the Norwegian Sea, and the 
western and southern parts of the Barents Sea and as far as 80°N off the north-west 
coast of Svalbard. Further south, they have been recorded around the British Isles, 
France, and northern Portugal. Additionally, a small population was also recorded 
in the Baltic Sea (Davenport, 1985). In Norway, the main populations are estimated 
to be located around Troms, Nordland and Finnmark (Durif, 2020).  
Historically, male lumpsuckers were caught for their flesh, while female 
lumpsuckers were caught for their roe, which was a cheaper alternative to 




diversified through use of both male and female fish as so-called ‘cleaner fish’, i.e. 
in biological control of salmon lice in farmed Atlantic salmon, as a more 
environmentally friendly alternative to chemotherapeutic methods of lice control 
(Powell et al., 2018b). To improve sustainability of the cleaner fish industry, efforts 
have been made to close the lumpsucker life cycle in captivity. Currently most 
broodstock is still wild caught and culled to collect eggs and milt which is then used 
to raise offspring in captivity. Historical and current commercial fishing practices 
has resulted in a sharp decline in the abundance of wild lumpsuckers across known 
populations by more than 30% over the past 20 years (Powell et al., 2018b), with 
the species considered near threatened by the International Union for the 
Conservation of Nature (IUCN) (Lorance et al., 2015).   
Lumpsucker and Norwegian Atlantic salmon production 
Current large-scale production of farmed salmon is not without its fair share of 
challenges, both to the natural environment as well as to fish welfare. Infectious 
diseases from bacterial, viral, and parasitic agents pose one of the biggest threats 
to fish welfare, however the introduction of multivalent vaccines and vaccination 
regimes in the 80s and 90s have helped to eradicate a large proportion of bacterial 
diseases (Sommerset et al., 2005).  
Despite advancements, bacterial diseases such as flavobacteriosis, furunculosis, 
bacterial kidney disease, winter ulcer disease, and pasteurellosis still pose 
problems to the industry (Sommerset, 2021a). In addition, viral diseases such as 
cardiomyopathy syndrome (CMS), heart and skeletal muscle inflammation (HSMI), 
pancreas disease (PD), infectious salmon anaemia (ISA), and infectious pancreatic 
necrosis (IPN) (Sommerset, 2021b), as well as ectoparasitic agents such as the 
amoeba Paramoeba perurans which causes amoebic gill disease (AGD), and the 
salmon louse (Lepeophtheirus salmonis) have become more serious (Bornø, 2021). 
Moreover, salmon lice infections are still both a persistent economic and welfare 
issue, with the estimated cost of sea lice management reaching USD 525 million in 




The salmon louse is a marine copepod ectoparasite which feeds off skin mucus, 
blood, and tissue of Atlantic salmon. At low burdens, the parasite causes skin 
lesions and results in reduced feeding of fish, while at high burdens it leads to high 
mortalities due to osmoregulatory failure and secondary infections (Grimnes & 
Jakobsen, 1996; Nolan et al., 1999). Although the salmon louse is a natural parasite 
of Atlantic salmon, the stocking densities typical of fish farms enable the lice to 
flourish, thus being detrimental to fish welfare even at low burdens. In addition, 
due to the vicinity of farms to migratory routes of wild salmonids, the potential of 
sea lice spilling over from farmed to wild salmonids is high (Serra-Llinares et al., 
2014). In Norway, this has led to weekly compulsory lice counts on farmed fish 
being introduced by regulatory authorities, with corrective measures being 
required by law if lice numbers exceed an average of 0.2 to 0.5 (season dependent) 
adult female lice per fish (Lovdata, 2017a). 
L. salmonis treatments have traditionally been of a chemotherapeutant nature, 
with organophosphates, pyrethroids, hydrogen peroxide and avermectins being 
the most commonly used agents (Overton et al., 2019). However, overuse of these 
chemicals has led to increased resistance of sea lice, drastically reducing the 
efficacy of such treatments (Fjørtoft et al., 2020). This, in addition to the 
deleterious impact of such chemicals on the surrounding flora and fauna (Haya et 
al., 2005; Parsons et al., 2020), has led to the development and use of more 
environment-friendly measures such as biological control in the form of cleaner 
fish (Brooker et al., 2018; Haugland et al., 2020; Powell, et al., 2018b; Treasurer, 
2002), and mechanical and thermal de-lousing methods (Overton et al., 2019). The 
latter have unfortunately been shown to result in high stress levels in salmon, with 
post-treatment mortalities also being recorded, due to handling and the 
temperatures at which the treatments occur (Overton et al., 2019). This highlights 
the need for alternative solutions which are less stressful to salmon, such as 
biological control through the use of cleaner fish.  
Cleaner fish are regarded as the best option to help tackle salmon lice infections, 




are ballan wrasse (Labrus bergylta) and lumpsuckers (C. lumpus L.), although other 
species of wrasse are also employed, such as goldsinny (Ctenolabrus rupestris), 
corkwing (Symphodus melops) and cuckoo wrasse (Labrus mixtus) (Imsland et al., 
2018; Powell et al., 2018b; Treasurer, 2002). Wrasse species are commonly used 
in climates with sea temperatures of 6°C or higher, where they have a higher 
feeding capacity compared to lumpsuckers. Wrasses enter a state of hypo-
metabolism at lower temperatures, and lumpsuckers are therefore favoured 
throughout Norway, especially due to the cold winter temperatures.  
Lumpsuckers predominantly originate from cold water climates, and they have 
shown to efficiently eat sea lice at low water temperatures (Imsland et al., 2018). 
This means that there is no need for introduction of a new species like wrasse in 
an unfavourable climate, such as northern Norway. In addition, lumpsuckers are 
more robust, easier to farm, and have a high growth rate which can reach up to 
3.65% daily (under optimal conditions) (Nytrø et al., 2014). This enabled more 
rapid improvements in farming and nutrition for lumpsuckers compared to 
wrasse, making lumpsucker farming more sustainable. In turn, biosecurity is 
improved, as introduction of pathogens from imported fish (as is a concern with 
wild-caught wrasse transported over large distances) is reduced. The high growth 
rate means that lumpsuckers reach a deployment size of 20g in a third of the time 
it takes farmed wrasse to reach a deployment size of 40-50g (Brooker et al., 2018; 
Erkinharju et al., 2021a; Powell et al., 2018a). 
In Norway, increasing demand for lumpsuckers from an ever-growing salmon 
farming industry has led to staggering numbers of lumpsuckers being sold 
annually (Fig. 2), increasing from 431,000 in 2012  to 36.5 million  produced in 





Figure 2. Sale of farmed lumpsuckers to Atlantic salmon producers in Norway. Data for 2020 is 
preliminary. (Source of data: Directorate of Fisheries, 2021). 
Biology and rearing practices 
Substrates: Lumpsuckers are diurnal foragers and attach to substrates at night by 
means of their ventral sucker, which likely represents predator avoidance 
behaviour. In net pens and hatcheries, farmed juveniles appear to prefer smooth 
plastic vertical surfaces, such as artificial kelp fronds (Imsland et al., 2015).   
Behaviour: Lumpsuckers are typically more active when housed with salmon and 
wrasse, compared to monoculture. However, as lumpsuckers grow larger and 
become more competitive, they tend to show aggressive behaviour towards large 
wrasse and salmon, which negatively impacts salmon growth (Imsland et al., 
2014).  
Hatchery management: The growth rate of juvenile lumpsuckers is greatly 
affected by temperature (Haugland et al., 2020). In fact, the optimum temperature 
for lumpsuckers decreases with increasing weight, from 16°C for juveniles 
compared to 9°C for adult lumpsuckers. The temperature tolerance, however, 
increases with increasing body weight (Nytrø et al., 2014). For vaccinations, the 
minimum size is 7g and a period of 500°D is recommended until protective 
immunity is achieved (Haugland et al., 2018; Jonassen et al., 2018). At that timeline, 





































Feeding: In the wild, lumpsuckers feed mainly pelagically on plankton and 
seagrass and only visit shallow waters to spawn (Powell et al., 2018a). In 
hatcheries, lumpsucker larvae are initially fed Artemia nauplii then weaned onto 
appropriate formulated feed. This feeding regime has resulted in improved growth 
rates and reduced mortality in larval and juvenile stages when compared to 
lumpsuckers fed formulated feeds only (Jonassen et al., 2018). However, 
incidences of nutrition-related deformities, such as cataracts, have been recorded 
(Jonassen et al., 2017). Imsland et al. (2019) also found that in hatcheries, daily 
feeding of lumpsuckers resulted in too rapid growth rates and increased the risk 
of cataract development and gut inflammation.  
In Norway, hatchery reared lumpsuckers are commonly fed formulated feed 
pellets as early as 2-5 days post hatch. However, a study by Dahle et al. (2017) 
found that since functional stomachs develop much later, at around 21-34 dph, 
such a feeding regime may impact the mucosal linings of the gut and energy 
storage, increasing the risks of nutritional-related issues and mortalities. An 
additional study investigating the impact of live first-feeds for lumpsucker larvae 
indicated that using copepods and enriched Artemia nauplii resulted in better 
growth rates compared to larvae fed only formulated feeds (Rian, 2019). Moreover, 
it has been suggested that delaying the weaning period from live to formulated 
feeds by a few days may be beneficial for increased larval survival (Dahle et al., 
2017; Rian, 2019). 
Once deployed in net pens, lumpsuckers continue to feed and grow at low 
temperatures, and can be over-wintered in the pens with salmon. Kousoulaki et al. 
(2018) reported that only around 30% of lumpsuckers actually feed on lice when 
deployed and suggested that the high incidence of cataracts observed in juveniles 
may be the cause. Lumpsuckers tend to ignore slow-moving or sessile organisms, 
which may be an alternative explanation if low delousing activity occurs. Adults 
also become sexually mature at approximately 500g, at which point their delousing 
efficacy greatly diminishes. Fish above this size are not recommended for use as 




1.2 Lumpsucker health  
Welfare status 
Research on lumpsucker welfare indicators has gained momentum, and the 
Norwegian Food Safety Authority recently published of a report looking into the 
welfare situation of lumpsuckers in Norway (Mattilsynet, 2020). Treasurer et al. 
(2018) reviewed morphological, physical, and behavioural indicators that can be 
used to monitor lumpsucker welfare. Morphological indicators include fin erosion 
and damage to the suction disc. Behavioural indicators include swimming activity, 
aggression, and ventilation rate. Physical indicators are linked to stress and 
allostasis. Lumpsuckers have been documented to show lower cortisol levels 
immediately following stress episodes, however they are more prone to the 
chronic effects of stress (Jørgensen et al., 2017). Noble et al. (2019) also compiled 
a factsheet series on lumpsucker operational welfare indicators (OWIs) based on 
current scientific knowledge, and Imsland et al. (2020) and Eliasen et al. (2020) 
suggested a number of OWIs related to the physical condition of the fish. In the 
most recent study, Gutierrez Raban et al. (2021) developed a Lumpfish Operational 
Welfare Score Index based on visual assessment of several physical indicators, that 
can be used by farmers in hatcheries and for employees at fish farms.  
Bacterial diseases 
As a relatively new species to aquaculture, several bacterial diseases have been 
documented in farmed lumpsuckers (Fig. 3). Mortality spikes seem to occur soon 
after hatching, after vaccination, and following transfer to salmon cages (Johansen, 
2013). The most commonly encountered bacterial agents are Vibrio species 
(including V. anguillarum and a V. ordalii-like bacterium), Tenacibaculum spp., 
Moritella viscosa, Pseudomonas anguilliseptica, atypical Aeromonas salmonicida 
and Pasteurella atlantica (Alarcón et al., 2016; Ellul et al., 2021, Paper 3; Erkinharju 





Figure 3. Commonly recorded bacterial infections in lumpsuckers in Norway between 2012 and 
2020 (Source of data: Fish health report 2019 and 2020).  
Atypical A. salmonicida subtype VI, based on A-layer typing (using the vapA gene), 
is the most problematic in lumpsuckers (Gulla et al., 2016a), and infections caused 
by isolates expressing the  A-layer result in 100% mortality (Scholz et al., 2018). 
The disease can be acute or chronic, with symptoms including skin ulcers, 
haemorrhaging at the base of fins and internal organs, and darkening of the skin 
(Scholz et al., 2018). Histopathology typically shows bacterial colonies present 
throughout the visceral organs and in musculature. As the pathology is similar to 
that caused by P. atlantica, molecular analysis and bacteriology are required to 
confirm a diagnosis. Antibiotics can be used to treat the disease albeit with limited 
success, as re-emergence of infection is common (Kverme et al., 2021 [manuscript 
submitted]; Scholz et al., 2018). Vaccine development is difficult due to antigenic 
heterogeneity among strains, however preliminary studies have shown that 
vaccination can provide protective immunity (Rønneseth et al., 2017).  
V. anguillarum serotypes O1 is typically isolated from lumpsuckers in Norway 
(Erkinharju et al., 2020). The disease is mostly acute, and symptoms include 
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darkening of the skin, and tail rot (Scholz et al., 2018). Histopathology shows 
bacterial cells present in tissues. Antibiotic treatment is usually effective if the 
disease is diagnosed at early stages (Scholz et al., 2018), and both florfenicol and 
oxolinic acid have been used in preliminary work to treat lumpsuckers 
experimentally challenged with V. anguillarum (Kverme et al., 2021[manuscript 
submitted]). Vaccination is also effective, with outbreaks in salmon pens being 
rare. A Vibrio ordalii-like bacterium (formerly V. anguillarum biotype 2) (Lillehaug 
& Colquhoun, 2020) has recently been recorded in lumpsuckers in Norway 
(Erkinharju et al., 2020, 2021b) and is associated with white lesions around the 
eyes (Scholz et al., 2018).  
There are two ‘types’ of M. viscosa that affect farmed fish species: the type strain 
and the variant strain. The latter of the two is most problematic for lumpsuckers 
in Norway. The disease presents as a systemic infection with superficial lesions 
that can be secondarily infected by Tenacibaculum spp. The variant strain can 
cross-infect salmon, but this only occurs where the type strain is already an 
established problem (Scholz et al., 2018). The type strain does not appear to cross-
infect lumpsuckers (Einarsdottir et al., 2018). Antibiotics are not effective against 
this disease, and no data exists on vaccine efficacy in lumpsuckers (Scholz et al., 
2018).  
Tenacibaculum maritimum infections are encountered at every life stage, including 
in lumpsuckers cohabitating with salmon in net pens. Symptoms include ulcers in 
the mouth and skins, fin rot, and may also become systemic. Diagnoses are best 
made using molecular analysis. Vaccine development is hindered due to antigenic 
variation between isolates (Scholz et al., 2018; Småge et al., 2016).  
P. anguilliseptica was initially problematic for Japanese aquaculture, where it was 
responsible for red spot disease in Japanese eel. However, it has lately been also 
recorded in Europe from several species, including Atlantic salmon and 
lumpsuckers. In the latter case, the isolate responsible for disease is different from 




where temperature plays an important factor. In lumpsuckers, the symptoms 
include haemorrhaging at the vent, mouth and fin bases, skin irritation, and 
haemorrhagic septicaemia. While there are no commercial vaccines available 
against the disease, antibiotic treatments are usually successful (Scholz et al., 2018; 
Walde et al., 2019). 
Outbreaks of pasteurellosis caused by P. atlantica in lumpsuckers in net pens 
mostly occur in late summer and autumn and are typically associated with prior 
stressful events such as handling and delousing treatments (Erkinharju et al., 
2021b). In Norway, most outbreaks often result in mortalities of up to 100% 
(Erkinharju et al., 2021a). Symptoms include haemorrhaging at fin bases, tail rot, 
and skin lesions (Ellul et al., 2019a, Paper 1). Florfenicol treatment can be used to 
treat pasteurellosis in lumpsuckers in the field (Alarcón et al., 2016) and under 
experimental challenge (Larsen, 2019), but infections tend to re-emerge in the field 
(Alarcón et al., 2016). As histopathology is similar to atypical A. salmonicida 
infections, diagnosis is best confirmed by molecular analysis (Ellul et al., 2019a 
Paper 1; Scholz et al., 2018).  
1.3 Pasteurella atlantica 
Background and geographical distribution 
The first confirmed outbreak of pasteurellosis caused by P. atlantica in Norwegian 
lumpsuckers was reported by the Norwegian Veterinary Institute from a farm in 
southern Norway in 2012 (Johansen, 2013). Additional cases have since been 
reported from sites along the western coast of Norway (Erkinharju et al., 2021b). 
Pasteurellosis has been recorded in fish ranging from juveniles to broodstock, in 
hatcheries, following deployment in salmon cages and in wild-caught broodstock 
(Alarcón et al., 2016). P. atlantica has also been detected in milt and eggs from 
lumpsuckers in higher levels than are usually detected during regular tissue 
screenings (Kui, 2017), suggesting that vertical transmission of disease is 
theoretically possible. In Norway, this has led to screening programs of lumpsucker 




pathogen, especially as no vaccines are yet available. Since the first recorded 
outbreak, cases of pasteurellosis have been steadily increasing, with 36 sites 
reporting outbreaks in 2020 (Erkinharju et al., 2021b). P. atlantica therefore 
remains a welfare and economic issue, and as the infection is non-notifiable, under-
reporting of outbreaks cannot be excluded. 
Taxonomy 
The Family Pasteurellaceae is composed of commensals, opportunistic and 
primary pathogens and includes the genera Pasteurella, Actinobacillus and 
Haemophilus amongst others (Christensen et al., 2014). The genus Pasteurella has 
a broad host range, but little is known about pathogenic Pasteurella spp. in the 
marine environment.  
Based on 16S rRNA gene sequence phylogenetic analysis these three genera are 
polyphyletic and include five, ten and three species, respectively. However, 
phylogenies based on single genes such as 16S rRNA may result in incorrect 
classification due to, amongst others, horizontal gene transfer (HGT) and 
insufficient information within the gene to resolve relationships between closely 
related species. For this reason, phylogenies based on multiple genes such as 
multilocus sequence analysis (MLSA) or whole genome analyses would be more 
appropriate and may improve the separation of species-like taxa and confirm 
monophyletic taxa (Christensen et al., 2014).  
Protein signatures identified from published genome sequences show that taxa 
within the Pasteurellaceae can be divided into two groups, with Pasteurella and 
Haemophilus in one group, and Actinobacillus in a second group (Christensen et al., 
2014). 
Alarcón et al. (2016) carried out initial phylogenetic analyses, using partial 
sequences of the 16S rRNA gene and the rpoB gene, from a number of isolates 
collected following outbreaks of pasteurellosis in lumpsuckers and these were 
found to represent a novel Pasteurella species. The authors also included strains of 




Atlantic salmon in Norway, and Pasteurella skyensis isolates from Scotland causing 
pasteurellosis in Scottish Atlantic salmon. It was shown that all the Norwegian 
isolates formed a separate cluster from the Scottish P. skyensis isolates and 
pairwise sequence identity between the two clusters was 97.1–98.0% for the 16S 
rRNA gene, indicating that the lumpsucker and ‘varracalbmi’ isolates were a 
distinct species or sub-species from P. skyensis. Following current suggested 
nomenclature, the lumpsucker Pasteurella isolate is termed P. atlantica (Nilsen et 
al., 2021).  
In 2018, an additional Pasteurella variant was detected following outbreaks of 
disease in farmed Atlantic salmon in Norway (Colquhoun, 2019). This has since 
continued to increase in importance and was identified in 57 salmon farming 
localities in 2020 (Nilsen et al., 2021). The strain has also been identified in a small 
number of cases in infected lumpsuckers cohabiting with infected salmon. While 
also belonging to the species P. atlantica, this new strain is genetically distinct from 
the P. atlantica strain primarily affecting lumpsuckers in the field. However, 
lumpsuckers have been found to be susceptible to both strains under laboratory 
conditions (Sandlund et al., 2021).  
Pasteurellosis caused by P. atlantica should not be confused with pasteurellosis, 
commonly termed pseudotuberculosis or photobacteriosis (Romalde, 2002), a 
disease recorded in warm water climates, characterised by white granulomas on 
internal organs. This latter disease is caused by Photobacterium damselae subsp. 
piscicida (Phdp) (previously Pasteurella piscicida) now classified under the Family 
Vibrionaceae. Phdp has a wide host range including ayu (Plecoglosus altivelis), and 
yellowtail (Seriola quinqueradiata) in Japan, gilthead seabream (Sparus aurata), 
and sea bass (Dicentrarchus labrax) in the Mediterranean, and striped bass 





Isolation and phenotypical characteristics 
P. atlantica is a relatively slow-growing bacterium when cultured on blood agar, 
needing a 4-day incubation at 15 °C for colonies to be identifiable. In liquid 
medium, P. atlantica flocculates in the early lag phase of growth. These clumps 
disappear as cell numbers increase (Fig. 4). Alarcón et al. (2016) carried out 
comprehensive biochemical characterisation of the bacterium. Briefly, the colonies 
were described as small, pinpoint, non-haemolytic and grey. Blood and NaCl were 
also documented as requirements for growth of P. atlantica on agar. P. atlantica 
cells are Gram negative, non-motile coccobacilli which produce acid from glucose 
both aerobically and anaerobically and are highly sensitive to the vibriostat 0/129. 
The authors noted that although P. atlantica was phenotypically similar to both 
‘varracalbmi’ and P. skyensis isolates, it was biochemically less reactive.  
 
Figure 4. Culture of P. atlantica. A: liquid culture in early lag phase with clumps indicated by 
arrows. B: liquid culture at late exponential growth. C: Colonies on blood agar.  
Susceptible species and clinical signs of disease  
Symptoms in diseased lumpsuckers (Fig. 5) may vary according to the severity of 
infection and include characteristic white spots all over the skin and eyes, with 
frayed fins and haemorrhage at the base of the jaw and fins in more chronic cases 




additionally recorded tail rot, bleeding from gills, and granulomas on visceral 
organs.  
Histopathology indicates that bacterial cells aggregate into microcolonies within 
organs, and are often associated with focal necrosis and an influx of inflammatory 
cells (Alarcón et al., 2016; Ellul et al., 2019a Paper 1). Some similarities were 
present in histopathological findings between the varracalbmi and P. skyensis 
isolates in Atlantic salmon and P. atlantica in lumpsuckers (Alarcón et al., 2016). 
 
Figure 5. Gross pathology of P. atlantica infection in lumpsuckers, shown by arrows. A: 
haemorrhage at base of fins. B: haemorrhage and erosion of caudal fin. C: haemorrhage around 




1.4 Virulence factors 
The first interaction between pathogenic bacteria and their host involves 
attachment to the cell surface of the latter, which may lead to colonization followed 
by infection and disease. The cellular components and structures that serve to 
evade host defences and mediate bacterial pathogenicity are known as virulence 
factors. They can be present within the bacteria (endotoxins), on the surface of the 
bacterial cell (e.g., bacterial capsule, flagella, fimbriae/pili), or even released 
extracellularly (exotoxins).  While endotoxins can elicit antibody responses, these 
are rarely protective. An exception to this is lipopolysaccharide (LPS) which is a 
major protective endotoxin found in most Gram negative bacteria (Welch & 
LaPatra, 2016). Exotoxins, conversely, can be immunogenic, and are typically 
known to elicit protective antibody responses, although this depends on various 
factors including size of the toxin (Casadevall & Pirofski, 2001). This property 
makes exotoxins possible vaccine targets, as they can be used to generate a 
protective immune response in the host.  
Colonisation and infection of a host by pathogenic bacteria is typically coordinated 
through a class of proteins known as adhesins, which are found on the outer 
membrane of the bacteria and are considered to be attributes of virulence. 
Aggressiveness of the pathogen can be conferred through a capsule surrounding 
the pathogen resulting in resistance to phagocytosis or survival within 
phagosomes, hence inhibiting or overcoming host defences. Bacterial components 
can alternatively result in disease indirectly, through damage caused by the host’s 
own reaction to such components, such as an inflammatory response to 
polysaccharide components of bacterial capsules which results in disease 
(Casadevall & Pirofski, 2001).  
Virulence factors are classified into two categories. They can be requisite, whereby 
they confer pathogenicity on their own (e.g., bacterial capsules, toxins) or 
contributory, where they modify the degree of pathogenicity and may not be 




components would form part of a group of components acting synergistically. 
Perhaps most importantly, bacterial virulence factors rely on antigenic variation to 
constantly adapt in response to host selective pressures and thereby increase 
survivability of the pathogen (Casadevall & Pirofski, 2001; Linke et al., 2006). An 
example of this is resistance to serum components conferred by the YadA adhesin 
of Yersinia species (Linke et al., 2006). 
There is little to no information available on virulence factors of P. atlantica, as 
genomic analyses that can provide answers are still sparse. Consequently, 
annotations of the genome are limited. At this stage, therefore, only extrapolation 
can be made on virulence factors from other members of the Pasteurellaceae. 
Outer membrane proteins (OMPs): Members of the Pasteurellaceae family are 
known to cause septicaemia, respiratory disease, and mastitis amongst other 
conditions. OMPs present in Pasteurella multocida are immunogenic, and rabbits 
and turkeys inoculated with these antigens were protected against disease. P. 
multocida toxin (PMT) extracted by sonication and expressed in Escherichia coli 
has also been found to be a potent immunogen. When used as an inactivated toxin, 
good protection was achieved in rodents and pigs (Confer, 1993).  
Lipopolysaccharide (LPS): The LPS O-antigen from P. multocida is toxic to mice 
leucocytes, and vaccination with this antigen resulted in strong opsonising 
antibody production, but no protection on challenge (Confer, 1993).  
Haemagglutinins: Two loci were identified in the genome of P. multocida PM70, 
PfhB1 and PfhB2, which code for haemagglutinins and were found to have strong 
homology to a haemagglutinin of Bordatella pertussis. This protein is involved in 
adhesion to host cells and is used in the vaccine against whooping cough in 
humans, and conserved motifs in PfhB1 and PfhB2 indicate that the same 
properties may be present in P. multocida. Some regions of these haemagglutinins 
are also similar to the serum-resistance protein p76 of Haemophilus somnus, which 
confers resistance to opsonisation and enhances pathogen survival (May et al., 




Repeats-in-toxin (RTX) proteins: RTX proteins are present in Pasteurella, 
Mannheimia, and Aggregatibacter, as well as Vibrio species and E. coli, amongst 
others. They are secreted by the Type 1 secretion system (T1SS) and an ABC 
transporter system, and typically exhibit cytotoxic pore-forming activity. They also 
cause tissue damage by eliciting anti-inflammatory responses (Linhartová et al., 
2010).  
They are produced by a wide range of Gram negative bacteria and are 
characterised by nonapeptide repeats of glycine and aspartate-rich sequences in 
the toxin peptide, which are sites of calcium ion binding. RTX proteins may have 
originated in Pasteurellaceae and spread to other species through HGT (Linhartová 
et al., 2010). This is supported by the G:C ratio which, at approximately 36-46% 
G:C, is similar to most Pasteurellaceae genomes, indicating the source of origin 
(Frey & Kuhnert, 2002).    
Despite their antigenicity, they are not essential virulence factors, but rather work 
synergistically with other virulence factors to cause disease (Frey & Kuhnert, 
2002). Another example is LktA, a moderately haemolytic and cytotoxic protein 
present in Mannheimia haemolytica (responsible for bovine and ovine 
pasteurellosis) which induces histamine release and stimulates neutrophil 
respiratory burst (Frey & Kuhnert, 2002).  
Iron uptake mechanisms: Iron acquisition systems are important virulence 
mechanisms. Siderophore-mediated systems are used to sequester iron usually 
from host transferrin which is crucial for bacterial growth. The mechanism for 
uptake of iron is well conserved, with unique transporters for siderophores found 
in different species. Bacteria can have more than one different system besides their 
own. These would typically be acquired through HGT and indicate survival and 
bacterial protection mechanisms.  
In the Pasteurellaceae, iron uptake systems are not particularly notable, and only 
a few proteins with occasional affinity to iron sequestration systems have been 




iron enrichment when culturing the bacteria, especially the need for blood and 
foetal calf serum, which is recorded for a number of members of the family 
(Christensen et al., 2014), including P. atlantica (Ellul et al., 2019a Paper 1). 
However, despite the limited presence of specific uptake systems, homologs to 
proteins involved in iron uptake have been recorded in the genome of P. multocida 
PM70. Specifically, genes are present that are homologous to those in 
Actinobacillus pleuropneumoniae and Yersinia pestis (May et al., 2001).   
Siderophore-independent mechanisms are also present, where haem is used as the 
source of free iron. This is sequestered via haemolysis and cytotoxins such as RTX 
proteins. In P. multocida strain PM25 a number of haemin- and haemoglobin-
binding proteins have been identified. However, despite some of these proteins 
being immunogenic, these were not protective (Bosch et al., 2004). It is possible 
that the availability of a wide range of receptors can be manipulated by the bacteria 
to use different receptors in different hosts, at different stages during the infection 
process, or even to evade host responses, thus ensuring a supply of iron. 
Pili: There are two types of pili recorded in the Pasteurellaceae, Flp and Type IV 
pili. Flp pili encoded by the tad locus are found in P. multocida, and A. 
pleuropneumoniae, but not in Haemophilus influenzae. They are important for 
adhesion, auto aggregation and biofilm formation, and are implicated in disease 
progression. The second type of pili, Type IV pili, have similar functions. They are 
associated with motility, biofilm formation and colonisation of host cells and are 
found in H. influenzae, P. multocida, and A. pleuropneumoniae (Christensen et al., 
2014).  
Adhesins: Adhesins are a class of surface-bound proteins involved in facilitating 
bacterial attachment to host tissues. They are classed as fimbrial or non-fimbrial 
based on the absence or presence, respectively, of an outer membrane anchor in 
the protein. Among the different types of adhesins, bacterial lectins are the most 
common (Wizemann et al., 1999). The mediation of attachment occurs through 




surface. Trimeric autotransporters are a family of non-fimbrial, bacterial adhesins 
which are secreted by the Type 5c secretion system (T5cSS), and whose main 
function is attachment of pathogenic Gram negative bacteria to hosts and other 
abiotic surfaces. Yersinia adhesin A (YadA) is the most extensively studied member 
of this family, and others include H. influenzae adhesin (Hia) and Neisseria adhesin 
A (NadA) (Comanducci et al., 2002; El Tahir & Skurnik, 2001; St. Geme & Cutter, 
2000). 
In the first functional genomic work done on lumpsucker isolates of P. atlantica, 
we have identified several proteins that are promising vaccine targets, which 
include an as yet uncharacterised adhesin similar to Hia and YadA from H. 
influenzae and Yersinia species, respectively (Ellul et al., 2021, Paper 3).  
YadA is a potent virulence factor present in Y. enterolitica and Y. tuberculosis 
relying on attachment to collagen, fibronectin, and laminin, and colonises the 
intestine by adhering to the intestinal mucosa (El Tahir & Skurnik, 2001; Spahich 
& St Geme, 2011; Tsugo et al., 2017). Immunologically, YadA has been shown to be 
a highly immunogenic antigen, with vaccines using inactivated Y. enterolitica 
resulting in a more comprehensive protective immune response in mice than when 
using live bacteria (El Tahir & Skurnik, 2001). 
Hia is an adhesin found in 25% of clinical non-typable strains of H. influenzae and 
causes respiratory tract infections and meningitis in humans (Winter & 
Barenkamp, 2009). Like YadA it is highly immunogenic, and opsonophagocytic 
antibodies were generated in serum in guinea pigs and mice following vaccination 
(Winter & Barenkamp, 2009). 
Adhesins also promote the delivery of bacterial toxins through the upregulation of 
additional virulence genes that facilitate invasion of the host (Wizemann et al., 
1999). An example of this is the triggering of the Type 3 secretion system (T3SS) 
by bacterial attachment to host cells to secrete effector molecules from the bacteria 
into the host cell. These effectors modify host cell proteins, typically immune cells, 




reside within the inactivate immune cells to evade host immune responses 
(Hoepelman & Tuomanen, 1992). These interactions can compound the severity of 
disease by inducing reactions from the host such as cytokine production or 
lectinophagocytosis (Abraham et al., 2014).  
Given this high potential of virulence, adhesins can be utilised as targets for vaccine 
development through reverse vaccinology (RV) (He et al., 2010). Protective 
immunity can be achieved in theory by inducing adhesin-specific antibodies 
targeting and blocking epitopes required for microbial attachment. The 
development of such vaccine will be of great advantage to combat pasteurellosis in 
lumpsuckers. Although few in number, successful adhesin vaccines developed 
through RV have been tested for farmed fish including those against diseases 
caused by Vibrio harveyi, Edwardsiella tarda, and Aeromonas hydrophila (Fang et 
al., 2004; Jin & Li, 2021; Maiti et al., 2012; Zhu et al., 2019).  
1.5 Teleost immune system 
The immune system of teleosts is divided into the innate and adaptive systems, and 
the major lymphoid organs are the thymus, kidney, spleen, and mucosa associated 
lymphoid tissues. Recently, Løken et al. (2020) identified a teleost analogue to the 
bursa of Fabricius in Atlantic salmon with secondary lymphoid functions and age-
dependent characteristics, which suggest the functions involved are related to 
lymphocyte maturation. 
Immune organs and cells 
In marine teleosts, the ontogeny of lymphoid organs is different from that of 
freshwater species. In the former, it is the kidney that develops first followed by 
the spleen, and lastly the thymus. In freshwater teleosts, the thymus becomes 
lymphoid first, followed by the kidney and spleen (Castro & Tafalla, 2015; Uribe et 
al., 2011; Zapata et al., 2006).  
The kidney is the largest site of haematopoiesis with erythropoiesis, 




the anterior kidney. It is the primary site for the production of B cells and contains 
a large presence of melanomacrophage centres (MMC) which are encapsulated 
accumulations of pigment-containing macrophages. For this reason, the anterior 
kidney is a primary lymphoid organ, while the posterior kidney is a secondary 
lymphoid organ (Uribe et al., 2011).  
The structure of the thymus varies among teleosts in terms of differentiation, as it 
can be one or several pairs of organs, and it is usually difficult to observe 
differences between the cortex and medulla. As a primary lymphoid organ, it 
contains an aggregation of macrophages promoting the encapsulated proliferation 
of T cells (Castro & Tafalla, 2015; Uribe et al., 2011).  
The spleen is a secondary lymphoid organ with specific T and B cells and contains 
lymphoid cells in the red pulp, and MMCs, and splenic ellipsoids in the white pulp. 
The latter are thick-walled capillaries whose cells are involved in macrophage 
phagocytosis of antigens. MMCs retain antigens for long periods and increase in 
size and frequency depending on environmental stress and infections. 
Furthermore, the spleen is important in adaptive immunity due to the presence of 
memory cells (Castro & Tafalla, 2015; Uribe et al., 2011). 
Other organs (tissues) are also important for immune responses, despite not being 
primarily lymphoid in function. These include the mucosa-associated lymphoid 
tissues (MALTs), which are present in the nasopharyngeal tract, gills, intestine, and 
skin, which are major tissues for antibody secreting cell production through the 
mucosa. Lymphocytes accumulate at the base of gill filaments (Koppang et al., 
2010), and local Ig responses (IgT) can be produced through the mucosa of the 
intestine. IgT is specialised for mucosal immunity and is almost exclusively 
produced only in the intestine (Hansen et al., 2005).  
MALT, especially skin associated lymphoid tissue (SALT), is a crucial physical 
barrier for fish. Mucus contains innate humoral factors such as complement 
proteins, natural antibodies, antimicrobial peptides, lysozymes, and agglutinins 




eliminate a range of pathogens and foreign material. For cohabiting lumpsuckers 
and Atlantic salmon, frequent delousing treatments risk stripping away the SALT 
leaving the already stressed fish vulnerable to pathogenic attack. 
Innate immune system 
The innate immune system is also known as the non-specific system and is 
therefore first involved in attacking invading foreign materials. Due to their non-
specific nature, these responses are consistent and are not known to possess 
immune memory. As it is the first defence system to develop during fish 
embryogenesis, it provides a broad range of protective functions based on physical 
barriers such as skin, scales, and mucus, followed by humoral and cellular 
components. Studies have shown that the innate immune system does not act in 
isolation; several innate responses result support adaptive immune responses. 
Furthermore, studies have shown that the innate immune system can be “trained” 
using immune-modulating compounds such as β-glucans, such that protection can 
be conferred against a secondary infection independently of T and B cells by 
relying on non-specific cytotoxic cells (NCC), which are teleost equivalents of 
natural killer (NK) cells, and macrophages (Petit et al., 2019; Petit & Wiegertjes, 
2016).  
The major teleost cell types involved in non-specific defence against pathogens are 
phagocytes and NCC cells. Auxiliary cells such as basophils, eosinophils, mast cells 
and platelets are also present and are involved in inflammatory responses. The 
teleost equivalents of NK cells have been identified in channel catfish and are of 
two classes- NK-like cells which are large, granular, and isolated from blood, and 
NCC, which are small, agranular and located in lymphoid tissues. These cells can 
kill stressed or infected cells either directly or by secreting inflammatory cytokines 
(Jørgensen, 2014).  
Phagocytes can be antigen presenting cells (APC) which express MHC class II and 
include B cells, monocytes, macrophages, and dendritic cells (mononuclear). The 




to T-cells in the mature form.  Neutrophils (polynuclear granulocytes) are also 
phagocytic cells and have been shown to express major histocompatibility complex 
(MHC) class II in some species (Cuesta et al., 2006;) but their role in antigen 
presentation is still unclear.  
While macrophages are always present in the peritoneal cavity, neutrophils are 
only recruited during inflammatory responses. A subset of macrophages, 
melanomacrophages, are present in the head kidney and spleen. They are also 
antigen presenting cells and are recruited during inflammatory responses. During 
phagocytosis, the pathogen is internalised into a phagosome, which fuse with a 
lysosome and develops into a phagolysosome where the pathogen may be 
neutralised by exposure to enzymes and reactive oxygen and nitrogen species such 
as  superoxide anion and nitric oxide (Jørgensen, 2014).  
Despite their widespread use, knowledge of the lumpsucker immune system 
remains limited. Haugland et al. (2012) first characterised the components and 
functionality of the lumpsucker innate immune system by isolating leucocytes 
from peripheral blood, spleen, and head kidney, and determined the non-specific 
phagocytic capacity of lumpsucker leucocytes to be very high. Rønneseth et al. 
(2015) then characterised B cells from lumpsuckers and found high phagocytic 
ability among IgM+ B cells isolated from serum.  
Recognition of pathogens occurs through pathogen- or danger-associated 
molecular patterns (PAMPs or DAMPs) and is mediated by pattern recognition 
receptors (PRRs) which can either be cell membrane-associated or soluble. PAMPs 
include bacterial membrane lipids, peptidoglycan, flagellin, as well as bacterial and 
viral nuclei acids. The most important classes of PRRs include Toll-like receptors 
(TLRs), of which 12 have been described in lumpsuckers (Eggestøl et al., 2018), 
retinoic acid inducible gene-like (RIG-I) receptors (RLRs); MDA-5 and LGP2 are 
two examples described in lumpsuckers, and nucleotide binding oligomerisation 
domain-like receptors (NLRs), five of which are found in lumpsuckers (Larsen, 




although their primary roles are related to phagocytosis. However, they 
additionally regulate adaptive immunity by mediating antigen recognition by 
dendritic cells. Most components of the complement pathways are identified in 
lumpsuckers (Haugland et al. 2018; Eggestøl et al., 2018). PAMP-PRR interactions 
activate intracellular signalling pathways which result in cytokine expression 
tailored to neutralise different pathogens (Jørgensen, 2014).  
Intracellular bacteria have developed mechanisms to avoid phagocytosis. The most 
common methods involve modulation of cytokine pro-inflammatory and anti-
inflammatory responses to inhibit the elimination of infected cells and promote 
bacterial survival within the cell, respectively, as well as producing own cytokines 
that help resist toxic reactive oxygen and nitrogen species. They can also modulate 
development of the phagosome in order to resist the acidic environment within 
phagolysosomes (Munang’andu, 2018).  
Adaptive immune system 
The adaptive immune response is initiated by the innate response, and although it 
is usually delayed, it is essential for long lasting protection against pathogens, and 
its activation is the key goal for vaccines. Adaptive immune responses are mediated 
by B cells (memory and antibody responses) and T cells (helper T (Th) cells that 
are needed for activation of other immune cells and cell-mediated responses by 
cytotoxic T (Tc) cells). When naïve B cells are activated by antigens (both T-
dependent and T-independent) and stimulated by Th2 cells they proliferate into 
plasma cells which secrete antibodies, and into memory cells which will ensure a 
more rapid response upon second encounter with the same antigen (Fischer et al., 
2013). Tc cells, activated by Th1 cells, recognise the antigen by the T-cell receptor 
(TCR) when presented by MHC class I and eliminate infected cells by secretion of 
cytotoxic compounds (Secombes & Wang, 2012).   
MHC proteins are the tools directly involved in activation of T cells. MHC class I is 
present on the majority of cells and presents viral or intracellular bacterial 




pathogen components to CD4+ Th cells. This then results in a complex signalling 
cascade (Magnadottir, 2010).  
Cellular responses 
T cells are produced in the thymus, then migrate to tissues to induce responses 
directly. They can be differentiated into Tc cells that eliminate infected host cells 
or Th cells that produce cytokines to stimulate cells of the innate system to 
eliminate the pathogen (Secombes & Wang, 2012). In addition to CD4+ and CD8+, 
T cells also possess CD3 signalling molecules that facilitate cellular immune 
activation upon receptor-antigen interaction (Secombes & Wang, 2012). Both CD4 
and CD8 have been identified in lumpsucker (Straumsnes, 2018). 
Pathogenic peptides presented on the cell surface by MHC class I are usually 
derived from viruses, intracellular bacteria, or tumours (Secombes & Belmonte, 
2016). IL-2 promotes the differentiation of naïve Tc cells into effector Tc cells and, 
further on during the immune response, into memory Tc cells (Yamaguchi et al., 
2019). The differentiated forms can be distinguished from naïve Tc cells by the 
expression of their surface markers (Laing & Hansen, 2011). 
CD4+ T cells (Th) are stimulated by peptides derived from extracellular pathogenic 
peptides presented on the cell surface by MHC class II on APCs and regulate 
immune responses via cytokine release. Only TCRs that bind with antigens of 
sufficient affinity will trigger activation. Th cells may then differentiate into four 
cell groups which can be distinguished by their unique cytokine profile, 
transcription factors, and functions. Th1 (express INF-γ and IL-2) mount a cell 
mediated response against the target cell and activate macrophages and Tc cells. 
Th2 (express IL-4, IL-13, and IL-20) drive the humoral response, upregulate 
antibody production through B cell activation, and decrease inflammation. Th17 
(express IL-17A, IL-17F, and IL-22) upregulate tissue inflammation to defend 
against extracellular bacteria that are not cleared by Th1 and Th2. Treg (express 
TGF-β1, IL-10, and IL-35) control the inflammatory response mounted by Th17 




Humoral responses  
B cells are produced in the anterior kidney but can be found in a number of tissues 
even in the absence of infection. They recognise soluble antigens directly via the B-
cell receptor (BCR) present on the cell surface and can also form soluble version of 
the BCR (Ig) which are secreted as antibodies that bind to antigens that triggered 
their production. Binding of antibodies to targets may have several functions such 
as inactivation of toxins and prevention of attachment to the host and marking of 
antigens for destruction by phagocytic cells. These antibodies can be classified as 
neutralising (act against the pathogen directly) or opsonising (assist phagocytes 
with internalising the pathogen) (Secombes & Wang, 2012; Secombes & Belmonte, 
2016). Furthermore, binding of antibodies to microbes and antigens can lead to 
agglutination, activation of the complement system and antibody-dependent cell 
mediated cytotoxicity (ADCC). 
Tetrameric IgM is the most predominant antibody in teleosts (Sunyer, 2013) 
including lumpsuckers (Rønneseth et al. 2015), followed by IgD and IgT/Z 
(Danilova et al., 2005; Hansen et al., 2005). IgM levels are affected by 
environmental factors such as temperature, and is found in various locations in the 
fish, predominantly in plasma, but also in skin, intestine, gills, and bile. While IgT 
has mainly been recorded from intestinal tissues of rainbow trout (Zhang et al., 
2010),  IgT (also identified as IgZ in zebra fish) has been recorded in the thymus 
and head kidney of zebrafish (Danilova et al., 2005).  
Teleosts have two major subsets of B cells: ones that express IgM and IgD both in 
the same cell (IgM+IgD+) and those that express IgT only (IgT+). IgD+ B cells have 
also been identified in catfish and rainbow trout (Edholm et al., 2010; Ramirez-
Gomez et al., 2012). Exact proportions, however, depend on individual species, 
highlighting the complexity of B cell composition. The immune response from B 
cells is dependent on the location of the infection: if this occurs in the intestine, a 
local IgT response is mounted. Interestingly, IgT levels following an intestinal 




be true for IgM levels (Secombes & Wang, 2012). Rønneseth et al. (2015) found 
that immunisation of lumpsuckers using a range of inactivated bacterins resulted 
in the production of specific antibodies in each case, and further demonstrated that 
such immunisation resulted in vaccine-induced protective immunity following 
experimental challenge with atypical A. salmonicida (Rønneseth et al., 2017).  
B cell activation occurs following antigen binding to BCR, internalisation, 
processing, and presentation of antigens by MHC class II to Th cells. Once activated, 
B cells mature leading to the differentiation to plasma cells (produce and secrete 
antibodies) and memory cells (remember the pathogen upon a second encounter). 
Activation depends on complex signalling pathways and communication with Th2 
cells. 
Once matured, plasma cells differentiate into short-lived plasma cells and long-
lived plasma cells. These cells do not proliferate further and can only secrete 
antibodies for the duration of their lifecycle. Short-lived plasma cells are generated 
upon a high affinity interaction at the tissue site of infection and typically die off 
once the pathogen is destroyed. Low affinity B cells migrate to MMCs in the anterior 
kidney where they slowly mature to long-lived plasma cells and persist for long 
periods, where they will continue secreting antibodies without needing to be 
restimulated. These low affinity cells will over time be replaced by higher affinity 
ones, resulting in a memory immune response (Secombes & Belmonte, 2016).  
In the case of immune memory, T-independent antigens are those that activate B 
cells in the absence of Th cells either through binding of innate receptors or 
through simultaneous binding of several B cell receptors, and do not result in an 
immunological memory response, whereas T-dependent antigens are those that 
can only stimulate B cells in the presence of Th cells and leads to the formation of 
an immunological memory (Cruse et al., 2004).  
The presence of antigen specific antibodies confirms that the entire process from 




occurred. This is the key for humoral adaptive responses and the goal for 
protective vaccines. 
1.6 Vaccine status of lumpsuckers 
The rapid development of global aquaculture is not without its fair share of 
challenges. Management and control of diseases poses one of the biggest impacts 
to welfare and economic viability, and hence sustainability, of the industry. 
Improvements therefore need to be made to limit and prevent disease outbreaks 
that lead to significant losses of fish during each production cycle. In the past, 
antibiotics were the standard method of treating outbreaks of bacterial diseases. 
Unfortunately, this soon led to antibiotic resistance. Better prophylactic, rather 
than remedial, measures were therefore required to protect fish against pathogens, 
and the first vaccines were produced and utilised successfully. Nowadays, 
vaccination has become the new standard for the industry and for some high value 
aquaculture species such as Atlantic salmon, tilapia, sea bass, and sea bream, 
commercial vaccines are available against major diseases.  Commercial vaccines to 
protect against novel emergent pathogens are very few, as are vaccines to protect 
lower value farmed fish species such as cleaner fish. Advances in vaccine 
development technologies are therefore vital to ensure improved welfare of 
aquaculture species. 
Vaccines for aquaculture have been developed since the 1940s, to protect fish 
species all over the world against diseases caused by numerous pathogens, 
including A. salmonicida, V. anguillarum, Yersinia ruckeri, and Phdp, amongst 
others. A variety of vaccine types are available for fish ranging from whole bacterin 
inactivated vaccines, subunit vaccines available against ISA in Chile, live attenuated 
vaccines against disease caused by Edwardsiella ictaluri and Flavobacterium 
columnare infections are licensed in the USA (Evensen, 2016), and DNA vaccines 
against infectious haemopoietic necrosis (IHN) and pancreas disease (PD) in 




Bacterial diseases in lumpsucker hatcheries are often treated using antibiotics; 
however, there are no approved protocols available to provide adequate 
treatment. Furthermore, in cases of outbreaks in sea cages, treatment is not 
possible due to their cohabitation with Atlantic salmon. Therefore, prophylactic 
measures in the form of autogenous or commercial vaccines are of increasing 
importance to combat diseases and improve the welfare status of farmed 
lumpsuckers. Currently, the majority of farmed lumpsuckers in Norway are 
vaccinated against disease caused by V. anguillarum and atypical A. salmonicida. As 
P. atlantica is a relatively recently discovered pathogen, vaccine development 
against pasteurellosis is still in its infancy, and P. atlantica antigens are currently 
not included in commercially available lumpsucker vaccines. 
Vaccination is the most important prophylactic measure that aims to stimulate the 
adaptive immune system to respond protectively against particular immunogenic 
antigens of a pathogen. Immunogenicity occurs when host antibodies bind a 
pathogenic component (antigen) and raise a humoral or cellular immune response 
specific to that antigen to neutralise it, thus protecting the host. Conversely, a 
number of antigens may be bound by host antibodies, but which do not result in a 
protective immune response generated in the host. Such antigens are not 
immunogenic. 
Through evolutionary forces, host immune responses influence virulence factor 
expression, as pathogens constantly adapt to try to evade these responses. 
Therefore, by knowing the antigenic targets to which host protective responses are 
directed, the bacterial components responsible for disease can be identified. These 
can then be used as vaccine targets to develop refined vaccines that confer better 
protection, thus reducing the virulence of the pathogen.  
Additionally, the stronger the immune response generated, the better the 
suitability of the target for vaccine development. In turn, individual targets on their 
own may not be sufficient for a protective immune response to be generated and 




satisfactorily protective host immune response. This would need to be given due 
consideration in the process of vaccine development. 
Through the principles of RV and using bioinformatic analyses of pathogen 
genomes, immunogenic antigens can be predicted in silico to be utilised as targets 
for vaccine development. RV is a more rapid process than the conventional 
approach of vaccine development, and is considered to reduce development time 
by about 2 years (He et al., 2010). It also ties into the 3Rs with a reduction in the 
number of fish required for vaccine testing, as well as resulting in a more accurate 
and effective vaccine being developed. RV has been successful in the identification 
of vaccine targets and the development of vaccines against disease caused by a 
number of farmed fish pathogens, including those caused by A. salmonicida 
(Marana et al., 2017), Phdp (Andreoni et al., 2013, 2016), A. hydrophila (Kaur et al., 
2021), and V. anguillarum (Baliga et al., 2018). 
Technology to aid RV has come a long way since the principles were established 
and applied. A number of programs and databases are now available that facilitate 
the prediction of suitable targets. These programs rely on criteria based on 
physical characteristics from the bacteria, such as sub-cellular localization, adhesin 
probability, and the number of transmembrane domains present in outer 
membrane proteins (Ong et al., 2020). In order to ensure reliable targets are 
predicted, they should be only present in virulent strains and have protein 
sequences that are dissimilar to host sequences (He et al., 2010). 
Vaccine components and categories 
Vaccines typically contain an antigen dissolved in water (water-based) or in a 
stabilising emulsion of water and oil (oil-based). In the latter, the antigen can be 
present in either phase. Adjuvants are also often present in vaccines to enhance the 
immune response, with the most common being mineral oil. Water-based vaccines 
can be administered orally, by immersion or by injection (intraperitoneal (IP) or 
intramuscular (IM)) whereas oil-based vaccines can only be IP injected. The main 




acid based. Inactivated vaccines are the most commonly encountered vaccines and 
are generally effective against extracellular bacteria. However, their efficacy 
against intracellular bacteria may be limited. In subunit vaccines, the antigen is 
produced recombinantly in an expression system and purified at the end of the 
production cycle, then used for formulating the vaccine. All these categories of 
vaccines usually require the addition of adjuvants to prime the host immune 
system. Alternatively nucleic acid vaccines (mRNA or DNA) can be produced, using 
only the sequence encoding for the antigen (Evensen, 2016; Knappskog et al., 
2014). 
Adjuvants  
Adjuvants are necessary to improve the efficacy of non-replicating vaccines. They 
are compounds that modulate the immunogenicity of an antigen and are 
categorised as Signal 1 or Signal 2 based on the immunological events they induce. 
Additional roles include promoting the induction of mucosal immunity and 
through their use, lead to a reduction in antigen doses and antigen competition in 
multivalent vaccines (Tafalla et al., 2014). Signal 1 facilitators extend the immune 
availability of the antigen by slow release of the antigen (depot effect) and 
attracting APCs to the antigen. Signal 2 facilitators provide co-stimulatory signals 
to increase or skew the immune response towards the antigen. A third class of 
adjuvants, signal 0, mimic PAMPs to trigger PRRs and in doing so simultaneously 
function as signal 2 facilitators to induce secondary signals (Dalmo et al., 2016). 
Signal 1 adjuvants include oil-based adjuvants such as Freund’s complete adjuvant, 
Freund’s incomplete adjuvant, and Montanide ISA, amongst others. FCA is 
composed of inactivated Mycobacterium and mineral oil with surfactant. While it 
has been shown to elicit Th1 and Th17 responses, use of this adjuvant is very 
limited due to the resulting severe side-effects including granulomatous peritonitis 
(Dalmo et al., 2016). Furthermore, an increase in immunogenicity is not always 
guaranteed, as observed in vaccines against Phdp in yellowtail (Kawakami et al., 




protection was conferred in rainbow trout in a vaccine containing A. hydrophila 
(LaPatra et al., 2010) and F. psychrophilum (Högfors et al., 2008). 
Freund’s incomplete adjuvant was then developed which lacks Mycobacterium and 
is still highly effective at priming the immune system. However, peritonitis is still 
a side effect, for example in cod (Gjessing et al., 2012). This adjuvant provided 
significant protection and induced innate, humoral, and cellular responses in 
Japanese flounder vaccinated with an E. tarda vaccine (Jiao et al., 2010). Protection 
was also conferred to vaccinated Atlantic salmon challenged with T. maritimum 
(van Gelderen et al., 2009). Encapsulation of antigens (vis a vis oil-based adjuvants) 
has been shown to improve the depot effect of Signal 1 adjuvants and results in 
lower antigen doses required in vaccine formulations (Tafalla et al., 2014).  
Signal 2 adjuvants boost the immune response to enhance the establishment of 
protection and can include inflammatory cytokines and DAMPs. These are 
recognised by innate receptors such as TLRs that in turn activate Th responses. 
The most commonly used adjuvants for fish are aluminium-containing, β-glucans 
and Poly I:C (Dalmo et al., 2016). 
Aluminium compounds induce Th2 responses and promote protective humoral 
immunity and lead to a depot effect which is beneficial for long-term immunity. 
This may not be sufficient however, if cellular immunity is required. Furthermore, 
potential side effects include melanisation and organ adhesions resulting in 
degraded flesh quality at slaughter (Dalmo et al., 2016; Tafalla et al., 2014). When 
tested in Atlantic salmon vaccines against disease caused by A. salmonicida, 
protection was conferred, however not significantly (Mulvey et al., 1995). 
Conversely, when tested together with inactivated E. coli in a catfish E. ictaluri 
vaccine, significant protection was achieved (Tyler & Klesius, 1994). 
The effect from β-glucans is dose dependent and short-lived, but may result in 
increased innate immune responses via a C-type lectin receptor and can provide a 
degree of protection (Petit & Wiegertjes, 2016). Poly I:C induces type 1 IFNs 




haemorrhagic septicemia (VHS) in Japanese flounder, good protection was 
conferred (Kim et al., 2009; Takami et al., 2010). Cytokines are potential adjuvants 
for fish vaccines though few have been explored (Dalmo et al., 2016; Tafalla et al., 
2014). IL-8 has been shown to modulate early immune responses in rainbow trout 
against VHS (Jimenez et al., 2006). 
Replicating vaccines 
These vaccines can consist of either live attenuated bacteria, or bacterial/viral 
vectors carrying genes encoding for and expressing the antigen of interest. An 
extensive knowledge of the molecular biology of the pathogen is required to ensure 
its attenuation. Live attenuated vaccines carry some of the highest risks due to 
potential impacts from virulence reversion, effect in non-target species, spread in 
the environment, persistence in the vaccinated organism, and high documentation 
costs (Knappskog et al., 2014).  However, recent advances have been made where 
reverse genetics can be used to attenuate the pathogen, greatly reducing the risk 
of reversion of virulence. On the other hand, this makes the pathogen a genetically 
modified organism, so legislation surrounding the production and use of the 
vaccine is stricter. They also require very specific storage conditions as the vaccine 
requires cold temperatures for stability. Despite this, live vaccines are generally 
efficacious and require a 1000-fold lower dose than inactivated vaccines. As 
adjuvants are not required, the administration of these vaccines is much more 
straightforward, and they have been successful in inducing both humoral and 
cellular immunity. The drawback with vector vaccines is that an immune response 
will be generated against the vector, and any pre-existing antibodies against such 
vectors may counteract the usefulness of the vaccine itself. Live attenuated 
vaccines for use in farmed fish include those against disease caused by 
Renibacterium salmoninarum, E. ictaluri, F. columnare, and Piscirickettsia salmonis, 
as well as a replicon vaccine based on the salmonid alphavirus (SAV) genome that 
provided protection against ISA in salmon (Aas-Eng, 2016; Knappskog et al., 2014; 




Inactivated vaccines  
Whole cell vaccines have historically been preferred for safety reasons as they do 
not cause or spread disease. Bacteria are harvested at late exponential growth 
phase, then inactivated by physical (temperature, radiation) or chemical 
(formaldehyde) methods. At low concentrations, formaldehyde maintains the 
immunogenicity of the bacterin. Additionally, in order to confer effective protective 
immunity, adjuvants are required along with the inactivated bacterin to prime the 
immune system, as the bacterins alone often do not generate strong enough 
responses, despite being immunogenic. 
Rønneseth et al. (2015) vaccinated lumpsuckers with inactivated bacterin vaccines 
containing two strains of atypical A. salmonicida, P. atlantica, V. anguillarum and V. 
ordalii, and found that for each pathogen except the latter, specific antibodies were 
generated at high levels. A commercially available vaccine against vibriosis (V. 
anguillarum serotypes O1 and O2a) similarly appears to result in protective 
immunity in lumpsuckers. Protection following vaccination against other 
pathogens is not always achieved, however, since difficulties may arise, for 
example due to antigen heterogeneity among different isolates- as is the case for 
atypical A. salmonicida, or due to challenges such as cultivation of the bacterium, in 
the case for P. atlantica.  
Subunit vaccines 
Subunit vaccines are also considered to be inactivated vaccines and can be 
produced either directly or indirectly. The direct method is not commonly used 
and involves purification of the antigen directly from the bacteria in culture. For 
the indirect method, the antigen is produced in a heterologous expression system, 
commonly E. coli or Saccharomyces cerevisiae. Here, the sequence  encoding the 
antigen is inserted in plasmids and introduced into the expression system which is 
cultured, and the antigens purified following harvest of the expression system at 
the end of the production cycle (Knappskog et al., 2014). An example of such 




in Chile. Overall, these vaccines can be safer to use than live attenuated or 
inactivated bacterin vaccines and have the additional advantage of containing a 
selection of highly immunogenic antigens in the vaccine formulation. This method 
is also preferable over the purification of antigens directly from bacterial culture 
as the antigen can degrade during purification (Wizemann et al., 1999).  
The choice of plasmid relies on the ability to produce large quantities of 
immunogen in vitro, the ease of manipulation and the ability to express the 
quaternary structure of the protein. However, despite stimulating both humoral 
and cellular immune systems, subunit vaccines have been associated with low 
protective immunity, thus typically require high doses or booster doses, and the 
addition of adjuvants to boost immune responses (Biering & Salonius, 2014).  
Nucleic acid vaccines  
DNA and mRNA vaccines rely on genes encoding protective antigens rather than 
the antigens themselves. In the case of DNA vaccines, the coding sequence are 
present in bacterial plasmids and provided to the host by IM injection. The 
constructs within the plasmid additionally contain a suitable promoter that ensure 
gene expression in the fish.  
mRNA vaccines are designed to facilitate the short-term translation and 
production of the antigen in the host and consist of the mRNA sequence for the 
protein required, along with additional sequences necessary for correct translation 
of the protein.  
Through IM injection of DNA vaccines, the plasmids are introduced into myocytes 
and dendritic cells and expression of the protein will persist in the cells, whereas 
for mRNA vaccines the protein is translated directly from the mRNA sequence 
presented, which will subsequently be degraded. The goal in either method is for 
antigens to be exhibited by MHC class I and class II, which induces Th and Tc cells 
in addition to antibody production (Adams, 2019). This makes them effective 




vaccines as the risk associated with genomic integration is eliminated (Evensen, 
2016; Knappskog et al., 2014). 
Development of nucleic acid vaccines is much faster compared to traditional 
inactivated bacterin vaccines, as the only requirement is the gene sequence of the 
vaccine target. Additionally, this ease of development also facilitates the 
development of multivalent vaccines (Biering & Salonius, 2014). Production of the 
plasmids is straightforward, and storage and transport are simpler than for other 
vaccine formulations since plasmids are more stable. Furthermore, the need for 
adjuvants added to the vaccine is eliminated as the constructs can include 
sequences which replicate adjuvant effects: namely those which increase the 
potency of the vaccine or to improve delivery and uptake of the antigen genes. 
Additionally, the associated side effects, notably peritonitis, are eliminated 
(Biering & Salonius, 2014).  
Biosecurity is higher in nucleic acid vaccines compared to other methods. There 
are also no risks or impacts from the pathogen such as reversion of virulence or 
incomplete inactivation. Despite the risk of potential integration of the construct 
in the vaccine into the genome, this is approximately 40 times less likely to happen 
than spontaneous mutation. Moreover, the risk of these constructs being passed on 
to the consumer is therefore smaller, practically negligible. However, one notable 
disadvantage is high variability between pathogens in terms of efficacy or stability 
of the translated protein, and only two commercial DNA vaccines are available for 
fish: against IHN and PD in Atlantic salmon (Biering & Salonius, 2014; Dalmo, 
2018). 
Autogenous vaccines produced by commercial companies under controlled 
conditions are authorised to be used when available commercial vaccines do not 
offer protective immunity against a field strain, or when no commercial vaccines 
are available due to emerging pathogens or strains of pathogens causing 
outbreaks- such as the increasing outbreaks of pasteurellosis in Norway. Such 




protection may not be comparable between different strains (Evensen, 2014; 
Knappskog et al., 2014).  
Measures of efficacy  
One method of measuring the efficacy of a vaccine is the relative percent survival 
(RPS). However, it is not an adequate measure for diseases that do not result in 
mortalities. Such diseases require alternatives such as the determination of the 
specific mechanisms of protective immunity induced by vaccination. Correlates of 
protection are biomarkers that serve as thresholds at which a vaccine is deemed 
to be protective and include antibody production and antigen dose threshold. The 
antibody titre can be used as an indicator of the level of protective immunity 
conferred by the vaccine, although this only holds true if the antibodies produced 
are neutralising or opsonising in nature. As antibodies can be produced that bind 
to non-immunogenic antigens, the absolute titre may not be accurate in 
determining the efficacy of a vaccine. Additionally, by increasing the antigen dose 
in a vaccine until the antibody titre reaches a plateau, a threshold for protective 
immunity can also be derived (Munang’andu et al., 2014).  
Improving the ethics and sustainability of vaccine development  
Using experimental challenges to test vaccine development presents an ethical 
issue with regards to fish welfare, although challenges are currently the only 
possible route for fish vaccine development in most cases. Possible alternatives 
include in vitro serological tests, such as ELISA. However as explained above, these 
have practical limitations which need to be overcome in the development stage. An 
amelioration of experimental challenges would be to introduce early humane 
endpoints which replace death as an endpoint, in order to reduce the impact on 
experimental fish welfare. Experiments involving fish are strictly regulated by the 
European Union (EU Experimental Animals Directive 2010/63/EU; EU, 2010) and 
Norwegian legislation (Regulation concerning the use of animals in experiments; 




the experimental design. This is to ensure that fish welfare is maintained to the 
highest standard possible. 
Batch potency or efficacy tests are required for each vaccine batch release to 
ensure consistency and high quality of the vaccine produced and are typically 
based on challenge experiments or serology tests. Such tests must comply with 
established and published protocols when these are available for the vaccine and 
are set by the European Pharmacopeia. At present, protocols are only available for 
vaccines against furunculosis, cold water vibriosis and classical vibriosis. As most 
vaccines are multivalent or contain multiple serotypes of a pathogen, challenge 
models may not be practically adequate to test for all antigens present (van Hulten, 
2016).  
If serological tests (in vitro), such as ELISA can be developed and validated to show 
good correlation between antibody response and protection, then this will initially 
refine, and eventually replace, challenges (in vivo) when testing vaccine efficacy. 
This decreases the number of animals use, improving animal welfare, and can also 
be used to distinguish any sub-standard batches (Figa Bosch, 2016). Effects from 
variations in disease development present in challenge models are not 
encountered in serological tests, making them more robust, and multivalent 
vaccines can be studied more adequately (van Hulten, 2016).  
In vitro tests are not without their issues, however. Serological tests require 
extensive optimisation and refinement, to ensure standardised and consistent 
results across different labs, individual fish, batches, and vaccines. Adjuvants 
present in the vaccine may influence serology, and the effect on the immune 
response resulting from them cannot be distinguished from the antigen-induced 
effect. There is therefore a need for separate evaluation methods. DNA and mRNA 
vaccines have more potential options regarding flexibility of testing: as there are 
no adjuvants, antigen DNA/mRNA can be quantified directly, and functionality can 




2.  Aims of the study 
The main purpose of this work was to investigate the pathogenicity of P. atlantica 
in Norwegian lumpsuckers, develop and test the efficacy of vaccines and to study 
the related immune responses. Specifically, the aims of this project were: 
• To establish optimal growth conditions of P. atlantica in liquid medium.  
• To establish a replicable challenge model that can be used to investigate 
disease progression in lumpsuckers, as well as testing vaccine efficacy. 
• To develop R&D vaccines against pasteurellosis and examine the resulting 
immune responses post-vaccination, and protection upon challenge. 
• To carry out phylogenomic and gene expression analyses to determine the 
taxonomic status of P. atlantica and identify virulence factors that may serve 




3.  Major findings of the project 
• Cultures of P. atlantica were established in liquid medium, with peak growth 
of approximately 1.5x109 cells mL-1 obtained at 18-19 hours incubation 
(Paper 1). 
• A bath challenge model was identified as the most adequate to study disease 
progression and vaccine testing in lumpsuckers (Paper 1). 
• Koch’s postulates were fulfilled for P. atlantica upon re-isolation of bacteria 
following challenge (Paper 1). 
• Characteristic gross pathology of pasteurellosis in lumpsuckers is white 
spots over the entire skin, especially around the eyes (Paper 1). 
• Fish surviving challenge can be carriers of the bacteria, thus re-emergence 
of disease cannot be excluded (Paper 1). 
• Vaccination using whole cell formaldehyde-inactivated bacterins resulted in 
high levels of specific antibodies (Paper 2). 
• Vaccination with inactivated bacterins conferred some protection 
(approximately 40%) against pasteurellosis upon experimental challenge 
(Paper 2). 
• An uncharacterised putative adhesin protein (named <Hia> in this project) 
was identified in the P. atlantica genome as a potential vaccine target (Paper 
3).  
• Gene expression analysis showed that the gene encoding the putative 
adhesin is upregulated significantly when bacterial cells are exposed to 
lumpsucker head kidney leucocytes, which may indicate regulation by 
leucocyte activities (Paper 3). 
• Comparative phylogenomics resulted in its distinct taxonomic position as a 
novel species of the Pasteurellaceae family with the suggested name of P. 




4.  Methodological considerations 
Paper 1: 
• 16S rRNA sequencing for differentiation of fish pathogenic Pasteurella: 16S 
rRNA sequencing was used in combination with growth characteristics to 
confirm the identity of the Pasteurella sp. isolate collected from Norwegian 
lumpsuckers to be used for this work. 
• Challenge models: Injection, cohabitation and bath challenge models were 
tested, to determine which model would result in the most accurate 
depiction of the pathogenesis of pasteurellosis in lumpsuckers, and which 
subsequently can be used for vaccine testing. Experimental fish were 
screened and found to be pathogen free and were monitored closely 
throughout the duration of the study to ensure that fish welfare was 
maintained. 
• Challenge doses: The doses used were chosen based on previous work 
carried out by Rønneseth et al. (2014), and bacterial numbers were verified 
by CASY cell counts and counting of colony forming units from titrations of 
the challenge material. The aim was to establish different levels of 
mortalities, ranging from high to low, to better understand the progression 
and pathogenicity of P. atlantica and find an optimal dose for vaccine testing.  
• qPCR: The protocol enabling quantification of bacterial load in the 
challenged fish was adapted from that established by Gulla et al. (2016b). 
While it cannot be guaranteed that the bacterial load detected by qPCR 
indicates live bacteria, the survivors from challenges were analysed after 
three consecutive days of no mortalities and swabs from the head kidney 
were streaked onto blood agar where P. atlantica was successfully grown. It 
is for this reason that inferences were made regarding carrier status of the 
challenge survivors. SYBR-green assay for the sodA gene from P. atlantica, 





• Vaccines: Whole cell inactivated vaccines were preferred at this stage both 
for ease of production as well as being the most straightforward type of 
vaccine, when taking into consideration that no work had been done on 
vaccination of lumpsuckers against pasteurellosis. The two doses 
considered were formulated, with adjuvant from PHARMAQ, to investigate 
the effect of the presence or absence of extracellular proteins (based on the 
inclusion or exclusion of bacterial supernatant in the final vaccine 
formulation) on the degree of protection conferred, if at all. 
• Enzyme-linked immunosorbent assay (ELISA): ELISA was used as the most 
sensitive technique to measure the antibody levels generated following 
vaccination. The reasons for choosing ELISA were two-fold: to determine 
that a specific antibody response was in fact generated, and to confirm that 
the 500°D timeline for a sufficient antibody level prior to challenge was 
adequate in this study. 
• SDS-PAGE and Western blotting: The high resolution of separated proteins 
obtained by SDS-PAGE allow for clear analysis of proteins which may be 
identified as immunogenic through Western blotting. Western blotting 
provides insight into which proteins sera from immunised fish are reacting 
to, and to what degree. It may also indicate the level of immunogenicity of 
the proteins present. A shortcoming of this method is that glycosylated 
antigens would not be transferred to the membrane, thus any such 
immunogens may be missed.  
• Bath challenge doses: The bacterial doses used for this challenge were based 
on results from Paper 1, and the range of bacterial concentration for the 
doses was chosen to determine the limits at which the vaccines would be 
protective, if at all. The time point for challenge was chosen to be 500D 
post-vaccination, following established procedures from literature 




• Head kidney leucocyte (HKL) exposure to bacteria: The number of bacteria 
and leucocytes were chosen to ensure sufficient amounts of each, to allow 
interactions between the host and pathogen to be followed. The timings of 
the challenge were such to allow the infection process to be followed from 
the earliest point of bacteria interacting with leucocytes until establishment 
of infection. Visualisation of the bacteria was performed by using a rabbit 
anti-Pasteurella antibody for immunofluorescence analysis.  
Paper 3: 
• Illumina and PacBio sequencing: Two sequencing methods were used as 
these methods complement each other.  Illumina sequencing provides short 
reads of the genome with high accuracy and PacBio sequencing provides 
longer reads with slightly lower accuracy. Taken together, both methods 
provide a clear overall picture of the P. atlantica genome. 
• Phylogenomics: Whole genome phylogenetic analysis provided insights to 
the phylogenetic positioning of P. atlantica within the Pasteurellaceae. 
• Virulence factors: The proteome of P. atlantica was screened against major 
virulence factor databases in order to identify virulence factors, including 
their localisation within the bacterial cell, their secretion systems, and 
structural properties. The strongest candidates were then selected and 
analysed for use as vaccine targets. 
• Identification of vaccine targets: Vaxign and VaxiJen were used to predict the 
vaccine targets based on characteristics that are known to be highly 
immunogenic, such as adhesion potential. 
• In vitro work: The gene expression analysis on leucocytes exposed to P. 
atlantica were designed to investigate whether the gene for the putative 
vaccine target adhesin was expressed only in the presence of host cells, or 
whether it was also expressed in bacteria during growth, which would 




5.  Discussion 
In this study, the pathogenicity of P. atlantica was investigated in Norwegian 
lumpsuckers through development of appropriate challenge models and vaccine 
testing. Vaccination of lumpsuckers with inactivated P. atlantica bacterins 
provided only limited protection against disease following experimental challenge 
despite high antibody levels, indicating that cellular immunity and use of strongly 
immunogenic antigens should be targeted for effective protection. In the first two 
papers, the Pasteurella isolate used in this study was not yet classified and referred 
to as Pasteurella sp. In Paper 3, through phylogenomic analysis, the taxonomic 
position of the bacteria was identified, and the bacteria was named P. atlantica. 
Furthermore, an uncharacterised putative adhesin was identified as a potential 
vaccine target for use in vaccine development through RV. In vitro investigations 
on the interactions between P. atlantica and lumpsucker head kidney leucocytes 
showed that bacteria tend to form chains and attach to the surface of the 
leucocytes, and expression of the adhesin increased significantly in the presence of 
leucocytes. 
Defining the taxonomic position of Pasteurella atlantica 
At the beginning of this project, it was unclear where P. atlantica belonged within 
the Pasteurellaceae family. Through phylogenomic analysis (Paper 3), the distinct 
taxonomic position of the bacteria was determined, and it clustered with Ph. uteri 
and P. skyensis, lying closer to the latter than the former. Phylogenetic analysis 
carried out by Alarcón et al. (2016) of various isolates collected from outbreaks of 
pasteurellosis in Norway, showed that P. atlantica was found to be genetically 
distinct from the related species P. skyensis.  
Until 2020, P. skyensis had not been recorded in Norway. The Norwegian 
Veterinary Institute has since then confirmed two outbreaks of disease caused by 
P. skyensis in Norwegian farmed Atlantic salmon (Nilsen et al., 2021). Additionally, 
since Spring 2018, a new type of Pasteurella has been recovered from several 




including cases involving Atlantic salmon in monoculture and cohabiting salmon 
and lumpsuckers (Nilsen et al., 2021).  
Although the route of transmission of the new salmon Pasteurella strain between 
cohabiting salmon and lumpsuckers is still unclear, a study by Sandlund et al. 
(2021) indicated that lumpsuckers are also susceptible to this new strain isolated 
from salmon. Furthermore, knowing the taxonomic position of the pathogen is 
useful to identify similarities between P. atlantica and other members of the 
Pasteurellaceae. In the case of a newly discovered pathogen, this will provide a 
starting point for investigations into prevention and treatment both in hatcheries 
and especially in the field.  
Pasteurellosis as a novel disease in Norwegian lumpsuckers 
As a bacterial disease, pasteurellosis in farmed lumpsuckers is a relative 
newcomer, with the first cases recorded around 10 years ago (Johansen, 2013). As 
it was such a new species, Koch’s postulates were at the time unfulfilled. The 
challenges concerning culturing of P. atlantica in broth, due to the requirement of 
foetal calf serum supplementation, additionally complicated studies to investigate 
the disease, which translated to delayed vaccine development.   
The first step, therefore, was to establish growth of P. atlantica in liquid medium. 
It was already known that the bacteria could be isolated and grown on marine 
blood agar (Alarcón et al., 2016), but large volumes of bacteria would be required 
for extensive studies, as well as in industrial settings. We tested two different broth 
compositions, and tryptic soy broth supplemented with foetal calf serum was the 
most straightforward composition that enhanced bacterial growth in a timely 
manner (Paper 1). Peak exponential growth of bacteria of approximately 1.5x109 
cells mL-1 was reached after 18h of incubation at 20°C. The ability to grow P. 
atlantica in liquid medium and obtain relatively high cell numbers per mL was an 
important step forward towards understanding the disease, investigating 




Development of a challenge model to study pathogenicity of P. atlantica and 
test vaccine efficacy 
A variety of challenge models were tested and evaluated to follow the progress of 
pasteurellosis and mortality in lumpsuckers (Paper 1). Models based on injection 
of the pathogen (IM and IP) resulted in highly acute mortalities within a very short 
timeframe, highlighting the toxicity of P. atlantica. Similarly, as the cohabitation 
model relied on IP injected shedders, it is likely, although not confirmed, that only 
low numbers of bacteria were available to infect the naïve cohabitant fish. These 
models were therefore considered unsuitable for further work. The bath challenge 
model however, resulted in a more stable and gradual mortality pattern, although 
deaths still rose to almost 100% across the dose range used. Having such results 
from this model was promising, in the process of investigating disease progression 
and for vaccine efficacy testing. Bath models are a close replication of a natural 
infection route, as pathogens infect the fish orally and through mucus membranes 
and no natural defence barriers are artificially breached to aid the infection 
process. Several studies have employed bath challenges to monitor disease caused 
by problematic fish pathogens, including Y. ruckeri (Ohtani et al., 2019), SAV 
(Jarungsriapisit et al., 2016), V. anguillarum (Gudmundsdóttir & Björnsdóttir, 
2007), and atypical A. salmonicida (Rønneseth et al., 2017). 
As P. atlantica was re-isolated from the challenged fish, the criteria required to 
fulfil Koch’s postulates were met (Paper 1). The pathognomonic symptom of 
disease was the appearance of white spots over the skin and around the eyes in the 
bath challenged fish. Inflammation and haemorrhage at the base of the jaw and fins 
were observed in both bath and cohabitation challenges, although these symptoms 
are not unique to P. atlantica infections. In fact, Scholz et al. (2018) noted that these 
latter symptoms may be confounded with those resulting from an atypical A. 
salmonicida infection in lumpsuckers, and recommended molecular tests for 
diagnostic confirmation. The occurrence of symptoms from the cohabitant fish is 
still noteworthy, as despite the acute mortalities amongst shedders (and potential 




cohabitants, significant symptoms of disease were still observed. No symptoms 
specific to the disease were recorded from the IP and IM injection challenges, 
mostly due to the acute mortalities. However, severe tissue damage was recorded 
at the injection point, highlighting the toxicity of P. atlantica. Similar symptoms 
(white spots, inflammation, and haemorrhage) were also observed following bath 
challenge of vaccinated fish (Paper 2), with the addition of frayed tail fins. The 
latter symptoms were also reported by (Alarcón et al., 2016) as occurring during a 
natural outbreak of pasteurellosis in lumpsuckers. Interestingly, the cohabitation 
model results in symptoms typically observed in chronic infections, while the bath 
model exemplifies symptoms of acute stages of pasteurellosis.  
The remaining survivors from the cohabitation and bath challenges were shown 
by qPCR to be asymptomatic carriers of P. atlantica, several days after mortalities 
ceased. The lower level of bacteria in the cohabitation survivors compared to the 
bath survivors is likely due to the lower concentration, or slower replication, of 
bacteria available from the shedders, although there was no significant difference 
in bacterial levels from the survivors of the two challenges. Other fish pathogens 
with known ability to induce latent infections include Y. ruckeri (in rainbow trout) 
and E. ictaluri (in channel catfish), which both result in re-emergence of disease in 
the surviving fish following the introduction of a stressor (Antonio & Hedrick, 
1994; Busch & Lingg, 1975; Hunter et al., 1980). This has serious implications for 
the fish farming industry, as the re-emergence of disease following a stress episode 
cannot be ruled out (Paper 1). The carrier state of lumpsuckers following 
pasteurellosis outbreaks has also been reported from industrial settings, where the 
disease re-emerged following outbreaks where the fish had been treated by 
antibiotics (Alarcón et al., 2016). This highlights an additional issue, that antibiotic 
treatments for lumpsuckers are not yet optimised at a commercial level to provide 
an adequate treatment regime in the face of this disease. Despite this, Kverme et al. 
(2021 [manuscript submitted]) show that florfenicol is efficient against 
pasteurellosis, at least after experimental challenge. These results highlight the 




of outbreaks. Overall, this initial work served to emphasise the pathogenicity of the 
bacteria, even at different challenge doses, and its persistence in surviving fish, and 
indicates the rapid need for vaccine development. 
Despite the high pathogenicity of P. atlantica, transmission of disease is not always 
straightforward. In cases recorded in the field from Atlantic salmon, outbreaks of 
pasteurellosis typically occur in situations where a prior stress event has taken 
place, such as lice treatments and sea transfers. This could also be the case for 
outbreaks recorded from lumpsuckers. Since these are housed with salmon and 
exposed to the same stressors, it is plausible that the increased stress or 
suboptimal conditions in this environment would lead to decreased immune 
fitness making lumpsuckers more susceptible to pasteurellosis. Experimental 
infections, due to their controlled nature may not always result in disease, as 
reported by Sandlund et al. (2021). In this study, the authors carried out an 
experimental cross-infection of Atlantic salmon by lumpsuckers through a 
cohabitation challenge model, where the lumpsucker shedders were infected using 
the bath model described in Paper 1 using P. atlantica and a recently identified 
salmon strain of Pasteurella. While the lumpsucker “shedders” were infected 
successfully with both Pasteurella isolates, the naïve salmon were not, as 
evidenced by qPCR, which might support stress theory.  
Vaccine efficacy and adaptive immune responses in lumpsuckers 
challenged with P. atlantica  
The next step was to evaluate the adaptive immune responses mounted by 
lumpsuckers on exposure to P. atlantica (Paper 2). Accordingly, two formalin-
inactivated whole cell vaccines were formulated, one containing supernatant from 
the culture medium, and one with 90% of the supernatant removed, resulting in an 
approximate 10x bacterin concentration (termed concentrated). Both vaccines 
resulted in P. atlantica specific antibodies at levels comparable to those recorded 
in literature for other bacterial pathogens (Rønneseth et al., 2015), following triple 
immunisation of lumpsuckers. The ‘concentrated’ vaccine also resulted in 




is likely due to the final higher concentration of bacterial cells present per mL in 
the concentrated vaccine. 
Despite the high levels of antibodies, these were only slightly protective in nature 
and the RPS post-challenge was around 40% in the vaccinated groups. 
Furthermore, the higher antibody level resulting from the concentrated vaccine 
was not reflected in increased protection levels. Småge et al, (2018) reported 
similar results in a study of Atlantic salmon vaccinated and challenged with 
Tenacibaculum finnmarkense.  
Such results draw attention to the shortcomings of in vitro methods used to 
measure correlates of protection for some bacterial pathogens. While ELISA is a 
useful technique to measure antibody levels following vaccination, it cannot 
always be used as a standalone procedure. This is because it does not specifically 
detect neutralising or protective antibodies unless a ‘neutralising’ antigen is used 
in the test. Non-neutralising antibodies can be present in high levels, but are not 
involved in protective immunity and therefore do not correlate with protection 
(Plotkin, 2008).  
In order for vaccines to provide protective immunity, they need to elicit the 
production of opsonising or neutralising antibodies, which in turn lead to cellular 
and humoral immune responses, including complement degradation. In the 
process of vaccine development, a number of aspects must be taken into 
consideration to develop effective vaccines.  
Initially, having a robust challenge model is crucial to establish reliable endpoints 
for determining vaccine efficacy. Subsequently, knowing measures of vaccine 
efficacy will allow for improved understanding of the immune processes involved. 
Briefly, such measures can include prevention of adherence, prevention of 
infection following penetration, prevention of distribution within the host, 
prevention of pathogen loading, and prevention of pathology in target tissues 




involve their measurement in vitro and determining whether they are correlates of 
protection.   
In the case of prevention of adherence and distribution of the pathogen, mucosal 
and neutralising antibodies, respectively, can prevent adherence to mucosal 
surfaces and eventual systemic dispersal, including in intracellular locations. In 
both cases, high antibody levels can correlate with protection, and the absence of 
pathogen in host tissues or cells is a measure of efficacy of the vaccine. Vaccines 
can also be targeted to suppress replication in target organs, thus limiting the 
spread of the pathogen, and a suppressed pathogen load is a measure of efficacy 
(Munang’andu & Evensen, 2019). Crucially, antibody levels become correlates of 
protection if they are able to exceed a threshold at which they confer protective 
immunity. 
Various studies in salmonids have successfully determined abilities of specific 
antibodies to eliminate pathogens and protect through antibody-mediated 
opsonophagocytosis (Lamas & Ellis, 1994; Michel et al., 1990; Nikoskelainen et al., 
2007; Sakai, 1984). Specifically, the antibodies activated the complement system 
which in turn also enhanced the phagocytic ability of macrophages and neutrophils 
and this activity could be quantified by measurement of respiratory burst activity 
(Nikoskelainen et al., 2007). Opsonising antibodies can therefore be considered a 
suitable correlate of protection.  
However, it is worth noting that a number of facultative intracellular fish bacterial 
pathogens such as E. tarda, P. salmonis, Y. ruckeri, Francisella noatunensis, and R. 
salmoninarum (as reviewed by Munang’andu, 2018) are able to evade respiratory 
burst activity and survive in macrophages. For that reason, other correlates may 
be more suitable for the determination of protective immunity against these 
pathogens.  
As cellular immunity is involved in protection against intracellular pathogens, a 
theoretical stance would be to investigate whether T cell responses correlate with 




(Straumsnes, 2018), indicative of Th and Tc cells, as well as different subtypes of 
Th cells (Nelsson & Haugland, 2020; unpublished data). However, the 
quantification and duration of protection awarded by these cells has not been 
established to date, and no studies have correlated these responses with 
protection. Despite the drawbacks, alternatives are possible. Nucleic acid and 
attenuated vaccines still induce antibody production, and although these vaccines 
primarily target cellular immune responses, the antibody levels produced can be 
used as surrogates or proxies of protection as they can still be reliably used to 
predict efficacy of vaccines (Munang’andu & Evensen, 2019; Plotkin, 2008). A 
number of studies have employed this mechanism and related the upregulation of 
cellular immune genes with antibody levels generated following vaccination which 
was then correlated with protective immunity in rainbow trout against IHN and 
VHS, and in Japanese flounder against VHS (Kim et al., 2000; McLauchlan et al., 
2003; Yong Byon et al., 2005). 
Sera from the vaccinated lumpsuckers analysed by immunoblotting at 500°D post-
vaccination reacted to only few P. atlantica proteins separated by SDS-PAGE, 
specifically: high molecular weight proteins at approximately 75kDa and 100kDa 
as well as proteins at 48kDa and 15kDa. These reactions were similar to, although 
less pronounced, than those observed in lumpsuckers vaccinated three times 
against P. atlantica which reacted to additional bands of mid-range molecular 
weight. This limited reactivity may indicate that the antibodies generated 
following vaccination were not directed towards easily accessible cell wall-
integrated antigens, thus partly explaining the limited protection conferred.  
It is also possible that potentially antigenic components did not transfer to the 
immunoblot due to glycosylation of proteins. Antibodies reactive to such antigens 
would have to be detected by other techniques (Wood & Kaattari, 1996). Among 
such methods is the microarray technique, where antigens (either purified or from 
inactivated whole bacterins) are covalently bound to silica or glass plate chips and 
immunofluorescent methods are then used to detect the specific antibody-antigen 




reactive bands resulting from the triple immunised lumpsuckers were visible, it is 
also possible that vaccination boosts or different adjuvants might be required to 
generate an appropriate response. Agglutination tests were also carried out, and 
live P. atlantica was agglutinated by lumpsucker immune sera. This could indicate 
that binding to bacterial surface components such as capsule or loosely associated 
carbohydrates may occur. 
P. atlantica: intracellular or extracellular pathogen?  
A closer look at the interactions between P. atlantica and lumpsucker HKLs 
revealed two potential infection routes: intracellular or extracellular. Confocal and 
transmission electron photomicrographs showed P. atlantica likely were present 
intracellularly within HKL. At early stages of leucocyte infection, the bacteria were 
observed as individual entities while after 24h, bacteria had aggregated into chains 
and were attached to the surface of leucocytes. Such bacterial aggregations were 
also observed in histopathological images of tissues (heart, spleen and head 
kidney) from experimentally challenged lumpsuckers (Paper 1).  
Similarities in host-pathogen interactions as those observed between P. atlantica 
and lumpsucker leucocytes have been noted for other pathogens such as 
uropathogenic E. coli. These bacteria are known to form aggregates which enable 
the ‘microcolony’ to evade the host immune system physically, rather than by 
regulating host immune responses (Justice et al., 2004). The large size of such 
aggregates confers protection and enhanced survivability of the pathogen, as 
despite any protective responses raised against the pathogen, phagocytosis would 
not be possible. This in turn leads to impaired antibody functionality and 
suboptimal bacterial clearance and is a potential explanation for the limited 
protection conferred to lumpsuckers by the vaccines tested in this work (Paper 2). 
The observations of P. atlantica possibly present inside lumpsucker HKLs 
highlighted two avenues for further work. If P. atlantica is a facultative intracellular 
pathogen, further work should focus on stimulating cellular immunity to confer 




cells infected with intracellular pathogens. On the other hand, the agglutination 
results indicated that cell surface proteins may be involved in disease 
transmission, as immune sera agglutinated live P. atlantica, and this would require 
genomic analysis to identify potential virulence factors. 
In silico identification of virulence factors and gene expression analysis of a 
potential vaccine target 
In the final part of the project the genome of P. atlantica was sequenced to establish 
its taxonomic position within the Pasteurellaceae and to enable in silico 
identification of putative virulence factors and immunogenic components that 
would be suitable as potential vaccine targets by using the principles of RV. 
Functional analyses were subsequently carried out to investigate in vitro the 
expression of the vaccine target with highest adhesion potential (Paper 3).  
Through the in silico analyses, it was found that the genome of P. atlantica contains 
11 genomic islands (GIs) and five prophages. Of the 17 identified virulence factors, 
five were found in GIs and/or prophages, and accounted for 10% of the total 
genome. RV was used to identify these virulence factors, and specific criteria were 
applied to narrow the list to identify those with the highest virulence potential and 
suitability as vaccine targets. The criteria for the bioinformatic analyses centred 
mainly around subcellular localisation of the protein and predicted adhesion 
functionality. From these analyses a putative uncharacterised protein with high 
adhesin probability ranked highest both as a putative virulence factor as well as a 
likely vaccine target, with an adhesin probability of 92.5% (Paper 3). The protein 
is very similar to the adhesins Hia and YadA, which are characteristic adhesins 
from H. influenzae and Yersinia species, respectively (El Tahir & Skurnik, 2001; St. 
Geme & Cutter, 2000).  
Adhesins are used by pathogenic bacteria to attach to host tissue surfaces, 
commonly by binding to lectins which enables colonisation, followed by 
aggregation and infection.  This underlines the observations made in previous 




as well as attach to HKLs. Aggregation may serve a protective function for the 
bacteria against host defences and could explain the limited protection conferred 
by the vaccines tested in this project (Paper 2).   
Gene expression analysis determined that <hia> expression is significantly 
upregulated (compared to the reference gene used, gyrA) both in the absence and 
presence of leucocytes and confirmed the in silico results, as a potential target for 
subunit protein antigen, mRNA, or DNA vaccine development. The expression of 
<hia> in the absence of host (lumpsucker) leucocytes correlates with increases in 
bacterial growth rates (Papers 1 and 3) and indicates that the adhesin is 
expressed during bacterial growth. Upon exposure of the bacteria to lumpsucker 
leucocytes (where bacterial growth is likely inhibited by the L-15 medium used for 
maintaining leucocyte functionality), expression of <hia> was significantly 
upregulated following an initial period of acclimation of 6 h post exposure, 
suggesting that the presence of leucocytes triggers the increased expression of 
adhesins, possibly due to cell adherence. 
Since most of the virulence factors listed in Paper 3 as the most promising vaccine 
candidates are as yet uncharacterised, it is difficult to predict their functionality. 
However, suggestions can be made based on the protein class they likely belong to. 
Three of the listed virulence factors are linked to haemolysins, with one (PfhB1) 
identified as a filamentous hemagglutinin protein which is a known P. multocida 
virulence factor involved in colonisation and adherence (Fuller et al., 2000).  
Potential alternatives to adhesins for consideration as vaccine targets include 
extracellular proteins, outer membrane proteins, and lipopolysaccharides. 
However, further work on annotation of the P. atlantica genome is initially 





Implications for vaccine development 
The collective results from this PhD project provide good foundation for further 
work on development of a vaccine against pasteurellosis in lumpsuckers.  
Currently, lumpsuckers are vaccinated using vaccines licenced under special 
exemption against atypical furunculosis (caused by atypical A. salmonicida) and 
vibriosis. However, due to limited protection conferred by some vaccines in 
particular situations, autogenous vaccines are also used to protect the fish against 
disease. These are formulated by commercial vaccine producers under strict 
guidelines by regulatory authorities when new pathogens or strains of pathogens 
are not covered by commercially available vaccines, or in the case of new fish 
species being farmed.  
Based on the results from the vaccination trial carried out in this project, bacterin-
based vaccines against P. atlantica may be unlikely to develop sufficient protection, 
showing the need for investigation into different vaccine formulations. Using the 
information obtained from our genomic and functional analyses, subunit vaccines 
can be developed and tested. These can be produced either by using a heterologous 
expression system or native protein can be purified directly from a P. atlantica 
liquid culture. This latter method might be possible as results (Paper 3) show high 
upregulation of the <hia> transcript at peak exponential growth phase. 
Alternatively, DNA or mRNA vaccines can be manufactured for a more reliable and 
cost effective vaccine.  
In either case, the antigen or antigen sequence used in the vaccine, the PAMP, will 
be recognised by host immune cells upon vaccination. Depending on whether a 
recombinant or nucleic acid vaccine was used, this may trigger different signalling 
pathways or phagocytosis that activate cytokine expression. In turn, this will 





Although subunit vaccines are often straightforward to produce, their efficacy can 
be lower than that of vaccines containing inactivated or live attenuated 
microorganisms, or nucleic acids from these pathogens. This could be due to 
various reasons, such as limited induction of a protective immune response, low 
antigen repertoire, lack of glycosylation, or issues with folding of the protein 
antigen used in the vaccine, if recombinantly produced. In the latter case, 
environmental cues or host responses may impact the natural expression of the 
adhesin, rendering it different from the recombinant antigen. Moreover, if allelic 
variations of the adhesin are present across or within isolates (Klemm & Schembri, 
2000) or if multiple adhesins are involved in adherence, this will impact vaccine 
efficacy, and hence, development.  
Despite the potential drawbacks with subunit vaccines, some of these issues can 
be counteracted by developing vaccines that use the conserved region of an 
adhesin (Ofek et al., 2003). In fact, recombinant protein production has been used 
to develop vaccines containing major adhesins as the protective immunogens, 
which successfully conferred protection to farmed fish against bacterial disease by 
V. anguillarum, V. harveyi, E. tarda, A. hydrophila, A. salmonicida subsp. salmonicida 
and Francisella orientalis (Fang et al., 2004; Hamod et al., 2012; Jin & Li, 2021; 
Khushiramani et al., 2012; Maiti et al., 2012; Marana et al., 2017; Shahin et al., 2020; 
Zhu et al., 2019).  
Due to their rather low immunogenicity, subunit vaccines require adjuvants to 
boost the immune response. On the other hand, nucleic acid vaccines are more 
favourable since they combine the advantages of live vaccines of antigen 
presentation, without the risk of reversion of virulence. Furthermore, they can 
overcome the issues related to incorrect folding and incomplete glycosylation 
encountered in subunit vaccines. They are also more versatile since cellular 
immune responses can be targeted more specifically and in the case of DNA 
vaccines, antigen multivalency can be achieved through the development of 




Additionally, coating DNA plasmids with compounds such as Poly (D, L-lactic-co-
glycolic acid), chitosan nanoparticles, or alginate microparticles for use as oral 
vaccines could provide a less stressful alternative administration route to IM 
injections for DNA vaccines (Adomako et al., 2012). The compounds protect the 
vaccine from degradation by stomach acid and proteases, and allow for improved 
uptake compared to traditional oral vaccines where vaccines are coated onto feed. 
Adomako et al. (2012) found that it was possible to coat an IHN DNA vaccine for 
rainbow trout in PGLA, which in turn indicated slightly improved survival 
following challenge, in preliminary tests. Furthermore, Ahmadivand et al. (2017) 
coated an IPN DNA vaccine, also for rainbow trout, in chitosan-based nanoparticles 
and alginate microparticles, and observed good protection (up to 70%) conferred 
from the vaccine following challenge. 
Despite the benefits, only two DNA vaccines have been licenced for use in farmed 
Atlantic salmon as yet, one against IHN in 2005 and one against PD (Biering & 
Salonius, 2014; Dalmo, 2018). A number of studies have investigated DNA 
vaccination of fish using adhesins or membrane associated proteins and conferred 
protection following vaccination and challenge, including FliC from E. tarda (Jiao 
et al., 2009), OmpK from Vibrio spp. (Xu et al., 2019), and Omp38 from V. 
anguillarum (Kumar et al., 2007). These results are promising evidence for further 
investigation of the P. atlantica adhesin protein identified in Paper 3 in terms of 
DNA/mRNA vaccine development. 
One drawback of DNA vaccines is that genomic integration remains a potential risk 
that leads to development of DNA vaccines being a highly scrutinised process by 
regulatory bodies (Biering & Salonius, 2014). For that reason, mRNA vaccines 
would be preferable, as following expression of the antigen, the mRNA sequence 
itself is degraded within a short period of time, minimising risks to the host and the 
environment.  
mRNA used in a vaccine acts as a template of the protein to be produced in the cell 




degraded. However, mRNA vaccines have been accompanied by a number of issues 
which have held back vaccine development, including instability and possible high 
immunogenicity which could lead to toxicity in the host. Improvements in the form 
of using modified nucleosides have stabilised the immunogenicity of mRNA (Liu, 
2019). Contrary to DNA vaccines, research into mRNA vaccines for fish is hard to 
come across. However, recent successful advances in mRNA vaccine development 
as observed for SARS-CoV-2 vaccines provide a promising foundation for future 
development of mRNA vaccines against fish diseases. 
Concluding remarks 
In the first phase of this project, the growth of P. atlantica was established in tryptic 
soy broth enriched with sodium chloride and foetal calf serum. This enabled a 
number of challenge models to be tested, and bath challenge was found to be the 
most adequate to investigate the disease progression and vaccine testing in 
lumpsuckers. These experiments also exposed an asymptomatic carrier status that 
occurs on exposure of the fish to the pathogen. 
Subsequently, R&D vaccines were then developed for lumpsuckers using formalin-
inactivated P. atlantica bacterins. Immune responses were measured post-
vaccination, and the level of protection conferred was evaluated post-challenge. 
Despite high P. atlantica-specific antibody levels present following vaccination, the 
vaccines did not confer satisfactory protective immunity against the pathogen, 
indicating that inactivated bacterin based vaccines may be insufficient. In vitro 
exposure of P. atlantica to head kidney leucocytes indicated the bacteria may 
potentially be facultatively intracellular and may auto-aggregate and adhere to 
host cells. In turn this indicated the possible involvement of adhesion-involved 
virulence factors. 
This was the first time the genome of P. atlantica was fully sequenced, through 
which the taxonomic position of P. atlantica within the Family Pasteurellaceae was 
established. Moreover, through this work, further research in RV will be facilitated. 




highest ranking protein (<Hia>) is still uncharacterised, however found to be 
similar to Hia from H. influenzae and YadA from Yersinia spp.. Gene expression 
analysis revealed that expression levels of <hia> in P. atlantica increased 
significantly both in bacteria in liquid culture as well as following exposure to 
lumpsucker leucocytes. This supports in silico analysis that <Hia> is a virulence 
factor, which is additionally triggered by the presence of and possible adherence 
to host immune cells. 
Future perspectives 
The work carried out in this project investigating pasteurellosis in Norwegian 
lumpsuckers is by no means exhaustive, and a number of avenues remain to be 
explored.  
Arguably the most important next step will be structural analysis of <Hia> and the 
development and testing in lumpsuckers of a recombinant protein or nucleic acid 
vaccine using this antigen. Elucidating the structure of the protein will ensure that 
the recombinant protein produced will be stable and contain relevant epitopes, 
which will increase the likelihood for an efficient vaccine. Moreover, in silico 
analysis will be further looked into to identify other potential vaccine candidates 
in addition to <Hia>. The generation of protective immunity in this species 
following vaccination will be an important step in the direction of tackling the 
pressing issues of cleaner fish welfare and sustainability.   
A recently identified salmon Pasteurella strain has been documented to cause 
disease in lumpsuckers both in the field as well as under experimental challenge 
(Nilsen et al., 2021; Sandlund et al., 2021), however outbreaks caused by other 
species in the same genus (such as P. skyensis) have not been recorded in 
lumpsuckers. Genomic analyses will need to be undertaken to predict differences 
in pathogenicity and the most important virulence factors involved in disease, 
across the various isolates/groups. Furthermore, work also needs to be done to 
determine whether the Hia-like protein identified in Paper 3 is also present in the 




pasteurellosis in Atlantic salmon and lumpsuckers. If <Hia> is not present in the 
different isolates, this can highlight the need to develop different vaccines to confer 
protective immunity in lumpsuckers and salmon. 
Genomic analyses carried out in this project have identified five intact and 
inducible prophages present in the genome of P. atlantica. Pangenomic analysis 
could be the way forward to investigate how widespread and conserved these 
genes are among the various field isolates of P. atlantica. This in turn will shed light 
on new, additional potential routes for the treatment of pasteurellosis, through the 
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Abstract
The incidence of disease caused by Pasteurella sp. in farmed lumpsuckers in Norway
has been steadily increasing in recent years, causing significant economic losses and
fish welfare issues. The disease affects all life stages, both in hatcheries and after
release into salmon cages. Therefore, it is important to establish robust challenge
models, to be used for vaccine development. Exposure experiments via intramuscu-
lar and intraperitoneal injection underlined the high virulence of the bacteria,
whereas the cohabitation and bath models allowed the chronic symptoms of the
disease to be studied more accurately. Skin lesions and haemorrhage at the base of
fins were observed in the more acute cases of the disease. Symptoms including
white spots over the skin, especially around the eyes, characterized the chronic
cases. The latter were most prominent from the bath challenge model. Histopathol-
ogy indicated a systemic pattern of disease, whereas qPCR analysis from head kid-
ney showed that bacteria may be present in survivor fish at the end of the
challenges. In all the challenge models investigated, Pasteurella sp. was re‐isolated
from the fish, thus fulfilling Koch's postulates. These findings highlight the impor-
tance of screening of lumpsuckers prior to transfer to minimize the risks of carrying
over asymptomatic carriers.
K E YWORD S
challenge, cleaner fish, infection, lumpfish, pasteurellosis, pathology
1 | INTRODUCTION
Prior to their recent introduction as cleaner fish, the biology and
immune system of lumpsuckers were not very well known or not
well studied. As is common with most fish species introduced in
aquaculture, bacterial diseases encountered during farming were
rapidly recognized. The mortality spikes seem to occur soon after
hatching, after vaccination procedures and often following transfer
to salmon cages (Johansen, 2013). So far, the most common bacterial
species identified from disease outbreaks include Vibrio anguillarum
(Marcos‐López, 2013), atypical Aeromonas salmonicida, Tenacibaculum
spp., Moritella viscosa, and a Pasteurella‐like isolate (Alarcón et al.,
2016; Bornø and Gulla, 2016; Rønneseth, Haugland, Colquhoun,
Brudal, & Wergeland, 2017).
The first confirmed outbreak of pasteurellosis caused by Pas-
teurella sp. in lumpsuckers was reported by the Norwegian Veteri-
nary Institute from a farm in southern Norway in 2012 (Johansen,
2013). Additional cases have since been reported from sites along
the western coast of Norway (Alarcón et al., 2016). Pasteurellosis
has also been recorded in production facilities where the affected
fish ranged from juveniles (6–8 g) to broodstock (340 g), as well as
in lumpsuckers deployed to salmon cages where disease occurred
within the first few weeks following transfer (Alarcón et al., 2016).
More recently, pasteurellosis was diagnosed in lumpsuckers from 14
Received: 26 June 2018 | Revised: 31 August 2018 | Accepted: 5 September 2018
DOI: 10.1111/jfd.12905
J Fish Dis. 2019;42:35–46. wileyonlinelibrary.com/journal/jfd © 2018 John Wiley & Sons Ltd | 35
different sites in 2015 (Bornø & Gulla, 2016). Pasteurella sp. has also
been detected several times in milt and eggs from lumpsuckers in
higher levels than are usually detected during regular tissue screen-
ings (Kui, 2017). This may suggest that vertical transmission of dis-
ease is theoretically possible.
Bacterial diseases in hatcheries are currently treated using antibi-
otics; however, there are no approved protocols available to provide
adequate treatment. Furthermore, in cases of outbreaks in sea cages,
treatment is not possible due to their cohabitation with Atlantic sal-
mon. Vaccine development against this disease is still in its infancy,
and Pasteurella sp. antigens are currently not included in commer-
cially available lumpsucker vaccines, due to lack of culture protocols
for this bacterium.
The Pasteurella sp. isolate from lumpsuckers in Norway is sero-
logically distinct from both Photobacterium damselae subsp. piscicida,
and Pasteurella skyensis—a pathogen of Atlantic salmon in Scotland,
when analysed using rabbit antisera. In addition, partial sequencing
of the 16S rRNA gene of P. skyensis and that of Norwegian Pas-
teurella sp. isolates showed that they may represent different species
or subspecies (Alarcón et al., 2016).
Phenotypically, lumpsucker Pasteurella sp. isolates appear similar
to a Pasteurella associated with “varracalbmi,” which is a systemic
infection characterized by severe ophthalmitis in farmed Atlantic sal-
mon in Norway (Valheim, Hastein, Myhr, Speilberg, & Ferguson,
2000). As the characteristics of varracalbmi have not been recorded
in lumpsuckers suffering from pasteurellosis, it is possible that the
Pasteurella sp. isolate from lumpsuckers may differ in pathogenicity
from the varracalbmi isolate. However, histopathological similarities
between the two infections exist and include skin, fin, and gill lesions
and visceral organ granulomas (Alarcón et al., 2016).
Alarcón et al. (2016) found that lumpsucker Pasteurella sp. iso-
lates were Gram‐negative, nonmotile coccobacilli that produced acid
from D‐glucose both aerobically and anaerobically. Very weak acid
production was observed form lactose, mannose, and galactose
under aerobic conditions. All strains were highly sensitive to the
vibriostatic compound 0/129. They were weakly oxidase positive,
did not produce indole, catalase, gelatinase, or urease, and a combi-
nation of sodium chloride and blood were recorded to be strict
growth requirements (Alarcón et al., 2016). In this paper, we explain
how Pasteurella sp. was successfully cultured in liquid medium. We
also tested the most commonly used challenge models to identify
which would be the most appropriate to investigate pasteurellosis
caused by Pasteurella sp. in lumpsuckers. These results were subse-
quently used to describe how Koch's postulates were fulfilled for
this disease.
2 | MATERIALS AND METHODS
2.1 | Fish and rearing conditions
Farmed, unvaccinated lumpsuckers were obtained from Vest Aqua
Base AS, Norway. The fish stock had a disease‐free history and dis-
played no signs of infection or mortality and were health screened
and certified free from atypical A. salmonicida, Pasteurella sp., V. an-
guillarum, and lumpfish flavivirus (PHARMAQ Analytiq). The fish
were acclimated during the quarantine period for 15 days at 12°C in
500 L tanks at a photoperiod of 12L:12D, a salinity of 34 ppt and
oxygen saturation of >77% in the outlet water, at the holding facili-
ties in the Industrial Laboratory (ILAB) at the Bergen High Technol-
ogy Centre. The fish were fed Amber Neptun (Skretting) dry feed by
automatic feeders and fasted for 36 hr prior to challenge. The fish
were transferred to the challenge unit 3 days prior to the challenge
and split into 150 L tanks, with 50 fish per tank. The same water
parameters were used as for the holding tanks.
2.2 | Bacterial isolation and characterization
The Pasteurella sp. isolate used in the challenge experiments was the
same as described by Alarcón et al. (2016). This isolate originated
from a site on the southwest coast of Norway. For these experi-
ments, a second passage of the bacteria was used. The bacteria were
cultured in Tryptic Soy Broth (TSB) (Becton Dickinson) or Brain and
Heart Infusion Broth (BHIB) (Becton Dickinson). These media were
supplemented with 1.5% NaCl and a series of foetal calf serum (FCS)
(Gibco, Lot no. 1633098) concentrations, and cultures were incu-
bated in an orbital incubator, at 200 rpm and 20°C. An additional
Pasteurella sp. isolate (named Pasteurella sp. P2) originating from the
central western coast of Norway, and found to be 100% similar by
16S rRNA analysis to the isolate mentioned above, was used for the
intramuscular (IM) and intraperitoneal (IP) injection trials.
Growth curves were compiled for bacteria grown in both media
by measuring bacterial cell numbers using a cell counter (CASY
Model TT (Innovatis) and CASY worX V1.26). Metabolic characteriza-
tion was done using API 20NE and API ZYM (Bio Merieux). For the
challenge models, only TSB supplemented with sodium chloride and
FCS was used to culture the bacteria. The bacterial cultures to be
used in the challenge experiments were harvested at the late
exponential phase, centrifuged at 2,500 g (Beckman Coulter Allegra
X‐15R) for 15 min at 4°C. Cells were washed once with sterile phos-
phate‐buffered saline (PBS) (Lonza, Lot no. 7MB031), followed by
centrifugation and resuspension in PBS prior to use.
2.3 | Sequencing of the 16S rRNA gene
The 16S rRNA gene of the bacteria used for challenge was amplified
from a single colony from TSA supplemented with 2% NaCl and
10% FCS, and from another colony isolated on blood agar (BA) with
1.5% NaCl. The 16S rRNA gene was amplified using universal pri-
mers 27F: 5′‐AGAGTTTGATCMTGGCTCAG‐3′, 1525R: 5′‐AAG-
GAGGTGWTCCARCC‐3′ (Collins et al., 1991). The template reaction
mixture had a final volume of 50 μl and this consisted of 5× HF buf-
fer, 0.5 U of Phusion DNA polymerase (Thermo Scientific), 10 mM
dNTP, 2.5 μl of 10 μM of each primer and 2 and 10 μl template
from each of the two media types, respectively.
The cycle conditions were as follows: 1 cycle at 98°C for 3 min;
30 cycles‐ 98°C for 30 s, 58°C for 30 s and 72°C for 1 min; and a
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final cycle at 72°C for 10 min. The PCR products were then visual-
ized on a 1% agarose gel. The PCR products were purified using a
GenElute™ PCR Clean‐Up Kit (Sigma Aldrich) and sequencing was
performed by the DNA sequencing facility at the High‐Technology
Centre, Bergen, Norway.
2.4 | Challenge models
For the cohabitation and bath challenge models, three bacterial
doses were tested, and duplicate tanks were used for each of the
three doses, as well as for the nonchallenged control. The groups,
bacterial doses, and fish numbers for the cohabitation and bath chal-
lenge experiments are shown in Table 1. Water temperature was
maintained at 12°C.
The average weight of the fish was 20.1 g, ±4.0 (mean ± SD) for
the intraperitoneal and intramuscular injection challenge, 18.6 g,
±0.62, (number of fish weighed = 80) for the cohabitation challenge
and 37.2 g, ±8.7, (number of fish weighed = 50) for the bath chal-
lenge. Harvested bacteria were washed twice with PBS and cen-
trifuged at 2500 g for 15 min prior to use for challenge experiments.
Confirmation of infection was performed by growth of bacteria iso-
lated from head kidney samples on blood agar (with 2% NaCl) from
all the dead fish from every challenge experiment. Presence of Pas-
teurella sp. was also confirmed by quantitative PCR (qPCR) analyses
using head kidney samples from the challenged fish.
2.4.1 | Cohabitation challenge
For each tank under the same dose, the challenge was performed by
IP injection of 25 fish with 50 μl washed bacterial suspension in
PBS. These fish were then VIE tagged and housed with 25 naïve fish
(cohabitants). The control fish were treated similarly, but IP injected
with 50 μl sterile PBS, and VIE tagged.
2.4.2 | Bath challenge
The fish were transferred to the aerated static challenge tanks (25 L)
containing the respective bacterial doses (Table 1) for 1 hr, after
which they were returned to their experimental holding tanks. In the
control tanks, the fish were treated similarly to the fish in the chal-
lenge tanks except that sterile PBS only was used instead of the
bacterial suspension.
2.4.3 | Intraperitoneal and intramuscular challenge
Both isolates of Pasteurella sp. isolated from lumpsuckers (Alarcón
isolate and P2 isolate) were used in this small‐scale study to compare
the effects of injection site and microbial culture medium on
pathogenicity. For each isolate, fish were challenged by IM injection
above the lateral line below the dorsal fin or by IP injection. Chal-
lenge material was either 50 μl of bacterial suspension in enriched
TSB harvested at late exponential growth phase (see Figure 1) or
50 μl of bacterial suspension collected from blood agar plates and
TABLE 1 Challenge model details showing fish number and
bacterial doses
Tank number Challenge Dose (bacteria/ml) n fish
1 Cohabitation (IP) 1 × 107 25
1 Cohabitation (Co) — 25
8 Cohabitation (IP) 1 × 107 25
8 Cohabitation (Co) — 25
2 Cohabitation (IP) 1 × 106 25
2 Cohabitation (Co) — 25
7 Cohabitation (IP) 1 × 106 25
7 Cohabitation (Co) — 25
3 Cohabitation (IP) 5 × 105 25
3 Cohabitation (Co) — 25
6 Cohabitation (IP) 5 × 105 25
6 Cohabitation (Co) — 25
4 Cohabitation (IP‐NC) PBS 25
4 Cohabitation (Co‐NC) — 25
5 Cohabitation (IP‐NC) PBS 25
5 Cohabitation (Co‐NC) — 25
9 Bath 1 × 107 50
16 Bath 1 × 107 50
10 Bath 5 × 106 50
15 Bath 5 × 106 50
11 Bath 1 × 106 50
14 Bath 1 × 106 50
12 Bath (NC) PBS 50
13 Bath (NC) PBS 50



















F IGURE 1 Growth curve for Pasteurella sp. in TSB (×) and BHIB
(●) supplemented with 10% FCS for confirmation of growth medium
composition used for bacterial culture for the challenge experiments
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transferred to enriched TSB using 1 μl inoculation loops. Challenge
by the two isolates (Alarcón isolate and P2 isolate) for comparison
was performed in separate tanks. Separate tanks were also used for
fish challenged by IP and IM injection. This resulted in four tanks
each containing sixteen fish, eight injected with bacterial suspension
harvested from enriched TSB and eight injected with suspension of
bacteria harvested from agar plates.
2.5 | Histopathology
Samples for histopathology were taken from heart, kidney, spleen,
liver, pancreas, intestine, musculature, skin, and gills of moribund fish
only from the bath challenge and from cohabitants from the cohabi-
tation challenge experiment. Tissues were fixed in 10% neutral
buffered formalin (Sigma) and kept at 4°C until processing. Formalin‐
fixed tissues were processed, embedded in paraffin wax, sectioned
and stained with haematoxylin and eosin at the Norwegian Veteri-
nary Institute, Bergen. Samples from a natural Pasteurella sp. out-
break provided by the Norwegian Veterinary Institute were used for
comparison.
2.6 | Quantitative PCR
The protocol used for this study was validated using the method of
Gulla, Duodu, Nilsen, Fossen, and Colquhoun (2016), with a few
modifications as follows. A late exponential phase culture of Pas-
teurella sp. was used to prepare 10‐fold serial dilutions in sterile PBS
(1.5 × 1010 to 1.5 × 105 bacteria/ml). For each dilution, 25 μl were
added to 20 mg samples of head kidney tissue from noninfected
lumpsuckers that were cut into very small pieces (concentration of
bacteria in the head kidney samples was approximately 3 × 108 bac-
teria/ml). A negative control sample was included where PBS was
used instead of bacterial dilution. These were then incubated for
1 hr at room temperature to allow bacteria to be adsorbed to the
head kidney cells in the case of the spiked samples, before proceed-
ing with DNA extraction and qPCR.
Kidney samples from all the dead fish, survivors, and control fish
from the cohabitants from the cohabitation challenge experiment
and from the bath challenge experiment were stored in RNAlater®
stabilizing solution at −20°C. DNA was extracted from all samples
using the DNEasy Kit (Qiagen), according to the manufacturer's
instructions for animal tissue samples. The levels of Pasteurella sp.
were determined by qPCR using SYBR Green (Sigma). The primers
used were RK‐Past F: 5′‐TTCACCATTCAAAGCACCATCAAG‐3′ and
RK‐Past R1: 5′‐CTTCTAAAGCAGCATTGGCATTAT‐3′ targeting the
superoxide dismutase (sodA) gene. Each qPCR reaction contained a
volume of 25 μl and consisted of 12.5 μl 2× SYBR, 1 μl each of the
forward and reverse primers (10 μM), 0.5 μl of RNAse and DNAse‐
free water, and 10 μl of genomic DNA (50 ng). A C1000 Touch ther-
mal cycler (Bio‐Rad) was used for qPCR, with the following cycle
conditions: (a) 94°C for 5 min (b) 40 cycles of 94°C for 15 s, 60°C
for 1 min and (c) an increase from 60 to 92°C at a rate of 1°C/5 s.
Data was analysed using Bio‐Rad CFX Manager 3.1 software
(Bio‐Rad). The sizes of the qPCR products were analysed by
electrophoresis on 2% agarose gels containing GelRed (Biotium).
2.7 | SDS‐PAGE
Bacteria were harvested in late exponential growth phase and cen-
trifuged as described in Section 2.2. Other species of Pasteurella/Pho-
tobacterium were also included for comparison. Protein profiles from
whole bacteria were obtained by SDS‐PAGE (10% acrylamide)
according to the method of Laemmli (1970) with minor modifications
as follows. Electrophoresis was performed using a Mini Protean
Tetra Cell (Bio‐Rad). Antigens were heat‐treated (96°C for 5 min) in
sample buffer containing 5% β‐mercaptoethanol. Samples (5 mg in
10 ml) were loaded onto each well, electrophoresed at 190 V for
45 min, followed by oxidation with a periodic acid solution (0.7%
periodic acid (w/v), 2.7% ethanol, 0.3% acetic acid, 97% distilled
water) and stained using Silver Stain Plus kit (Bio‐Rad) based on the
method of Gottlieb and Chavko (1987).
2.8 | Statistics
The qPCR data on presence of bacteria in samples from challenged
fish were log10 transformed and analysed using the Kruskal–Wallis
test (nonparametric test for comparison of the means of two or
more independent samples). Differences were considered significant
when p < 0.05. All statistics were carried out in GraphPad Prism V5.
3 | RESULTS
3.1 | Growth and characterization of bacteria
Growth of Pasteurella sp. to be used for challenge experiments was
obtained in liquid medium when using both enriched TSB and BHIB,
under a variety of FCS concentrations ranging from 2% to 10% (v/v).
No growth was registered when FCS was excluded. The concentra-
tion of FCS required for optimal growth was 6%–10% for BHIB and
10% for TSB. The growth curves showed that an increase in FCS
concentration was proportional to an increase in numbers of bacteria
(Figure S1a,b). The maximum bacterial concentration obtained in TSB
was approximately 1.6 × 109 bacteria/ml and was reached after
20 hr, at 10% FCS. In contrast, a slower growth rate was observed
when using BHIB and the stationary phase was not reached after
20 hr. The initial growth phase shows that the bacteria grow rather
slowly for several hours. Cultures in TSB reached late exponential
phase at approximately 18–19 hr postinoculation (Figure S1b).
Growth curves were repeated with 10% FCS only, for confirmation
of the final chosen medium composition for bacterial culture, with
similar results as obtained previously (Figure 1).
We attempted metabolic characterization of Pasteurella sp. using
API 20NE and API ZYM kits, but only very weak or no reaction
could be observed up to 48 hr at 20°C. Using universal bacteria pri-
mers, the 16S rRNA gene sequence analysis confirmed that the
bacteria used in this study were Pasteurella sp.
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3.2 | Mortalities from the different challenge
models
All challenge models induced mortalities caused by Pasteurella sp.
The cohabitation challenge experiment, however, showed differences
when compared with the other challenge experiments, with low
mortalities when compared with the IM and IP injection challenges
and the bath challenge.
In the IM and IP challenge small‐scale study, the two isolates
tested resulted in similar mortality profiles for IM and IP injection,
both from the agar plate as well as from the broth culture methods.
For that reason, only results from the Alarcón isolate cultured by
broth method are presented.
Acute mortalities were observed in the IM and IP challenges,
with 100% mortality being reached by day 5 post challenge for the
IM challenge and 90% by day 7 post challenge for the IP challenge
(Figure 2). The rather high bacterial dose used for both types of
injection and the similar acute mortality profiles from IP and IM chal-
lenge indicated a very potent pathogenicity under these conditions.
To obtain a more gradual mortality profile, the cohabitation
experiment was performed. The IP injection part of this experiment
involved testing three doses of bacteria (1 × 107, 1 × 106, and
5 × 105 bacteria/ml). The IP‐injected fish (shedders) in the cohabita-
tion challenge experiment followed a similar pattern to the IM and
IP challenged fish previously tested. The only difference was the
onset of mortality which was delayed by a few days at lower doses
of bacteria and all shedder fish were dead by day 12 post challenge.
Thus lowering the dose did not induce a more gradual mortality in
the group (Figure 3).
In contrast to the acute mortalities after IP and IM challenge, the
first mortalities from the cohabitant fish were recorded on day 18
post challenge. The total mortalities in this case were 4% for the
highest dose, 14% for the intermediate dose and 10% for the lowest
dose tested (Figure 3).
When testing the bath challenge model a gradual mortality was
observed. The onset of the mortalities was day 10 post challenge
(Figure 4) and gradually increasing mortalities were observed until
day 42 post challenge. Here, the high and intermediate doses had a
similar profile with mortality at 96% and 99%, respectively, and the
low dose also resulted in 91% mortality. This experiment therefore
indicates that a clear dose response was not observed by these bath
challenge exposures.
No mortalities were observed in any of the nonchallenged con-
trol groups in any of the experiments.
3.3 | Re‐isolation of Pasteurella sp. from challenged
fish
Pasteurella sp. was re‐isolated from all fish sampled across the differ-
ent challenges when grown on blood agar supplemented with 2%
sodium chloride. Samples from all dead and surviving cohabitants


























F IGURE 2 Mortalities resulting from challenge of lumpsuckers



























F IGURE 3 Mortalities resulting from
challenge of lumpsuckers with Pasteurella
sp. by cohabitation. Curves with empty
symbols represent intraperitoneal (IP)‐
injected fish (shedders); curves with filled
symbols represent cohabitant fish. Doses
for IP injection: (○) 1 × 107 bacteria/ml, (▵)
1 × 106 bacteria/ml, (□) 5 × 105 bacteria/
ml, (♢) nonchallenged control
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bath challenge. Pasteurella sp. was also re‐isolated from IP and IM
challenged fish.
Quantitative PCR with Pasteurella sp. specific primers was also
used investigate the concentration of Pasteurella sp. present in head
kidney samples. This was done by comparing the values obtained
from challenge experiment samples with the values from a spiked
standard curve. Samples were collected from the cohabitants from
the cohabitation challenge experiment and from the bath challenge
experiment. Samples were analysed by qPCR to confirm presence of
bacteria as cause of disease. The reason was to confirm the pres-
ence of bacteria in fish that were not IP infected with bacteria.
The spiked standard curve, obtained by adding known amounts
of bacteria to noninfected head kidney samples, showed good corre-
lation (r2 = 0.9998) between Ct value and bacterial numbers. The
limit of detection for Pasteurella sp. in kidney samples was found to
be 3 × 103 bacteria/ml, which corresponds to a Ct value of 33.97
(Figure S2). Lower counts are not included as the resulting Ct values
did not maintain linearity.
Pasteurella sp. was found in high concentrations in the dead fish,
but also in low concentrations in the surviving fish (Figure 5). While
there were significant differences in bacterial load between the dead
cohabitants and surviving cohabitants, this was not the case in the
bath challenge. There were few surviving fish in the bath challenge
and there was high variation in amounts of bacteria. Comparisons
between the survivor groups across the two challenges could not be
made reliably as the low number of survivors resulted in no signifi-
cant differences (p > 0.05). The bacterial load in dead fish across the
two challenges was not significantly different, meaning that all dead
fish were highly infected. The nonchallenged control fish samples
were not positive for Pasteurella sp. by qPCR.
3.4 | Pathology
Redness which indicates inflammation was observed around the site
of injection with Pasteurella sp. in the IM‐challenged fish (Figure 6e,
f), whereas IP‐challenged fish did not show any lesions at the
injection site. Gross pathology in the cohabitant fish from the cohab-
itation challenge included cataracts, erosion of the lower jaw, and
haemorrhage and redness which indicates inflammation at the base
of the fins (Figure 6a,b). Symptoms in the bath challenged fish were
different compared to those of the cohabitants from the cohabita-
tion challenge. In the bath challenged fish, white spots were
observed all over the skin (Figure 6c), especially around the eyes
(Figure 6d) and darkening of the skin occurred in most fish. No inter-
nal symptoms other than ascites were observed, in any of the chal-
lenge experiments.
Histology was carried out on three representative moribund
cohabitant fish and one healthy control fish from the cohabitation
challenge (one from each dose). From the bath challenge, one mori-
bund fish from the lowest challenge dose was used. Additionally, a
dead fish with a severe reaction around the eye was sampled for his-
tology. Since we did not include an additional tank for histological
sampling, moribund fish were not encountered more frequently.


















F IGURE 5 Comparisons of bacterial loading (bacteria/ml)
between the cohabitation and bath challenge models based by qPCR
analysis. (●) Cohabitation survivors, (■) Cohabitation mortalities,


























F IGURE 4 Mortalities resulting from
challenge of lumpsuckers with Pasteurella
sp. by bath. (●) 1 × 107 bacteria/ml, (▲)
5 × 106 bacteria/ml, (■) 1 × 106 bacteria/
ml, (♦) nonchallenged control
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Histopathological examination showed variable amounts of short
rod‐shaped bacteria often in loosely shaped aggregates in heart, kid-
ney, spleen, liver, peritoneum, and gills and eye. The tissue response
was acute to subacute varying from just a few necrotic cells around
bacteria, to large necrotic areas, haemorrhage, eosinophilic exudate,
and leukocyte infiltration. There were no differences observed
between cohabitant fish from the cohabitation challenge, and fish
from the bath challenge.
In the lumen of the ventricle and atrium of the heart there were
multiple aggregates of bacteria (Figure 7a). In the kidney the bacteria
occurred in sparse amounts in the sinusoids and interstitium (Fig-
ure 7b). In the spleen there were abundant amounts of bacteria
throughout the tissue (Figure 7c). Both in the spleen and kidney
there were scattered necrotic cells mostly around bacteria and
increased amounts of circulating leukocytes. In the pancreas some of
the exocrine pancreas cells were degenerated. In the perivisceral
peritoneum there were multifocal aggregates of bacteria and infiltra-
tion of leukocytes. In the gills there were sparse amounts of bacteria
in the lamellar capillaries.
The eye and surrounding tissue from a dead bath challenged
fish was sampled due to the severity of the lesion around the
eye. Histopathological examination of the skin, connective tissue
and fatty tissue around the eye showed that the fish suffered
from keratitis. There were also large areas with necrotic cells, leu-
cocytes, eosinophilic exudate, haemorrhage, and abundant amounts
of bacteria (Figure 7d). The sclera was multifocally rich in leuco-
cytes and some bacteria. The histopathology described above is
also observed in histopathological examination of fish tissue
samples from natural outbreaks of Pasteurella sp. in lumpsuckers
(Figure 8a–c).
3.5 | SDS‐PAGE protein profiles of Pasteurella sp.
and Photobacterium/Pasteurella species
The protein profile of Pasturella sp. isolate from lumpsucker was
compared to other fish pathogenic bacteria, known to cause pas-
teurellosis. The Pasteurella sp. isolate from lumpsuckers is different
from the other Pasteurella and Photobacterium species (Figure 9). The
protein band between 21.5 and 45 kDa for the lumpsucker isolate is
not present in the other species, and the majority of bands common
to P. damselae subsp. piscicida are not visible in the lumpsucker iso-
late. However, a weak band at approximately 21.5 kDa is visible for
the lumpsucker isolate which is also present for P. damselae subsp.
piscicida.
4 | DISCUSSION
Pasteurella sp. isolated from Norwegian lumpsuckers has been very




F IGURE 6 Gross pathology of
Pasteurella sp. infection shown by samples
from the cohabitation challenge (a and b),
bath challenge (c and d), and IM challenge
(e). Panel f shows the internal morphology
of the localized reaction seen in panel e.
Lesions are marked by arrows [Colour
figure can be viewed at
wileyonlinelibrary.com]
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Until now, this bacteria has only been grown on blood agar, and it
has been found to have strict requirements for blood and sodium
chloride (Alarcón et al., 2016). This has resulted in only a few studies
being carried out on pasteurellosis in lumpsuckers and also delayed
vaccine development. In this study, growth of Pasteurella sp. in liquid
media was established, with relatively high numbers of bacteria
being harvested. Based on growth curves, bacteria were harvested in
the late exponential growth phase, ensuring standardized bacterial
samples for testing of different challenge models.
Foetal calf serum added to the media provided the necessary
growth factors required by the bacteria to grow well, with the
most optimal growth rates obtained at a FCS content of 10% in
TSB. Slightly higher numbers of bacteria were obtained in BHIB,
but this medium is not appropriate for growth of bacteria
(a) (b)
(c) (d)
F IGURE 7 Distribution of Pasteurella
sp. in heart (a), kidney (b), spleen (c), and in
the tissue surrounding the eye (d) from
challenged fish. Bacteria are seen in
loosely shaped aggregates (arrows). Scale
bar: a: 50 μm, b–d: 100 μm. a–d (HE). a:
40×, b: 20×, c: 10×, d: overview 2.5× and





F IGURE 8 Distribution of Pasteurella
sp. in heart (a), kidney (b), and spleen (c)
from fish from a natural outbreak of
Pasteurella sp. Bacteria are seen in loosely
shaped aggregates (arrows). Scale bar: a,b:
100 μm, c: 200 μm. a–c (HE). a and b: 20×,
c: 10× [Colour figure can be viewed at
wileyonlinelibrary.com]
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intended for vaccine production. Therefore, bacteria grown in TSB
were used since the challenge models are intended to be used for
vaccine testing.
The commonly used API characterization methods did not give
satisfactory results for this isolate, under the test conditions used,
indicating that more adequate tests are required. The biochemical
profile of Pasteurella sp. from lumpsuckers has previously been
described and found to be similar but weaker to that of a Pasteurella
strain known to cause ophthalmitis in Atlantic salmon (Alarcón et al.,
2016). This may be due to the growth requirement of the bacteria
which might not be optimal in these tests and therefore low growth
will influence the results.
Pasteurella sp. isolated from lumpsuckers is still uncharacterized
on the functional level with regards to virulence components and
antigenic properties. The protein profiles of whole bacteria compared
to other relevant bacterial isolates known to cause pasteurellosis
showed that this lumpsucker isolate is not similar to P. skyensis or
P. damselae subsp. piscicida. These two species are the commonly
encountered agents of pasteurellosis in aquaculture. Pasteurella
skyensis has been isolated from Atlantic salmon in Scotland (Birk-
beck, Laidler, Grant, & Cox, 2002) and P. damselae subsp. piscicida
has been extensively studied and has caused severe infectious prob-
lems in fish worldwide, such as in Japan including flounder (Fukuda,
Matsuoka, Mizuno, & Narita, 1996) and amberjack (Kawakami, Yama-
shita, & Sakai, 2007) and in Europe particularly in Mediterranean
species like gilthead seabream (Moriñigo et al., 2002).
The observed differences in protein profiles might indicate that
antigenic differences can also exist. Therefore, protein profiles, when
combined with immunoblotting, will provide important information
on immunoreactive antigens in tests using lumpsucker sera. Lump-
sucker sera should be used in analyses to identify the proteins
involved in lumpsucker immune responses. Anti‐sera from other ani-
mals provides information on differences obtained by the actual
serum but does not necessarily identify the immunogenic compo-
nents to lumpsuckers.
Since 2013, there has been a significant increase in the number
of Pasteurella sp. outbreaks in lumpsuckers from sites across Norway.
These have been recorded in both juvenile and sea transferred fish,
with mortalities often reaching 100%. According to Johansen (2013),
clinical infection can be triggered from subclinical infection by stress‐
inducing events such as vaccination, transfers, and transport. Some
success has been reported when using florfenicol for treatment of
the disease, however, recurrence of infection has been reported
from many sites. Furthermore, since pasteurellosis in lumpsuckers is
not a notifiable disease in Norway, it is possible that the number of
cases is under‐reported. Lumpsucker vaccines are currently commer-
cially available against atypical A. salmonicida and V. anguillarum.
Development of vaccines for other pathogens is underway, requiring
further optimization (Gulla & Bornø, 2018).
The results from the presented challenge experiments in this
study have shown that Koch's postulates have been fulfilled with
respect to Pasteurella sp. causing disease in lumpsuckers under
experimental conditions and with respect to pure cultures of bacteria
being reisolated from diseased fish.
The IM and IP challenges underlined the high virulence of the
bacteria, with acute and high mortalities obtained very early into the
challenge period. This suggests the presence of extracellular proteins
as virulence factors implicated in disease progression. As the disease
onset was too rapid, the fish died before any characteristic symp-
toms like the typical white skin spots, appeared. A severe local reac-
tion was obtained in the musculature at the injection site when IM
injection was used. Due to the severe tissue damage, this challenge
model is not recommended for use. The specific reasons for these
severe tissue reactions is not known, but bacterial virulence factors,
including toxins, might be involved in tissue damage and the result-
ing damage can also influence the host immune response.
The cohabitation and the bath challenge models allowed the
more chronic symptoms of the disease to be studied more accu-
rately. In the cohabitation model experiment, the IP‐injected fish fol-
lowed a similar mortality pattern to that observed in the IM and IP
challenged fish, with acute mortalities and no external lesions being
recorded. Results from different IP‐injected doses showed that
decreasing the dose of bacteria only delays the onset of disease, but
not the total mortality. This acute mortality of the shedders thus led
to a reduced level of shedding, and this was evident from the very
low mortalities in the cohabitant group. The highest bacterial dose
tested resulted in the lowest cohabitant mortality, indicating that not
enough shedding had occurred to result in infection of the cohabi-
tants. The middle dose resulted in slightly higher cohabitant mortali-
ties as the longer period of shedding from the shedders allowed the
cohabitants to be exposed to the bacteria for a longer period of
F IGURE 9 Silver stained SDS‐PAGE showing protein profiles of
various Pasteurella and Photobacterium species. 1: Pasteurella sp.
isolated from lumpsuckers; 2: Pasteurella skyensis (Scottish Atlantic
salmon); 3–6: Photobacterium damselae subsp. piscicida, 3: fnr 2289/
NCIMB, 4: from Cobia, 5: from European sea bass, 6: from
Senegalese sole
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time. Despite this, lesions typical of Pasteurella sp. infections were
still observed in these dead fish, and included haemorrhage at the
base of fins and jaw. Interestingly, no white skin spots or internal
symptoms were observed here, possibly due to the low bacterial
exposure and subsequent low bacterial concentration in the fish.
Concerning the acute mortalities obtained from the shedders in
the cohabitation challenge, one might have tested lower injection
doses to determine if this would have provided a more gradual mor-
tality. However, taking into consideration the low mortality in cohab-
itant fish, this indicates that evaluating the dose for IP infectivity
seems to be complicated due to the progression of disease. In a for-
mer study, Alarcón et al. (2016) reported an outbreak of pasteurel-
losis in lumpfish occurring 2 weeks post transfer to holding facilities
and this indicated that under “natural infection” the disease progress
might be slower, and that stress can induce onset of disease if bac-
teria already are present in the fish. In artificial media bacterial
growth is slow, but this might not be the case in infected fish. Fur-
thermore, it is not known whether toxic extracellular products or
other virulence factors are involved in disease development as is the
case for P. damselae subsp. piscicida (Magariños et al., 1992, 1996;
Romalde, 2002).
The bath challenge was found to be the most adequate challenge
model, as mortalities in this case were more gradual than the cohabita-
tion challenge. The onset of mortality was the same for all the doses,
but a more prolonged and lower total mortality was seen with the low-
est dose. The potency of Pasteurella sp. was again demonstrated as all
the doses tested exceeded 90% mortality. The results from the bath
challenge indicate that this model can be used for testing of vaccines
against pasteurellosis, based on the evaluation of the mortality profile
and the experimental period. However, the doses to be tested may
need to be refined when carrying out such trials.
The qPCR analysis indicated that Pasteurella sp. was present in
the survivor fish sampled at termination of the cohabitation and bath
challenge experiments. These fish were sampled at day 40 post chal-
lenge and day 42 post challenge, respectively and at that point they
did not show any external or internal symptoms of disease. This
implies that there may be an asymptomatic carrier status, and re‐
emergence of the disease cannot be excluded if these fish were to
have been stressed, particularly the surviving cohabitants. The low
and closely grouped qPCR values of bacteria for the cohabitation
challenge survivors compared to those from the dead fish seem to
corroborate this. The qPCR values from the bath challenge survivors
and corresponding dead fish on the other hand, did not show a simi-
lar pattern, as the values were overall higher and showed more vari-
ation. This might indicate that given a longer period of time, the
bath survivors might have succumbed to disease.
Additionally, the presence of bacteria in low numbers in surviving
cohabitants from the cohabitation challenge several days after mor-
tality ceased indicates that lumpsuckers can be asymptomatic carri-
ers and can possibly harbour Pasteurella sp. intracellularly, but this
needs to be verified by analysing bacterial virulence factors.
Histopathology findings show that the disease may cause a systemic
infection, with bacteria in loosely shaped aggregates. The white spot
around the eye of the examined fish is likely due to a subacute bac-
terial inflammation in the tissue surrounding the eye.
The histopathological findings from this study show similarities
to findings obtained from field cases and to findings reported by
Alarcón et al. (2016), with respect to redness at the base of fins and
the mouth as well as the white spots around the body. However,
granulomas were not encountered in this study. Typically, granulo-
mas would require a more latent and chronic form of the disease, as
well as the stressors encountered by the fish in the sea cages to
develop. Such conditions were not encountered in the facility where
the study was being carried out, which explains the lack of granulo-
mas. Furthermore, the fish studied by Alarcón et al. (2016) were
obtained from a production facility and likely harboured the bacteria
at subclinical levels, allowing granulomas to develop.
It is worth noting that the bacteria that seem to be particularly
potent in causing immediate and severe mortalities in short periods
when injected, can also cause low mortality and consequent har-
bouring of bacteria in cohabitants. This might indicate that a suffi-
cient number of bacteria must be present before mortality occurs or
that at low levels the bacteria might be under some control by lump-
sucker immune activities. It has been previously shown that both
phagocytosis and respiratory burst are highly active in lumpsuckers
and immunocytochemical analyses of enzymes and oxygen indepen-
dent mechanisms support the importance of innate immune func-
tions (Haugland et al., 2012). Such mechanisms may help to control
bacterial infection in lumpsuckers.
The possible carrier state of Pasteurella sp. has an important
implication for the lumpsucker farming industry, since the point of
infection or its ability to survive in a more dormant stage in fish is
not clear and cases of pasteurellosis have been recorded at different
life stages. The “carrier state” has been encountered previously in a
natural outbreak of pasteurellosis in lumpsuckers (Alarcón et al.,
2016). In that study, it was shown that the fish were asymptomatic
carriers and that the disease re‐emerged following a stress‐inducing
event in the form of routine handling of the fish. The carrier state
and re‐emergence has also been encountered in other fish species
and diseases such as A. salmonicida in Atlantic salmon (Hiney, Kil-
martin, & Smith, 1994), Yersinia ruckeri in rainbow trout (Busch &
Lingg, 1975), Edwardsiella ictaluri in channel catfish (Klesius, 1992)
Francisella piscicida in wild and farmed Atlantic cod (Ottem, Nylund,
Isakse, Karlsbakk, & Bergh, 2008) and P. damselae subsp. piscicida in
gilthead seabream (Magariños et al., 2001). For the above reasons,
screening of lumpsuckers before transfer into hatcheries, ongrowing
facilities, and onto sea cages is of utmost importance, in order to
minimize the transfer of asymptomatic carriers. Hopefully vaccines
against pasteurellosis caused by Pasteurella sp. can be developed,
but the mode of action by the bacteria on lumpsuckers seen from
these experiments, and a possible intracellular existence, might make
this a challenging task.
In summary, growth of Pasteurella sp. isolated from Norwegian
lumpsuckers was established in TSB enriched with sodium chloride
and FCS resulting in high numbers of bacteria harvested. These bac-
teria were then used to test a number of challenge models, where
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the bath challenge model was found to be the most adequate to
investigate the disease progression in lumpsuckers. qPCR analysis
indicated that an asymptomatic carrier status may be possible, and
this highlights the importance of fish health screening both of brood-
stock and fry before vaccination and transfer to sea. Further work
on the possibility of an intracellular mode of action of Pasteurella sp.
and its implications on lumpsucker immune cells and functions
should be performed. The presented results will contribute to pro-
gress in vaccine production to provide lumpsuckers with enhanced
protection against pasteurellosis.
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A B S T R A C T
Two monovalent vaccines against pasteurellosis were developed and tested for efficacy using a previously es-
tablished bath challenge model. High levels of specific antibodies were detected following vaccination. While the
vaccine efficacy trial indicated that some level of protection was obtained, high mortality was still observed.
qPCR analysis of head kidney tissues from surviving fish post challenge showed no difference in bacterial
numbers in vaccinated and non-vaccinated fish. Clinical symptoms observed in moribund and diseased fish
included white spots on the skin and around the eyes, frayed fins and redness around the mouth and fin bases.
Despite production of specific antibodies, the protection against experimental challenge was relatively weak. A
reason for this could potentially be that the specific antibodies produced are not alone enough to provide
complete protection against pasteurellosis in lumpsuckers. Confocal and scanning electron microscopy of head
kidney leucocytes exposed to Pasteurella sp. in vitro gave indications of the interactions between the pathogen
and leucocytes. The results indicate that parts of the immune system other than humoral antibodies could be
important for protection against pasteurellosis. Our combined results highlight the need for further work on
host-pathogen interaction between Pasteurella sp. and lumpsuckers.
1. Introduction
Lumpsucker (Cyclopterus lumpus L.) is a marine species of cleaner
fish used for biological control of sea lice infecting farmed Atlantic
salmon. In Norway, wild populations as well as farming operations can
be found all along the entire coastline, from Troms county in the north,
to Vest-Agder county in the south. Due to their ease of culture and
relatively high delousing activity at lower water temperatures, lump-
suckers are ideally suited and preferred over various species of wrasse
for use as cleaner fish. For this reason, the demand for farmed lump-
sucker has been steadily increasing, with approximately 40 million fish
used in Atlantic salmon production in Norway in 2018 [1].
As a relatively new species to aquaculture, several bacterial diseases
have been documented for farmed lumpsuckers. The most commonly
encountered bacterial agents from outbreaks are Vibrio species (in-
cluding V. anguillarum and V. ordalii), Tenacibaculum spp., Moritella
viscosa, Pseudomonas anguilliseptica, atypical Aeromonas salmonicida and
an as yet unnamed Pasteurella-like species [2–4].
Outbreaks of pasteurellosis have been steadily increasing since the
first case was recorded in 2012, with 28 sites reporting outbreaks in
2016 [5]. Despite the decrease by half in reported cases to 14 in 2018
[1], Pasteurella sp. remains a problematic pathogen for fish farmers, and
under-reporting of outbreaks cannot be excluded. The bacteria affect all
life stages of lumpsucker, and to date there is no adequate treatment for
this disease. The Pasteurella sp. pathogenic for lumpsucker is closely
related to, albeit serologically distinct from, Pasteurella skyensis [6],
when analysed using rabbit antisera [3]. It is also phenotypically si-
milar, but genetically distinct from a group of Pasteurella isolates pa-
thogenic for farmed Atlantic salmon in Norway, which causes “varra-
calbmi”, a systemic infection characterised by severe ophthalmitis [7].
Prophylactic measures including vaccines have been commercially
developed for several lumpsucker diseases. Currently, the majority of
farmed lumpsucker are vaccinated against V. anguillarum and atypical
A. salmonicida. As Pasteurella sp. is a relatively recently discovered
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pathogen, and is difficult to culture in liquid media, vaccine develop-
ment against pasteurellosis remains at an early stage. A Pasteurella
component is, therefore, not currently included in commercial lump-
sucker vaccines.
Despite their widespread use, knowledge of the lumpsucker immune
system remains limited [8]. Haugland et al. (2012) first characterised
the components and functionality of the lumpsucker innate immune
system by isolating leucocytes from peripheral blood, spleen and head
kidney, and determined the phagocytic capacity of lumpsucker leuco-
cytes to be very high. Rønneseth et al. (2015) [9] then characterised B
cells from lumpsuckers and found high phagocytic ability among IgM+
B cells isolated from blood. Further, it was found that immunisation
resulted in the production of specific antibodies and vaccine-induced
protective immunity against experimental challenge with atypical fur-
unculosis. In previous work [10], we confirmed that Pasteurella sp.
causes significant mortalities in lumpsucker, and determined that a
bath challenge model is the most adequate to study progression of the
disease.
In the current study, we investigated the adaptive immune response
of lumpsucker following immunisation against, and subsequent ex-
posure to Pasteurella sp.. We also studied the effects of in vitro exposure
of isolated lumpsucker head kidney leucocytes to Pasteurella sp. through
immunofluorescence and confocal microscopy, as well as scanning
electron microscopy. This was done to shed light on the mechanisms of
infection of the pathogen, and in turn clarify how the lumpsucker im-
mune system needs to be stimulated to prevent infection and disease.
2. Materials and methods
2.1. Bacterial isolates and culture
The Pasteurella sp. isolate described in previous studies [3,10] was
identified from a natural Pasteurella sp. outbreak in lumpsucker, and
was used in this work for vaccine preparation, challenge and in vitro
exposure of leucocytes. Briefly, bacteria were grown in tryptic soy broth
(TSB) (Becton Dickinson supplemented with 1.5% NaCl and 10% foetal
bovine serum (Gibco, Lot no. 1739464) at 20 °C with shaking
(200 rpm). For challenge, the cultures were harvested in the late ex-
ponential growth phase and centrifuged at 2500 g (Beckman Coulter
Allegra X-15R) for 15min at 4 °C. Cells were washed once with sterile
phosphate buffered saline (PBS) (Lonza, Lot no. 8MB014), followed by
centrifugation and resuspension in PBS prior to use.
2.2. Vaccine preparation and vaccination
The vaccines were formulated as water-in-oil emulsions by
PHARMAQ AS, Norway. Two different monovalent vaccine prepara-
tions were tested, both based on formalin killed Pasteurella sp. emulsi-
fied in adjuvant. Prior to inactivation, bacterial cell numbers were
measured using a cell counter (CASY Model TT (Innovatis) and CASY
worX V1.26) to be approximately 2×109 bacteria mL−1 and 150mL
culture volumes were used to prepare the vaccines. The antigen con-
centration in one of the vaccines was concentrated by centrifuging a
formalin-killed culture of bacteria and removing 90% of the super-
natant. The other vaccine was not concentrated. In addition, control
groups were vaccinated using a monovalent V. anguillarum O1 vaccine
(control vaccine) and phosphate buffered saline (PBS), respectively.
Vaccination was performed by intraperitoneal injection of vaccine
(50 μL) using Socorex self-refilling syringes. The antigen dose per fish
was>2×107 and>2×108 cells fish−1 for the non-concentrated and
concentrated vaccine respectively. Vaccination was carried out six
weeks before bacterial challenge. At the time of vaccination, the fish
had an average length and weight of 5.1 ± 0.3 cm (n=50) and
9.8 ± 1.8 g (n= 50) respectively. Vaccine groups were identified by
Visual Implant Elastomer (VIE tags, Northwest Marine Technology Inc.)
placed subcutaneously on the forehead.
2.3. Fish and rearing conditions
Farmed, unvaccinated lumpsuckers were obtained from Vest Aqua
Base AS, Norway. The experimental population had a disease free his-
tory, displayed no signs of infection or mortality and were screened and
certified free from atypical A. salmonicida, Pasteurella sp., Vibrio angu-
illarum and lumpfish flavivirus (PHARMAQ Analytic). The fish were
acclimated for 15 days at 12 °C in 500 L tanks at a photoperiod of 12 L:
12D, a salinity of 34 ppt and oxygen saturation of> 77% in the outlet
water, at the holding facilities in the Industrial and Aquatic Laboratory
(ILAB) at the Bergen High Technology Centre. The fish were fed Amber
Neptun (Skretting) dry feed by automatic feeders and fasted for 36 h
prior to vaccination and challenge. The fish were then transferred to the
challenge unit 3 days prior to the challenge and split into 150 L tanks,
with 100 fish per tank. The same water parameters were used as for the
holding tanks.
2.4. Lumpsucker immune sera
Blood samples were collected post-vaccination from individual fish
vaccinated with the test vaccines every 100° days for a period of 600°
days and stored overnight at 4 °C. Sera were then obtained by cen-
trifugation at 1300g and stored at −20 °C.
2.5. Quantification of lumpsucker-specific antibodies to Pasteurella sp.
Analysis for specific antibody production was carried out by en-
zyme-linked immunosorbent assay (ELISA). Freeze-dried Pasteurella sp.
was used as the antigen to coat 96-well plates (Nunc). The antigen was
dissolved in 0.01M PBS, pH 7,3 and sonicated for 2min at 20 kHz and
diluted to a concentration of 10 μgmL−1 before being used. Lumpfish
sera were diluted (1:50) in PBS containing 0.05% Tween 20. Specific
antibodies were detected using rabbit anti-lumpfish IgM serum
(1:1500) [4] and peroxidase conjugated goat anti-rabbit im-
munoglobulin (Dako) (1:2000).
The optical density (OD) was read at 492 nm in a Sunrise microplate
reader (Tecan Group Ltd.) using Magellan software. Each dilution was
carried out in parallels of two. The blank control employed was wells
containing PBS instead of lumpfish serum. For an internal positive
control, serum from lumpfish immunised with Pasteurella sp. antigens
used by Ref. [9] was included.
Agglutination tests were performed using sera from lumpsuckers
vaccinated against Pasteurella sp. in this work. The tests were carried
out by inoculating live Pasteurella sp. onto glass slides, followed by the
addition of the sera and observing for flocculation. Serum from lump-
sucker triple immunised against Pasteurella sp [9]. were used as a po-
sitive control, while pre-vaccination serum from this study was used as
a negative control.
2.6. SDS-PAGE silver staining and western blots of Pasteurella sp.
Whole protein profiles were analysed by SDS-PAGE (12% acryla-
mide) according to established methods [11] with minor modifications
as described previously [12]. Electrophoresis was performed using a
Mini Protean Tetra Cell (Bio-Rad). Pasteurella sp. prepared as described
in Section 2.5 was heat-treated (96 °C for 5min) in sample-buffer con-
taining β-mercaptoethanol. Samples of 10 μL were loaded onto each
well, electrophoresed at 190 V for 45min, followed by staining of
proteins using Silver Stain Plus kit (Bio-Rad) [13].
Western blotting was performed using whole bacteria after fractio-
nation on a 12% SDS-polyacrylamide gel as described above and
electro-blotted onto 0.45mm nitrocellulose membranes (Bio-Rad) as
described in Ref. [14] with some minor modifications. Briefly, analysis
was performed using serum collected from the vaccinated lumpsucker
diluted 1:100, and rabbit anti-Pasteurella diluted 1:10,000. Sera from
non-immunised fish were used as negative controls while sera from
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three times immunised lumpsuckers were also used for comparison [9].
For the production of rabbit and lumpsucker anti-Pasteurella immune
sera, Freund's Complete Adjuvant and Freund's Incomplete Adjuvant
were used respectively. Anti-lumpfish IgM serum was diluted 1:1000,
polyclonal goat anti-rabbit immunoglobulins/HRP (Dako) diluted
1:2000. These were developed with HRP Conjugate substrate kit (Bio-
Rad) or Clarity Western ECL substrate (Bio-Rad) and visualized in Bio-
Rad molecular image chemi Doc XRS þ Imaging system. The molecular
weight of the SDS-PAGE fractions and immune reactive bands were
identified using SDS-PAGE low range standard (Bio- Rad) and Kalei-
doscope pre-stained standard (Bio-Rad), respectively.
2.7. Challenge of vaccinated fish
Six weeks (500° days) post-vaccination fish were bath challenged as
described in previous work [10]. Each of the four bacterial doses used
for challenge were tested in duplicate, resulting in eight tanks used.
Each tank contained 25 fish for each of the two test vaccine groups and
control groups, giving 100 fish in each tank (Table 1). Briefly, fish were
transferred to aerated static challenge tanks (25 L) containing the re-
spective bacterial doses for 1 h, after which they were returned to clean
holding tanks. The fish were then checked twice daily and dead and
moribund fish removed accordingly.
Confirmation of infection was performed by re-isolation of bacteria
from head kidney samples on blood agar (with 2% NaCl) from all the
dead and moribund fish. Kidney samples from the dead fish were also
stored in RNAlater stabilising solution at −20 °C to confirm presence of
Pasteurella sp. by qPCR analysis.
2.8. Quantitative PCR
The qPCR analysis was performed as described previously [10].
DNA was extracted from head kidney samples using the DNEasy Kit
(Qiagen), according to the manufacturer's instructions for animal tissue
samples. The amount of Pasteurella sp. for each sample was determined
by qPCR using SYBR Green (Sigma). The primers used were RK-Past F:
5′-TTCACCATTCAAAGCACCATCAAG-3′ and RK-Past R1: 5′-CTTCTAA
AGCAGCATTGGCATTAT-3′ targeting the superoxide dismutase (sodA)
gene. Each qPCR reaction contained a volume of 25 μL and consisted of
12.5 μL 2X SYBR, 1 μL each of the forward and reverse primers (10 μM),
0.5 μL of RNAse and DNAse-free water, and 10 μL of genomic DNA
(50 ng). A C1000 Touch thermal cycler (Bio-Rad) was used for qPCR,
with the following cycle conditions: (1) 94 °C for 5min (2) 40 cycles of
94 °C for 15 s, 60 °C for 1min and (3) an increase from 60 °C to 92 °C at
a rate of 1 °C/5 s. Data was analysed using Bio-Rad CFX Manager 3.1
software (Bio-Rad).
2.9. Isolation and exposure of head kidney leucocytes to Pasteurella sp.
Six lumpsucker were quickly netted and killed by a sharp blow to
the head. Leucocytes were isolated from the head kidney on dis-
continuous Percoll gradients as described previously [8] with the fol-
lowing modifications. The supplemented L-15 medium did not contain
gentamicin sulphate, since the cells were to be exposed to viable Pas-
teurella sp. Additionally, resuspension of the isolated leucocytes was
done in L-15 supplemented with 5% foetal calf serum (L-15/FCS). The
leucocytes were counted in a CASY-TT Cell Counter TM (Innovatis AG)
and viability and aggregation factor determined.
The concentration of the isolated leucocytes was then adjusted to
1×107 cells mL−1 in L-15/FCS and 500 μL volumes were added to
each well of 4-chambered chamber slides (5×106 cells per well)
(Thermo Scientific Nunc) and incubated overnight at 15 °C. The next
morning, non-adherent cells were removed by removing the growth
medium.
An overnight culture of Pasteurella sp. was centrifuged and re-sus-
pended in L-15/FCS and adjusted to 2×105 bacterial cells mL−1.
500 μL volumes were then added to each well (1× 105 bacteria per
well). Sterile L-15/FCS medium was used for the non-challenged con-
trols. The cells were then incubated at 15 °C on a shaking incubator set
at 60 rpm for 6 h before washing and supplementing with sterile L-15/
FCS medium.
2.10. Immunofluorescence staining of bacterial exposed leucocytes
Leucocytes were sampled at 6 and 24 h post bacterial exposure. The
L-15/FCS medium including suspended bacteria was discarded and the
cells fixed in 3.7% freshly prepared paraformaldehyde for 10min.
Permeabilisation was carried out using 0.1% Triton-X 100 in PBS (v/v)
for 5min.
The wells were then blocked using 2% BSA in PBS (w/v) for 1 h,
then incubated for 1 h in a humidity chamber in the dark with primary
antibodies (rabbit anti-Pasteurella) diluted 1:10,000 in PBS containing
0.5% (w/v) BSA. This was followed by incubation in darkness with
Alexa Fluor™ 555 F(ab')2 fragments of goat anti-rabbit IgG (H + L)
(2 mg mL−1) (Invitrogen) diluted 1:400 in PBS containing 0.5% (w/v)
BSA for 1 h.
The cells were then incubated in darkness with Alexa Fluor™ 488
phalloidin (Invitrogen) diluted 1:40 in PBS containing 1% (w/v) BSA
for 20min and stained with Hoechst 33342 diluted 1:2,000 in PBS for
10min before mounting with Vectashield® antifade mounting medium
(Vector). Wells were washed three times using PBS between each in-
cubation, and further rinsed with distilled water prior to mounting.
Samples were imaged using a Leica TCS SP8 STED 3X confocal
microscope at the Molecular Imaging Centre (MIC), Bergen.
2.11. Scanning electron microscopy
Leucocytes were prepared and infected as described in Section 2.7
and sampled at 6 and 24 h post infection. The medium was then re-
moved, and cells washed three times using PBS. The cells were then
fixed in 2% glutaraldehyde diluted in 0.1 M sodium cacodylate for
2 h at 4 °C. These were then washed three times in 0.1M sodium ca-
codylate for 15min. Post-fixation was then done in 1% osmium tetr-
oxide diluted in sodium cacodylate for 1 h. Cells were then washed
twice in buffer and dehydrated in an alcohol series as follows. 35%,
50% 70% 96% alcohol each for 20min, respectively, followed by 100%
ethanol, three times for 20min each.
Samples were then submitted to critical point drying (Quorum
K850), mounted on aluminium stubs and sputter coated (Jeol JFC-
2300HR) with 10 nm Au/Pd and imaged with a Jeol JSM-7400F
(Tokyo, Japan) using 5 KV and LEI detector at the Molecular Imaging
Table 1
Challenge details showing tank group, total number of fish used and challenge
doses. There were two tank parallels for each vaccine group (25 fish per vaccine
group per tank).
Tank Dose (bacteria mL⁻1) Vaccine group n fish




















All statistical analyses were carried out using the software R 3.5.1 (R
Core Team 2018). In order to avoid false positives, the p values re-
sulting from multiple comparisons carried out on the same data set
were adjusted using the method of Benjamini & Hochberg (1995). The
level of statistical significance for all analyses was set at p=0.05. The
whiskers shown on box plot figures were scaled with factor 1.5, as the
default setting in R.
2.12.1. ELISA
The ELISA data is of hierarchical structure, with within-subject re-
peated measures. Therefore, linear mixed-effects models were used to
examine these effects. In order to evaluate which model is most ap-
propriate for the data, various model specifications were considered.
Following Pinheiro & Bates (2000), these data were compared using the
model selection criteria Akaike Information Criterion (AIC), Bayesian
Information Criterion (BIC), and Likelihood Ratio Tests (LRT). The
parameters of the finally selected models were re-estimated via REML.
When a significant effect was found, post hoc-type comparisons were
performed within the mixed effects framework.
2.12.2. Survival analysis
The results from the vaccine trial were analysed by classical
methods from survival analysis, specifically the non-parametric Kaplan-
Meier framework. Different Kaplan-Meier curves were compared by the
log-rank test. For each bacterial dose used in the bath challenge, a test
for an effect of any vaccine type on the hazard function was first carried
out. If an effect was found, post-hoc tests were carried out to determine
which of the vaccine types was significant.
Differences in mortalities between the non-concentrated and con-
centrated vaccines at the end of the trial were analysed using Chi square
tests for 2×2 contingency tables.
The qPCR data on presence of bacteria in fish sampled from the




Analyses of sera collected from vaccinated lumpsucker showed that
specific antibody production was induced by vaccination and that the
levels of antibodies produced increased over time. Significantly dif-
ferent levels of specific antibodies were detected when comparing sera
from fish vaccinated with the two test vaccines, where the fish vacci-
nated with the concentrated vaccine produced significantly higher le-
vels of specific antibodies. For both vaccines, the highest levels of
specific antibodies were detected at 500° days post vaccination.
The optical density (OD) of antibody levels induced by vaccines at
different degree days are shown in Fig. 1. The OD values increase with
time, with a strong effect at 300° days (for the concentrated vaccine)
and 400° days (for the non-concentrated vaccine); the OD values for the
non-concentrated vaccine seem to rise less steeply than for the con-
centrated vaccine.
Statistically, the results from post-hoc tests confirmed that the OD
values are significantly different to the baseline from 300° days on-
wards for the concentrated vaccine and from 400° days onwards for the
non-concentrated vaccine. Furthermore, from 400° days onwards, OD
values for the concentrated vaccine are significantly different from
those corresponding to the non-concentrated vaccine.
3.2. Vaccine efficacy trial
A range of bacterial challenge doses was investigated in order to
determine the optimal level to test the efficacy of the vaccines being
developed. As shown in Fig. 2, the lowest challenge dose resulted in
very low mortalities (below 40% in all groups) and for this reason, this
dose was not used for further statistical analysis. The other challenge
doses all resulted in mortalities higher than 60% for the two control
groups. The mortalities from the two vaccine groups follow a similar
pattern to each other; however, in the case of the highest challenge
dose, mortalities were considerably higher than 60% mortality.
The concentrated vaccine resulted in the best survival rates of all the
vaccines tested. However, statistical analysis failed to verify any sig-
nificant difference in survival rates found between the two Pasteurella
sp. vaccines tested, at any bacterial dose. For the highest three chal-
lenge doses there was a significant difference (p < 0.05) in survival
rates between the PBS controls and the fish immunised with the con-
centrated vaccine, overall. The survival rates from the fish immunised
with the non-concentrated vaccine differed significantly from those of
the control vaccinated fish only in the 1×106 and 5×105 bacteria
mL−1 challenge doses.
Chi square analysis of the relative percent survival at the end of the
challenge (Table 2) however indicates that a significant difference can
be observed between the two vaccines.
Clinical symptoms observed in the challenged fish included those
reported previously [10], such as haemorrhage and redness at the base
of fins and on the lower jaw, as well as white spots along the body and
around the eyes. In addition, frayed tail fins were also encountered, as
recorded in other work [3].
The antisera raised against Pasteurella sp. in lumpsucker contained
antibodies reactive towards proteins of high molecular weight (more
than 75 kDa) (Fig. 3 B, C, D). Sera from triple immunised lumpsuckers
(Fig. 3D) additionally contained antibodies reactive to proteins of ap-
proximately 37 kDa and 48 kDa, which may correspond to major pro-
tein bands identified by silver staining (Fig. 3A). The sera from the
vaccinated fish also reacted to the protein at approximately 48 kDa,
albeit not as strongly as the serum from triple immunised lumpsuckers.
The sera from lumpsucker vaccinated with concentrated and non-con-
centrated vaccine contained antibodies reactive towards proteins of
similar molecular weight. The sera produced in rabbit contained anti-
bodies reactive towards several proteins of varying molecular weight,
including a band at just below 20 kDa (Fig. 3E) which was not identified
by the other sera. By comparison, sera from the triple immunised
lumpsucker (Fig. 3D) did not contain the same variety of antibodies as
the serum from immunised rabbits. All sera, including the control
serum, reacted to components at approximately 15 kDa.
3.3. Re-isolation of Pasteurella sp.
Pasteurella sp. was re-isolated from all fish sampled following bath
challenge when grown on blood agar containing 2% sodium chloride.
qPCR also confirmed the presence of Pasteurella sp. in the head kidney
samples of dead fish (Fig. 4). This was done as previously described
[10], where the values obtained in this challenge were compared to
those from a spiked standard curve. Statistical analysis did not detect
any significant differences in bacterial load between the two test vac-
cines and the PBS-vaccinated control.
3.4. In vitro experiments
Confocal microscopy of leucocytes exposed to Pasteurella sp. showed
that bacteria were possibly present inside the cells both at 6 h and at
24 h post infection (Fig. 5). In SEM images (Fig. 6), bacteria were visible
as individual cells on the surface as well as possibly underneath the
surface of the leucocytes at 6 h post infection.
This is also seen in the confocal images (Fig. 5), where bacteria are
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seen as red dots within the cell, in and around the nucleus of the leu-
cocyte. The bacteria seem to aggregate into chains which gradually
become coiled, as can be seen from the SEM and confocal images at
24 h. They also appear to be attached to the surface of the cell. This
coiling effect was also observed from Gram stains of the bacteria kept in
L-15/FCS and TSB for 24 h, but not in Gram stains done after 6 h of the
bacteria in L-15/FCS or TSB (data not shown), and in confocal photo-
micrographs. As can be noted in Fig. 5B, the bacteria become slightly
more elongated and narrower with time as they accumulate to form the
coiled chains. The effect of the bacteria on the leucocytes can also be
observed with time as these become apoptotic with time but appear
Fig. 1. Antibody levels (OD) post-vaccina-
tion measured by ELISA. The horizontal
dashed line represents the non-vaccinated
baseline control; the boxes represent the
first and third quartiles, while the thick
solid horizontal line represents the median.
The whiskers represent the range of values
recorded. (NC: Non-concentrated vaccine,
C: Concentrated vaccine).
Fig. 2. Survival curves resulting from the vaccine efficacy trial using different bath challenge doses. A: 1× 105 bacteria mL−1, B: 5×105 bacteria mL−1, C: 1× 106
bacteria mL−1, D: 1×107 bacteria mL−1. n=100 per challenge dose. The results from identical duplicate tanks are combined prior to presentation.
Table 2
Relative percent survival (RPS) at the end of the vaccine trial. *p-value: com-
parison of mortalities from the two vaccine groups at the end of the trial and set









5× 105 44.83 44.83 1
1×106 41.03 20.51 0.39
1× 107 21.82 1.27 0.03
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morphologically intact and healthy at 6 h post infection.
4. Discussion
Vaccination of lumpsucker using Pasteurella sp. bacterins has, to our
knowledge, not been carried out. This has mostly been due to diffi-
culties in culturing the newly encountered pathogen in liquid media. In
this work, we used results obtained from previous experiments in order
to enhance our understanding of Pasteurella sp. and to establish pre-
ventative measures against pasteurellosis in lumpsuckers.
ELISA analysis of sera collected from vaccinated fish showed that
specific antibodies are generated in relatively high amounts following
vaccination with Pasteurella sp. bacterins. This is supported by earlier
findings showing that Pasteurella sp. is highly immunogenic in lump-
sucker, providing high levels of specific antibodies after triple im-
munisation [9]. Moreover, the concentrated vaccine resulted in higher
levels of specific antibodies generated, which was likely related to the
increased antigen dose. In the concentrated preparation of this vaccine,
the bacteria were centrifuged and approximately 90% of the super-
natant was discarded prior to further processing. Therefore, the ma-
jority of any extracellular proteins (ECPs) produced by the bacteria
were not included, unlike the non-concentrated vaccine. However, the
number of inactivated bacterial cells per mL were approximately 10-
fold higher for the concentrated vaccine, and the slightly higher pro-
tection after challenge observed for the concentrated vaccine was likely
due to the increased antigen content per dose.
The vaccines did not provide complete protection against the dis-
ease. Although the onset of mortality was delayed and the total levels of
mortality somewhat reduced, the protection provided by the vaccines
was relatively weak. Quite high mortalities still occurred for the vac-
cinated groups, with approximately 40% relative protection (RPS) at
the end of the trial at best. Although the infection pressure in the
highest challenge dose may have masked the effect of the vaccine, re-
sulting in the lack of protection observed, this was also seen in the next
weaker dose, where mortality in the vaccinated groups was higher than
40%.
The clinical signs of diseased fish observed in this experiment were
similar to those reported previously [10]. Of interest was the observa-
tion of an additional clinical sign in this study i.e. the frayed fins in the
early stages of the infection in the higher two challenge doses used in
the trial. This was also observed during a natural outbreak of pasteur-
ellosis in lumpsuckers [3]. Development of these clinical signs together
could be due to the different challenge pressure and dynamics present
in this trial.
Both experimental vaccines induced significantly increased levels of
specific antibodies. A weak trend was detected where the concentrated
vaccine consistently provided slightly better protection compared to the
non-concentrated vaccine and this might be related to the increased
antibody levels. However, significant differences in RPS between the
two groups at the end of the challenge could only be proven for the
Fig. 3. SDS-PAGE silver stained protein profile of
Pasteurella sp. bacterial components and serum an-
tibody specificity analysed by western blots. A: silver
stained protein profile of Pasteurella sp., B: Western
blot using serum from fish vaccinated with non-
concentrated Pasteurella sp. vaccine, C: Western blot
using serum from fish vaccinated with concentrated
Pasteurella sp. vaccine, D: Western blot using serum
from fish triple immunised with Pasteurella sp. E:
Western blot using rabbit anti-Pasteurella serum, F:
Western blot using serum from non-vaccinated
lumpsuckers.
Fig. 4. qPCR confirmation of presence of Pasteurella sp. in dead challenged vaccinated and control fish. The boxes represent the first and third quartiles, while the
thick solid horizontal line represents the median. The whiskers represent the range of values recorded. (NC: Non-concentrated vaccine, C: Concentrated vaccine).
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highest challenge dose.
Host-pathogen interactions between Pasteurella sp. and lumpsucker
leucocytes as observed in this study have also been noted for other
pathogens that interfere with the immune system of the host. M. viscosa
eludes protective immune responses of the host by suppressing the
production of IL1β, hence delaying bacterial elimination [15], while
Yersinia ruckeri [16] and Francisella noatunensis subsp. noatunensis
[17–19] reside and replicate within macrophages.
The immunoblot showing only a few highly antibody-reactive bands
from the SDS-PAGE separated bacterial components might suggest that
the specificity and reactivity of the antibodies is not directed towards
major cell wall-integrated components. This might partly explain the
limited protection conferred. The reason for the low number of reactive
bands on the immunoblot can be that the proteins are glycosylated and
not well transferred to the membrane. If any loosely attached carbo-
hydrate antigens are present in the antigen preparations of the vaccines,
Fig. 5. Confocal micrographs after in vitro infection of head kidney leucocytes (HKL) with Pasteurella sp. Leucocyte actin filaments and nuclei are stained green and
blue, respectively, while bacteria are stained red. A: Non-infected HKL. B: Isolated Pasteurella sp. Top series: sections through an infected HKL, 6 h post infection.
Bottom series: sections through infected HKL, 24 h post infection. All scale bars: 5 μm. (For interpretation of the references to colour in this figure legend, the reader is
referred to the Web version of this article.)
Fig. 6. Scanning electron micrographs (SEM) of head kidney leucocytes at two time points post in vitro infection. Scale bar= 10 μm for the first image in each series,
1 μm for the two following images. White arrows indicate leucocytes, while black arrows indicate bacteria.
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they can significantly contribute to the high levels of antibodies ob-
served in ELISA.
The presence of carbohydrate and protein reactive fish antibodies to
bacterial cell surface components can be detected by other methods
[20]. However, there is an obvious difference observed using rabbit
serum where many antibody-reactive bands are seen in the im-
munoblot. Thus, bacterial components are well transferred to the ni-
trocellulose membrane, and the differences observed between lump-
sucker sera and rabbit sera might be species dependent and also
dependent on immunisation procedure and adjuvants, since there are
more bands from the triple immunised lumpsucker serum, than from
the serum from the vaccinated lumpsuckers.
Previous studies on the adaptive immune responses of lumpsucker
indicated that IgM+ B cells abundant in blood were highly phagocytic,
and provided a specific antibody response following immunisation [9].
Further work [14] showed that lumpsucker vaccinated with atypical A.
salmonicida developed a strong humoral immune response to the bac-
teria, which resulted in significant protection of the fish against bac-
terial disease tested by challenge. This was also investigated in another
study [21], where it was found that specific antibody responses to V.
anguillarum serotype 01 and M. viscosa were lower than towards aty-
pical A. salmonicida. The levels of antibodies to the various bacteria
recorded in these studies are in the same range as those identified in the
current work. However, in contrast to the previously mentioned studies
for other bacteria, protection against Pasteurella sp. in the present study
was relatively weak.
The potency of commercial vaccines must be tested by means of
correlates of protection. For fish vaccines, this is usually performed by
vaccination-challenge experiments using the pathogens the vaccine is
intended to protect against. However, it is also acceptable to use ap-
propriately validates alternative methods not involving challenge of
fish. One example of such correlates are specific immune responses to
antigens present in a vaccine that elicit protection against an infection
or disease [22]. Therefore, vaccines should ideally induce opsonopha-
gocytic and/or neutralising antibodies and should activate immune
functions mediated by CD4+ and possibly also CD8+ cells [22].
Moreover, antibody levels measured post-vaccination in vitro (such as
through ELISA) will not distinguish between neutralising and non-
neutralising antibodies, and typically the latter would be antibodies
that are not involved in opsonophagocytosis [22] or complement
mediated killing. Such antibodies would be surrogates of protection,
since they are straightforward to measure, but not directly related to
the correlate of protection.
From confocal microscopy of in vitro infected leucocytes, one can
see aggregated bacteria interacting with the leucocytes. In a previous
study [10], diffuse bacterial aggregates were observed in tissue samples
from challenged lumpsucker. Whether this take place in natural infec-
tions is not clear, but bacterial aggregates would possibly have an im-
pact on the antibody functionality and cause suboptimal bacterial
clearance. These factors could possibly explain the results obtained
from our vaccine trial with findings of bacterial specific antibodies, but
a lack of protection in challenge experiments. Thus, despite the vac-
cines being capable of eliciting B cell production of specific antibodies,
these did not provide sufficient protection from disease and mortality.
The possibility of Pasteurella sp. being intracellular, may be in-
dicated from the immune detection of bacteria through confocal mi-
croscopy and to an extent, through SEM photomicrographs, as bacteria
are possibly found inside leucocytes. Whether this bacterium can reside
or even replicate within cells remains to be studied. In that case, im-
proved activation of cellular immune responses could be important to
achieve better protection against pasteurellosis. The aggregation of
bacteria seen during in vitro assays may be a survival strategy to protect
against either leucocytes activities, or the incubation medium itself, or
other factors including changes in pH. However, considering the results
from SEM and confocal microscopy, it cannot be excluded that
Pasteurella sp. may be a facultative intracellular pathogen and possibly,
therefore, stimulation of cellular immunity may be vital to achieve
protection of lumpsucker against Pasteurella sp.
Agglutination tests carried out showed that the immune sera raised
against the bacteria agglutinated live Pasteurella sp. indicating that
binding to bacterial surface components does occur. It is tempting to
speculate, however, considering the low protection obtained by the
tested vaccines, that an extracellular capsule, proteins or toxins may be
involved in disease progression. If toxic extracellular proteins were
involved, extensive genome analysis would be required in order to
identify the specific virulence factors and consider if antibodies with
antitoxin properties can be obtained.
5. Conclusion
In summary, despite lumpsuckers responding to vaccination with
monovalent inactivated Pasteurella sp. vaccines by producing specific
antibodies, the protection against experimental challenge was relatively
weak. A reason for this could potentially be that a specific antibody
response is not enough to provide complete protection. This indicates
that parts of the immune system other than the humoral part could be
important for protection against pasteurellosis, highlighting the need
for further work on the mechanism of infection of Pasteurella sp. in
lumpsucker. Additionally, there might be pathogen specific virulence
factors involved in disease development such as intracellular localisa-
tion, extracellular and toxic proteins, as well as aggregation.
Considering all these results and observations, we think the virulence
factors of Pasteurella sp. isolate from lumpsuckers should be thoroughly
investigated.
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Abstract: Pasteurellosis in farmed lumpsuckers, Cyclopterus lumpus, has emerged as a serious disease
in Norwegian aquaculture in recent years. Genomic characterization of the causative agent is
essential in understanding the biology of the bacteria involved and in devising an efficient preventive
strategy. The genomes of two clinical Pasteurella atlantica isolates were sequenced (≈2.3 Mbp),
and phylogenetic analysis confirmed their position as a novel species within the Pasteurellaceae. In
silico analyses revealed 11 genomic islands and 5 prophages, highlighting the potential of mobile
elements as driving forces in the evolution of this species. The previously documented pathogenicity
of P. atlantica is strongly supported by the current study, and 17 target genes were recognized as
putative primary drivers of pathogenicity. The expression level of a predicted vaccine target, an
uncharacterized adhesin protein, was significantly increased in both broth culture and following
the exposure of P. atlantica to lumpsucker head kidney leucocytes. Based on in silico and functional
analyses, the strongest gene target candidates will be prioritized in future vaccine development
efforts to prevent future pasteurellosis outbreaks.
Keywords: Pasteurella atlantica; lumpsucker; aquaculture; pathogenicity; phylogeny; in silico analysis;
virulence factors; mobile elements; vaccine
1. Introduction
The prevalence of pasteurellosis in farmed lumpsuckers, Cyclopterus lumpus, in Nor-
way has increased in recent years since the first case was recorded in 2012 [1]. Despite a
decrease in the number of affected localities [2], Pasteurella atlantica [3] remains a significant
problem, and as the disease is non-notifiable, under-reporting of outbreaks cannot be
excluded. Furthermore, while farmed lumpsuckers are vaccinated against vibriosis and
atypical furunculosis, there are no commercially available vaccines against pasteurellosis.
The family Pasteurellaceae is composed of commensals, opportunistic- and primary-
pathogens and includes the genera Pasteurella, Actinobacillus, and Hemophilus amongst
others. The genus Pasteurella has a broad host range, but little is known regarding the
ecology of marine species. P. atlantica isolated from diseased Norwegian lumpsuckers
is related to but serologically distinct from Pasteurella skyensis, which causes disease in
Atlantic salmon (Salmo salar L.) in Scotland, and a P. atlantica isolate first detected in 2018,
which causes disease in Norwegian farmed Atlantic salmon [1,3,4]. Pasteurellosis affects all
Microorganisms 2021, 9, 1215. https://doi.org/10.3390/microorganisms9061215 https://www.mdpi.com/journal/microorganisms
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life stages of a lumpsucker, from fry to fish deployed in salmon cages [4]. As P. atlantica has
been detected in lumpsucker eggs and milt, vertical transmission may also be possible [5].
In a previous work [6], we showed that whole cell-inactivated bacterin-based vaccines
do not provide adequate protection against the disease, despite the high titers of specific
antibodies raised. Such a situation highlights the need for a deeper characterization of the
bacterium and the identification of immunogenic and protective antigens.
Most pathogenic bacteria have several tools in their genetic arsenal to avoid host
defenses and to enhance their survival. Genetic determinants including pathogenicity
islands, antibiotic resistance genes, toxins, and adhesins are often shared between bacterial
populations via horizontal gene transfer and are commonly associated with plasmids,
prophages, and other mobile genetic elements. As adhesins are involved in the early
stages of colonization, they can be utilized as targets for vaccine development via reverse
vaccinology (RV).
Using in silico bioinformatic analyses, immunogenic antigens for vaccine development
can be predicted [7,8]. RV is a rapid process and can reduce vaccine development time by
up to 2 years [9]. It is also a more ethical approach due to a reduction in the number of ex-
perimental animals required for vaccine testing and results in effective vaccines. In human
medicine, RV has been successful in the development of vaccines against several bacterial
pathogens reviewed by Sharma et al. 2021 [10]. Pathogens of significant concern such
as Neisseria meningitidis [11,12], Mycobacterium tuberculosis [13], Chlamydia pneumoniae [14],
Streptococcus pneumoniae [15], Helicobacter pylori [16], Porphyromonas gingivalis [17], and
Bacillus anthracis [18,19] have been investigated using RV.
RV technologies have improved considerably since the principles were initially de-
veloped and applied. The main criteria required for reliable prediction of vaccine targets
include subcellular localization, the probability of adhesion functionality, and the number
of transmembrane domains [20]. Additionally, using targets that are present only in viru-
lent strains and having protein sequences that are dissimilar to host sequences results in
more reliable vaccine targets that also induce strong immune responses [9].
Adhesins are a class of surface-bound proteins involved in facilitating bacterial attach-
ment to host tissues. They are classed as fimbrial or non-fimbrial based on the absence or
presence, respectively, of an outer membrane anchor in the protein. Among the different
types of adhesins, bacterial lectins are the most common [15]. The mediation of attachment
occurs through the recognition of specific carbohydrates, proteins, or lipids presented on
the host cell surface.
In addition to attachment, adhesins also promote the delivery of toxins through the
upregulation of virulence genes leading to invasion of the host. Furthermore, such interac-
tions can trigger cytokine production or lectinophagocytosis by the host, compounding the
severity of disease [21]. For this reason, subunit vaccines that hinder microbial attachment
could be of great advantage in combating pasteurellosis in lumpsuckers. Examples of
successful adhesin vaccines include those against enterotoxigenic E. coli (ETEC) strains in
farm animals using the K88 fimbriae [22] as well as uropathogenic E. coli (UPEC) known
to cause urinary tract infections (UTIs) using the FimCH complex [23]. For the aqua-
culture industry, vaccines have been tested by targeting major bacterial adhesins from
Aeromonas hydrophila [24,25], Vibrio harveyi [26], and Edwardsiella tarda [27].
As research on P. atlantica in lumpsuckers is still in its infancy, no commercial vaccines
are available against pasteurellosis in lumpsuckers. Simple phylogenetic analyses using
the rpoB and 16S rRNA genes have shown that NVI-9100 is similar to other Pasteurella sp.
isolated from lumpsuckers [4]. Whole genome analysis can, however, determine more
accurate phylogenetic relationships. The purpose of this study is, therefore, to determine
the taxonomic position of the species through whole genome sequencing and to predict
potential vaccine antigens via in silico analysis. To further assess the predicted vaccine
targets, their expression levels during exposure to lumpsucker leucocytes were analyzed
in vitro.
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2. Materials and Methods
2.1. Bacterial Culture, Genome Isolation, and Sequencing
Two P. atlantica isolates described in previous studies (NVI 9100 and UiBP1-2013) [4,6,28]
collected from clinically sick lumpsuckers were whole-genome sequenced. Briefly, bacteria
were grown in tryptic soy broth (TSB) (Becton Dickinson, Sparks, MD, USA) supplemented
with 1.5% NaCl and 10% fetal bovine serum, Australian origin, (Gibco, Waltham, MA,
USA) at 20 ◦C with shaking (200 rpm).
Total genomic DNA was isolated using the DNeasy Blood and Tissue Kit (Qiagen,
Hilden, Germany) following manufacturer instructions. Briefly, 3 mL of an overnight
culture of P. atlantica containing a maximum of 2 × 109 cells was centrifuged at 2500× g
for 15 min and the pellet was resuspended in 180 µL of ATL buffer. Twenty microliters
of proteinase K were then added, and the bacteria were incubated at 56 ◦C in a rotating
heat block for 1 h. Two hundred microliters of AL buffer and two hundred microliters of
96% ethanol were added, vortexing well between additions. The mixture was then loaded
onto DNeasy Mini Spin columns and washed with the appropriate buffers (AW1 and AW2)
prior to elution using buffer AE. The eluted DNA was then purified and measured for
concentration before storing at −20 ◦C until further processing.
Extracted DNA was sequenced using either an Illumina (UiBP1-2013) or PacBio
(NVI 9100) platform. Illumina libraries were made using the Nextera DNA Flex Sample
Prep kit (Illumina, San Diego, CA, USA) according to the manufacturer instructions and
sequenced with Illumina MiSeq (Illumina, San Diego, CA, USA) using V3 chemistry. PacBio
libraries were prepared with the Pacific Biosciences 20 kb library preparation protocol, and
size was selected using BluePippin (Sage Science, Beverly, MA, USA), with subsequent
sequencing performed on a Pacific Biosciences RS II instrument using P4-C2 chemistry and
employing three SMRT cells (Pacific Biosciences, Menlo Park, CA, USA).
Raw Illumina sequences were adapter trimmed, quality filtered (Q > 20), de novo
assembled using [29,30]. Contigs shorter than 1000 bp or with <5 times coverage were
removed from each assembly prior to gene annotation. The genes of the Illumina se-
quenced genome were predicted by Glimmer 3, version 3.02b; Johns Hopkins University:
USA, 1999 [31].
PacBio sequences were de novo assembled using HGAP version 3 (Pacific Biosciences,
SMRT Analysis Software version 2.2.0) and circularized with the Minimus2 software
version 2 (Amos package). For post-circularization correction of bases, reads were subse-
quently mapped to the circularized sequences using RS_Resequencing.1 software (SMRT
Analysis version version 2.3.0).
This whole genome project has been deposited at GenBank under the Accession
Number PRJNA721926 (UiBP1-2013) and Accession Number CP074346 (NVI 9100).
2.2. Phylogenetic Analysis
Twenty-three Pasteurellaceae genomes (Table 1) were included for phylogenetic analyses.
In order to evaluate similarity among whole genomes, Orthologous Average Nu-
cleotide Identity Tool using OrthoANI [43] was used to provide reliable and fast assess-
ment of average nucleotide identity (ANI) for taxonomic classification purposes. A Similar
Genome Finder with high similarity parameters (max hits: 50; p-value threshold: 1; dis-
tance: 0.5) utilizing Mash, a fast genome distance estimation tool [44], mounted on the
Pathosystems Resource Integration Center (PATRIC) platform (https://patricbrc.org/ (ac-
cessed on 3 June 2021)) [45,46] was also used to assess the genomic similarity of P. atlantica
to the bacterial database.
PATRIC [45,46] was used to construct a whole-genome codon-based tree built on
500 single-copy genes [47] present in all genomes studied (Table 1). Both amino acid
and nucleotide sequences were aligned using MUSCLE [48] and the codon align function
of Biopython [49], respectively. The concatenated alignments of protein and nucleotide
sequences were used in order to generate a RAxML method-based phylogenetic tree with
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branch support values determined by 100 rounds of rapid bootstrapping [50,51]. The tree
was visualized using iTOL online platform [52].
Table 1. Twenty-three Pasteurellaceae genomes used to evaluate the phylogenetic position of P. atlantica.
Bacterial Species Name (GenBank) Animal Host Country Genome Ref.
Pasteurella strains
Pasteurella multocida strain ATCC43137 Pig n/a Assembly NCBI
Pasteurella dagmatis strain NCTC11617 Human n/a Assembly [32]
Pasteurella testudinis strain DSM23072 Desert tortoise USA WGS—69 contigs [33]
Pasteurella bettyae strain CCUG2042 Human USA WGS—47 contigs NCBI
Pasteurella langaaensis strain DSM22999 Ga0215636 Chicken Denmark WGS—29 contigs [32]
Pasteurella caecimuris strain NM44_TS2-9 Mouse Canada WGS—53 contigs NCBI
Pasteurella canis strain NCTC11621 Human n/a WGS—20 contigs [32]
Pasteurella oralis strain WCHPO000540 Human China WGS—30 contigs [34]
Pasteurella skyensis strain DSM24204 Atlantic salmon Scotland WGS—56 contigs [35]
[Pasteurella] aerogenes strain NCTC13378 n/a Finland Assembly NCBI
Pasteurella pneumonotropica strain DSM21403 Mouse USA WGS—22 contigs NCBI
Non-Pasteurella strains
Phocoenobacter uteri strain NCTC12872 Harbor porpoise Scotland WGS—5 contigs [36]
Hemophilus hemolyticus strain 65117 B Hi-3 Human Australia WGS—16 contigs NCBI
Hemophilus hemolyticus strain M19346 Human USA Assembly [37]
Hemophilus influenzae strain 156_HINF Human USA WGS—41 contigs [38]
Hemophilus influenzae strain NCTC8143 Human UK Assembly NCBI
Hemophilus parainfluenzae strain 155_HPAR Human USA WGS—61 contigs [38]
Hemophilus parainfluenzae strain T3T1 n/a n/a Assembly NCBI
Aggregatibacter aphrophilus strain C2008001782 Human USA WGS—16 contigs [39]
Aggregatibacter aphrophilus ATCC33389 strain NCTC5906 n/a UK Assembly NCBI
Glaesserella parasuis strain F9 Pig Spain WGS—182 contigs [40]
Actinobacillus indolicus strain AIFJ1607 Pig China Assembly [41]
Mannheimia hemolytica strain M42548 Ruminants n/a Assembly [42]
2.3. Analysis of Genomic Regions and Reverse Vaccinology Approach
The novel genomes were screened against major virulence factor databases. Specifi-
cally, the proteome of P. atlantica was blasted against VFDB [53] and VICTORS [54] using
an e-value of 1 × 10−10. A moderate e-value was applied to avoid false positive hits while
identifying as many presumptive virulence factors as possible. The prediction was com-
plemented by screening against PATRIC_VF [55], the integrated virulence factor database
inside the PATRIC platform (https://patricbrc.org/ (accessed on 3 June 2021)) [45,46]. Sub-
cellular localization for all presumptive virulence factors was examined by PSORTb 3.0 [56]
to evaluate putative interaction with the extracellular environment (localization score
threshold >7.5). Proteins with both extracellular and outer membrane subcellular localiza-
tion were imported to SignalP server [57] in order to further assess any known types of
signal peptides as well as the pathways in which they are involved during their secretion
or anchoring process (threshold >90%). The detection of possible adhesion-related func-
tionality was tested in SPAAN [58]. A Protein Fold Recognition Server, Phyre2 [59], was
applied to obtain insights on structure and folding properties of presumptive virulence
factors using confidence level of above 97%.
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Clusters of genes of probable horizontal origin, known as genomic islands (GIs),
were identified by IslandViewer 4, version 4; Simon Fraser University: Canada, 2017 [60].
Inducible prophages were detected using the prophage finder tool, PHASTER [61], while
VIRFAM [62] was used to classify intact prophages.
In line with reverse vaccinology principles, the identification of the strongest virulence
candidates was deduced through Dynamic Vaxign Analysis, Vaxign [63], a software plat-
form that has been developed and dedicated to vaccine design. The pipeline of Vaxign has
integrated PSORTb [56] and SPAAN [58] so it can also be used to validate the previously
identified virulence factors. Vaxign-ML [20] was also included in the reverse vaccinology
analysis as a machine learning model to improve the prediction of bacterial protective
antigens. VaxiJen [64] complemented the analysis to corroborate that the finally selected
candidates for vaccine development also can function as protective antigens, which is a
prerequisite for vaccine development.
2.4. Functional Studies
2.4.1. Processing Bacteria for qPCR Analysis
Cultures of P. atlantica (UiBP1-2013) used for the in vitro exposure experiment
(Section 2.4.5) were cultivated as described in Section 2.1, harvested in the late expo-
nential growth phase (18 h post inoculation) and centrifuged at 2500× g (Beckman Coulter
Allegra X-15R) for 15 min at 4 ◦C. For the gene expression analysis during bacterial cell
proliferation in growth medium, 1 mL samples were harvested 14, 16, 18, and 20 h after
inoculation. Bacterial cell counts were measured at harvest using a cell counter (CASY
Model TT (Innovatis) and CASY worX version 1.26) followed by centrifugation at 4000× g
(Beckman Coulter Allegra X-15R) for 10 min at 4 ◦C. For both methods, the growth medium
was then discarded, and the samples were stored on ice.
Total RNA was immediately extracted using the Bacterial RNA Kit (E.Z.N.A., Norcross,
GA, USA) according to manufacturer instructions. The RNA was then DNase-treated
(Sigma-Aldrich, Saint-Louis, MO, USA), converted to cDNA using qScript cDNA Synthesis
Kit (Quantabio, Beverly, MA, USA), and stored at −20 ◦C.
2.4.2. qPCR
Each qPCR reaction contained a volume of 25 µL and consisted of 12.5 µL 2× SYBR
Green JumpStart Taq Ready Mix (Thermo-Fisher Scientific, Waltham, MA, USA), 1 µL
each of the forward and reverse primers (10 µM final working concentration, Table 2),
0.5 µL of RNase and DNase free water (Sigma-Aldrich), and 10 µL of cDNA (concentration
depended on the specific analysis). A C1000 Touch thermal cycler with CFX96 Real-Time
System (Bio-Rad, Oslo, Norway) was used for qPCR, with the following cycle conditions:
94 ◦C for 5 min followed by 40 cycles of 94 ◦C for 15 s and 60 ◦C for 1 min. Melting curve
analyses were performed after each run (60 to 92 ◦C at a rate of 1 ◦C/5 s) to ensure that
the specificity of the primers and the qPCR products were visualized on a 2% agarose gel.
Three parallel reactions were performed for each gene, and negative controls excluding
cDNA (NTC) and cDNA reactions without reverse transcriptase (NRT) were included for
all master mixes. The gene expression levels were calculated by the ∆∆Ct method [65].
Table 2. Details of primers for reference genes and the target gene used for qPCR.
Gene Primer Name Sequence 5′-3′ Primer Length (bp)
gyrA #27-B_GYRA_F3 GTTCATCGGGTATTGCGGTCGGTAT 25
#28-B_GYRA_R3 TCCTGTGCGGTAAGCGTCTTCG 22
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2.4.3. Primer Design and Validation
Genes considered for this work were based on the results from an analysis of genomic
regions and potential vaccine targets. The genes selected as reference genes were rpoD and
gyrA. The target gene selected was the putative uncharacterized protein (<Hia>) (Table 2).
qPCR assays were designed using the software Primer Premier version 6.24 (Premier
Biosoft, San Francisco, CA, USA). The five highest rated assays for each target sequence
were then chosen for testing. The length of the amplicons was kept between 100 and
250 bp for optimal amplification efficiency. The specificity of the primers was confirmed
by qPCR (20 ng of cDNA used in each qPCR reaction), and product size was observed by
electrophoresis on 2% agarose gels. All of the qPCR assays produced single amplification
products. The best assay for each target gene based on Cq value, non-template controls,
melting curves, and the results of electrophoresis were then chosen for further work. The
resulting primers used for qPCR are listed in Table 2.
2.4.4. Bacterial Exponential Growth Phase Analysis
P. atlantica was grown as described in Section 2.1. At different time points after
inoculation, the bacteria were harvested, the RNA was isolated, and cDNA synthesis was
performed as described in Section 2.4.1. The synthesized cDNA was diluted across a
twofold dilution series to give a range from 10 ng/µL to 0.625 ng/µL of cDNA for both the
target and reference genes in qPCR (100 ng to 6.25 ng in each qPCR reaction). The relative
gene expression was calculated by the ∆∆Cq method using the most suitable dilution from
the range tested, and comparisons of gene expression were made to the lowest stable time
point of the analysis.
2.4.5. Head Kidney Leucocyte (HKL) Exposure Analysis
Four lumpsuckers were quickly netted and killed by a sharp blow to the head. Leuco-
cytes were isolated from the head kidney on discontinuous Percoll gradients as described
previously [66] with the following modifications. The supplemented L-15 medium did
not contain gentamicin sulphate since the cells were to be exposed to viable P. atlantica.
Additionally, resuspension of the isolated leucocytes was performed in L-15 supplemented
with 5% fetal calf serum (L-15/FCS). The leucocytes were counted in a CASY-TT Cell
Counter TM (Innovatis AG), and the viability (95%) and aggregation factor (1.2) of the
cells were determined. The concentration of the isolated leucocytes was then adjusted to
3.3 × 106 cells mL−1 in L-15/FCS, and 250 µL volumes were added to each well of the
24-well Nunc plates (approximately 8 × 105 cells per well) (Thermo-Fisher Scientific) and
incubated overnight at 15 ◦C prior to exposure to P. atlantica.
A late exponential phase (18 h) culture of P. atlantica was prepared as described in
Section 2.4.1, re-suspended in L-15/FCS, and adjusted to 1.5 × 108 bacteria mL−1. Volumes
of 250 µL were then added to each well (approximately 4 × 107 bacteria per well). Sterile
L-15/FCS medium was supplied to the leucocytes and used for the non-challenged controls.
The cells were then incubated at 15 ◦C, and samples were collected at 3, 6, 9, 12, and 24 h
after exposure. Samples were collected from the wells and centrifuged to remove all media
prior to storage at −80 ◦C, until the total RNA was isolated, DNase treated, and converted
to cDNA as described above. For qPCR, 80 ng per reaction was used as the template for
both the target and reference genes.
2.4.6. Statistical Analysis
The relative gene expression during the HKL exposure was calculated by the ∆∆Cq
method [65] and comparisons were made to the negative controls (bacteria without leuco-
cytes). The results were analyzed using two-way ANOVA and Fisher’s LSD for post hoc
tests, and differences were considered significant when p < 0.05. All statistical analyses
were carried out using SigmaPlot version 12 (Systat Software, San Jose, CA, USA).
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3. Results
3.1. Novel Sequenced Genome and Accession Numbers
The length of the PacBio sequenced P. atlantica genome (NVI 9100) is 2,301,649 bp,
with a GC content of 42.1%, and 2197 coding regions (CDS) were predicted. The length of
the Illumina sequenced P. atlantica genome (UiBP1-2013) is 2,260,408 bp.
3.2. Phylogenomics and Taxonomic Classification
The P. atlantica strains were isolated from Cyclopterus lumpus in a previous study
where preliminary phylogenetic analysis was performed based on 16S rRNA and rpoB
gene sequencing [4]. To assess pairwise similarity percentages among Pasteurella species,
nine different publicly availably Pasteurella species genomes (Table 1) and P. atlantica were
analyzed using the OrthoANI tool (Figure 1).
Microorganisms 2021, 9, x FOR PEER REVIEW 7 of 23 
 
 
converted to cDNA as described above. For qPCR, 80 ng per reaction was used as the 
template for both the target and reference genes. 
2.4.6. Statistical Analysis 
The relative gene expression during the HKL exposure was calculated by the ΔΔCq 
method [65] and comparisons were made to the negative controls (bacteria without leu-
cocytes). The results were analyzed using two-way ANOVA and Fisher’s LSD for post hoc 
tests, and differences were considered significant when p < 0.05. All statistical analyses 
were carried out using SigmaPlot version 12 (Systat Software, San Jose, CA, USA). 
3. Results 
3.1. Novel Sequenced Genome and Accession Numbers 
The length of the PacBio sequenced P. atlantica genome (NVI 9100) is 2,301,649 bp, 
with a GC content of 42.1%, and 2197 coding regions (CDS) were predicted. The length of 
the Illumina sequenced P. atlantica genome (UiBP1-2013) is 2,260,408 bp. 
3.2. Phylogenomics and Taxonomic Classification 
The P. atlantica strains were isolated from Cyclopterus lumpus in a previous study 
where preliminary phylogenetic analysis was performed based on 16S rRNA and rpoB 
gene sequencing [4]. To assess pairwise similarity percentages among Pasteurella species, 
nine different publicly availably Pasteurella species genomes (Table 1) and P. atlantica were 
analyzed using the OrthoANI tool (Figure 1). 
 
Figure 1. Heatmap generated with OrthoANI values calculated from the Orthologous Average Nucleotide Identity Tool 
(OAT) software. 
When compared to our genome of interest, P. skyensis shows the highest OrthoANI 
values (86.32%) whereas the other species generated much lower values (70 to 72%). 
Figure 1. Heatmap generated with OrthoANI values calculated from the Orthologous Average Nucleotide Identity Tool
(OAT) software.
When compared to our genome of interest, P. skyensis shows the highest OrthoANI
values (86.32%) whereas the other species generated much lower values (70 to 72%).
Apart from Pasteurella genus, a genomic analysis of P. atlantica against the entire
publicly available bacterial database, based on whole genome sequences, according to
Similar Genome Finder, returned the P. skyensis strain DSM 24204 as the only similar
genome at a genomic distance of 0.096 (Mash distance threshold: 0.1). The second most
similar genome at a genomic distance of 0.145 was the Ph. uteri strain NCTC12872, and
that was shown only when the threshold increased up to 0.5 (Figure 1). A bigger number
of Pasteurellaceae family bacteria were found to be less similar, at genomic distances of >0.2,
and for the sake of further analysis, representative genomes have been included in Table 1
as well. Substantially low-similarity levels compared to the bacterial database constitute
an additional piece of evidence supporting P. atlantica as a novel species, knowing that a
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pairwise Mash distance of at least ≤0.05, approximately corresponding to an ANI of ≥95%,
is taken for granted among conspecific bacterial genomes [44].
Multiple codons through the entire genomes of Table 1 were used as genetic markers
to finalize the taxonomy of P. atlantica (Figure 2).
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According to the genome-wide analysis, P. atlantica clusters together with P. skyensis
and Ph. uteri, forming a robust phylogenetic group supported by 100% confidence level
(highlighted in Figure 2). Both monophyletic taxa are phylogenetically distinct since their
nodes bear 100% support values.
3.3. Genomic Elements
The sequence of P. atlantica revealed mobile elements including genomic islands and
prophages that should further be analyzed due to their possible role in pathogenicity [67–69].
3.3.1. Genomic Islands and Prophages
Bioinformatic analysis on the genome of P. atlantica illustrated eleven genomic islands
(GIs) (Table 3) with various properties.
GC content of the GIs span between 29.4 and 36.6%. They encompass 207 coding
sequences (CDS), pprox mately 10% of the P. atlantica to al proteome, and many of the
were attributed to virulence-related r b oadly proteolytic activity functions. The most
prominent putative virulence functions belong to CDS such as RTX-like toxin (GI_1),
putative hemolysin toxin of HlyC family (GI_1), heme-binding protein (GI_4), bacterial
peptidoglycan degrading enzyme of NIpC/P60 (GI_6), spermidine-putrescine binding
(GI_8), acetyltransferase of gnat family (GI_9), ctx rstr-like repressor (GI_9), two-partner
secretion (TPS) system protein (GI_10), and toxin-antitoxin system proteins (GI_11).
The genome of P. atlantica (NVI 9100) harbors five different prophages that were in
silico predicted to be intact, hence inducible (Table 4).
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Table 3. Genomic features of the eleven genomic islands that were found in the genome of P. atlantica (NVI 9100).
# Sequence Location Sequence Length (bp) GC% CDS
GI_1 GI_64353_82229 17,877 31.3 19
GI_2 GI_322423_340166 17,744 34.8 26
GI_3 GI_685873_700034 14,162 34.4 11
GI_4 GI_922164_930860 8697 36.6 12
GI_5 GI_966979_985107 18,129 34.7 26
GI_6 GI_1040130_1045358 5229 35.2 7
GI_7 GI_1058606_1061839 3234 33 9
GI_8 GI_1287395_1293893 6499 29.4 7
GI_9 GI_1369488_1396082 26,595 31.1 34
GI_10 GI_1468334_1477249 8916 29.7 12
GI_11 GI_1534357_1558731 24,375 35 44
Table 4. Genomic features of the five prophages that were found in the genome of P. atlantica (NVI 9100).





P_1 P_322716_342002 19,287 35 26 Enterobacteria phage P4 Unknown NC_001609
P_2 P_972452_1005548 33,097 37.3 40 Mannheimia phagevB_MhS_535AP2 Siphoviridae NC_028853
P_3 P_1030690_1066158 35,479 35.6 49 Escherichia phage D108 Siphoviridae NC_013594
P_4 P_1527862_1576157 48,296 35.2 57 Mannheimia phagevB_MhM_587AP1 Myoviridae NC_028898
P_5 P_2056529_2078637 22,109 35 28 Hemophilus phage SuMu Myoviridae NC_019455
P_1 and P_3 were found to be somewhat related to Enterobacteria phages, whereas P_2,
P_4, and P_5 resemble prophages that have already been described in other Pasteurellaceae
family bacteria [70,71]. According to BLAST sequence similarity, it was only possible to
match 4 out of 26 CDS (7.7%) present in P_1 with any known phage genome implying that
this is a quite novel prophage, uniquely present in the genome of P. atlantica. Similarly, P_3
seems to be a unique prophage as only 9 of its 49 CDS (18.4%) aligned with Escherichia
phage D108. On the other hand, P_2 carried 9 of 40 CDS (22.5%) of Mannheimia phage
vB_MhS_535AP2 while P_4 has homologs of 24 out of 57 CDS (42.1%) that were present in
Mannheimia phage vB_MhM_587AP1. Last, P_5 has 23 out of 28 CDS (82.1%), resembling
Hemophilus phage SuMu more, which was also anticipated due to the close phylogenetic
relationships between P. atlantica and G. parasuis [40].
Interestingly, some of the predicted genomic islands and prophages do overlap in
the genome (Figure 3). Specifically, the entire GI_2 is part of P_1, part of GI_5 is included
in P_2, both GI_6 and GI_7 belong to P_3, while GI_11 is a part of P_5. Hence, there is a
prominent connection between prophages and genomic islands that may be directly linked
to the virulence properties of the bacterial host, with the former inciting the mobilization
of the latter.
3.3.2. Virulence Factors
The proteome of P. atlantica consists of 2197 protein coding sequences (Supplementary
Material S1), which were screened against an integrated matrix consisting of the VFDB,
VICTORS, and PATRIC_VF databases to generate 565 unique amino acid sequence hits
after discarding overlapping hits (Supplementary Material S1). This corresponds to ap-
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proximately 26% of the 2197 predicted coding sequences. However, significant uncertainty
needs to be removed from the analysis to achieve a better focus on the essential virulence
factors present in the species. Subcellular localization of presumptive virulence factors
showed that approximately 12% (70 out of 565) are presumably either extracellularly se-
creted (21) or with outer membrane surface exposure (49), setting these proteins as primary
candidates for the pathogenicity of P. atlantica. The amino acid sequences of the predicted
proteins accompanied by their most similar protein sequence GI number (SCL-BLAST),
subcellular localization, adhesion, and transmembrane (TM) helices probabilities are re-
ported in Supplementary Material S1. According to their amino acid sequences, 17 out of
the 70 virulence factors with extracellular and outer membrane subcellular localization
were the most critical for mediating bacterial invasion, such as adhesins with probabilities
higher than 75%. Adhesins correspond to 0.8% of the total proteome (Figure 4), and since
their expression may be a key determinant of the success of the infection process [72], they
could play an imperative role in the pathogenicity of P. atlantica (Table 5).
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Table 5. Seven extracellular and ten outer membrane localized putative virulence factors of the genome of P. atlantica








1 Putative uncharacterizedprotein <Hia> E (96) 92.5 n/a
Membrane protein/cell
adhesion (Hia) ND
2 Uncharacterized protein E (96) 74.8 n/a De novo protein (designedhelical bundle) GI_6 and P_3
3 Hemolysin-typecalcium-binding region E (96) 82 n/a
Cell adhesion (surface
associated protein csha) ND
4 Putative collagen triple helixrepeat protein E (96) 86.2 n/a
Membrane protein/cell
adhesion (Hia) GI_3
5 HbP1 protein E (97) 81.5 n/a Structural protein/contractileprotein (collagen I alpha 1) GI_2 and P_1
6 Uncharacterized protein E (97) 76 Sec/SPI Metal transport (hemophore) ND
7 Pilus A E (96) 82.9 n/a Cell adhesion (fimbrial protein) ND
8 Hep/Hag repeat protein OM (95) 85.8 n/a Cell adhesion (hep_hag family) ND
9 Uncharacterized protein OM (89) 82.6 n/a Toxin (hemolysin) ND
10 Protein PfhB1 OM (99) 75.4 n/a Membrane protein (znud) ND
11 Putative uncharacterizedprotein 4 OM (100) 74.7 n/a Toxin (hemolysin) ND
12 Putative septumsite-determining protein MinC OM (99) 82 n/a Pili subunits (pili subunits) ND
13 Putative uncharacterizedprotein 26 OM (95) 86.3 Sec/SPI Pili subunits (pili subunits) P_5
14 Phage-related protein tailcomponent-like protein OM (95) 74.6 n/a
Signaling protein receptor





OM (99) 80 n/a Transferase (udp-n-acetylglucosamine–peptide n-) ND
16 Auto transporterbeta-domain protein OM (95) 84.8 n/a Hydrolase (esterase esta) ND
17 Outer membrane antigeniclipoprotein B OM (99) 79.7 n/a
Sugar binding protein (chitin
elicitor-binding protein) ND
The strongest virulence factor candidate is a novel uncharacterized protein, the func-
tion of which would have passed unnoticed without examining its protein structure.
Therefore, PDB predictions based on protein fold recognition were included. All PDB pre-
dictions reported in Table 5 were above the 97% confidence level and encompassed major
virulence components such as hemolysins, toxins, and pili subunits. Specific secretory
signal peptides were detected in only 2 out of 17 adhesins, intended to be transported by
Sec translocon followed by Signal Peptidase I cleavage (Sec/SPI) to be released to the host.
3.3.3. Vaccine Targets
All 70 CDS with extracellular and outer membrane localization were assessed as
potential subunit vaccine candidates. However, apart from adhesion probability, additional
factors such as transmembrane helices and orthologue analysis need to be considered for
calculating their Vaxign-ML score, which was the metric applied to define their suitability
as targets for vaccine development. All vaccine targets with Vaxign-ML scores higher than
99.5% are presented in Table 6, and they are therefore suggested as the most promising
vaccine targets. All of the exact scores as well as further details about the remaining
60 extracellular and outer membrane CDS are included in Supplementary Material S1.
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Table 6. Three extracellular and seven outer membrane localized proteins are the most promising candidates for vaccine
development against P. atlantica (NVI 9100 and UiBP1-2013). E: extracellular, OM: outer membrane, GI: Genomic island, P:
Prophage, and ND: Not designated.
# CDS Localization (%) Adhesin (%) Signal Peptides PDB Header (PDB Molecule)
1 Putative uncharacterizedprotein <Hia> E (96) 92.5 n/a
Membrane protein/cell
adhesion (Hia)
2 Uncharacterized protein E (96) 74.8 n/a De novo protein (designedhelical bundle)
3 Uncharacterized protein OM (89) 82.6 n/a Toxin (hemolysin)
4 Hep/Hag repeat protein OM (95) 85.8 n/a Cell adhesion(hep_hag family)
5 Protein PfhB1 OM (99) 75.4 n/a Membrane protein (znud)
6 Putative uncharacterizedprotein 4 OM (100) 74.7 n/a Toxin (hemolysin)
7 Serine protease satautotransporter E (84) 69.4 Sec/SPI
Hydrolase
(hemoglobin protease)
8 PfhB1 OM (100) 69.5 n/a Toxin (hemolysin)








Since adhesion probability is not the only criterion for vaccine development, 6 out of
the 10 CDS reported in Table 5 are potential virulence factors (Table 6). The list can further
be confined by using VaxiJen as a tool to predict the protective antigenic properties of the
vaccine targets. Only the putative uncharacterized protein and the Hep/Hag repeat protein
had a score >80%, claiming that their antigenicity levels are high enough to trigger the
host’s immune response. However, the putative uncharacterized protein CDS not only was
ranked first in both tables, scoring the highest Vaxign-ML (100%) and adhesin probability
(92.5%), respectively, but also was characterized as a protective antigen, findings that
render it the most significant candidate for virulence and potential vaccine development.
According to its amino acid sequence, BLASTP identified it as a YadA-like family
protein, a collagen-binding adhesin originally characterized in Yersinia enterocolitica [73],
that is also present in the genome of P. skyensis. However, although the query coverage
was 100%, the identity rate was only 58.23%. Based on the predicted structure of the
protein, Phyre2 [59] identified it as a membrane protein for cell adhesion similar to Hia
(Tables 5 and 6), which is also a major adhesin expressed by H. influenzae [74]. Due to the
prominent role that this uncharacterized membrane/cell adhesion protein seems to play in
the virulence of P. atlantica, it was selected for further evaluation of its expression levels
against lumpsucker head kidney leucocytes.
3.3.4. Functional Analysis of the Major Virulence Factor
Expression of <hia> in Bacterial Exponential Growth Phase
The predetermined time points for measurement were chosen based on growth curves
of P. atlantica to coincide with the exponential growth phase of the bacteria. Furthermore,
from the range of cDNA dilutions tested, 50 ng of cDNA per qPCR reaction yielded the
clearest and most consistent results, and this dilution was used to calculate the <hia>
expression. Out of the two reference genes tested, gyrA gave the most stable results
compared to rpoD (Table 7) and was therefore used to calculate the relative expression of
<hia> during cell growth and leucocyte exposure studies. This highlights the importance of
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testing various reference genes for evaluation and stability for expression studies. In this
study, although rpoD seemed to be a stable gene to use for analysis when primer assays
were evaluated, experimental situations proved otherwise.
Table 7. Reference and target gene primers qPCR assay performance.
Gene Amplicon Size (bp) Assay Efficiency (%) Correlation (R2)
gyrA 200 102 0.998
rpoD 173 104 0.987
Putative uncharacterized
protein <Hia> 192 96 0.984
The expression level of <hia> changed over time, when analyzing samples collected
at different time points during the exponential growth phase. The expression levels were
upregulated by 6.5×, 11.5×, and 15.7× at 16, 18, and 20 h, respectively, compared to
the expression level at 14 h (Figure 5). The expression levels also mirror the exponential
increase seen in bacterial numbers from previous work performed on growth curves for
P. atlantica [28].




Figure 5. Expression levels of <hia> in P. atlantica (UiBP1-2013) during growth in liquid medium. 
The time period corresponds to the exponential growth phase of the bacteria. 
Head Kidney Leucocyte (HKL) Exposure Analysis 
The expression levels of <hia> increased with time, with the highest levels recorded 
at 9 and 12 h after leucocyte exposure (Figure 6), with significantly elevated expression 
levels compared with those in the early stages of the exposure (3 and 6 h after exposure). 
At 24 h after exposure compared to 3 and 6 h after exposure, the bacteria would have 
entered the lag phase of growth, and the expressions of both the reference and target genes 
are therefore not comparable with those from earlier time points. Furthermore, statistical 
analysis also showed that HKL from individual fish did not have an impact on the expres-
sion of <hia> (p = 0.33). 
 
Figure 6. Fold increase in relative expression levels of <hia> in P. atlantica (UiBP1-2013) over time 
in the presence of lumpsucker head kidney leucocytes, compared to bacteria not exposed to HKL. 
Error bars represent standard deviation (n = 4). Asterisks represent significant differences in ex-
pression between the time points indicated by square brackets. 
Figure 5. Expression levels of <hia> in P. atlantica (UiBP1-2013) during growth in liquid medium. The time period
corresponds to the exponential growth phase of the bacteria.
Head Kidney Leucocyte (HKL) Exposure Analysis
The expression levels of <hia> increased with time, with the highest levels recorded
at 9 and 12 h after leucocyte exposure (Figure 6), with significantly elevated expression
levels compared with those in the early stages of the exposure (3 and 6 h after exposure).
At 24 h after exposure compared to 3 and 6 h after exposure, the bacteria would have
entered the lag phase of growth, and the expressions of both the reference and target
genes are therefore not comparable with those from earlier time points. Furthermore,
statistical analysis also showed that HKL from individual fish did not have an impact n
the expression of <hia> (p = 0.33).
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4. Discussion
The isolates of P. atlantica used in this work were isolated and reported as the causative
agent of confirmed outbreaks of pasteurellosis in farmed lumpsuckers from Norway.
4.1. Phylogeny Reconstruction
Alarcón et al. [4] carried out preliminary phylogenetic analyses that included the
isolates used in this study, using the 16S rRNA and rpoB genes, and it was suggested
yet not concluded that the isolates might represent a novel species or subspecies. After
examining the existing phylogeny of the Pasteurellaceae family, which is based on 16S
rRNA genes, it can be deduced that using this molecular marker does not sufficiently
resolve the true phylogenetic relationships, since it reflects rather incongruent phylogenetic
relationships among its members. The available 16S rRNA based phylogenetic tree of
the Pasteurellaceae family provides clear evidence that the polyphyletic nature prevails
in the taxonomy of the family [75] and it has already been proven that there is room for
improvement on molecular markers [76]. Despite ongoing research, the current phylogeny
of the Pasteurellaceae family cannot be considered resolved according to the evolutionary
principle of monophyletic taxa formation. Phylogenomic and molecular demarcation
studies have been performed both on the major genera of the family such as Pasteurella,
Hemophilus, and Actinobacillus [77] and on the reclassification of individual species such as
the case of Hemophilus parasuis to G. parasuis [40].
Hence, the classification of P. atlantica in the current study was based on a dataset that
includes representative species from both Pasteurella and other genera that belong to the
Pasteurellaceae family to unravel a comprehensive taxonomy for P. atlantica. P. multocida is
the most thoroughly studied member of Pasteurellaceae due to its high pathogenicity in a
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broad range of livestock species [78,79]. The observed orthologous average nucleotide of
86.32% corroborates that P. atlantica and P. skyensis represent two different species. Whole
genome-based phylogeny validated the novelty of the studied genome and its accurate
taxonomic placement. Since P. skyensis and Ph. uteri are the only strains of marine origin
out of the entire bacterial database, the habitat seems to be a strong differentiating factor
for this taxon of Pasteurellaceae. Second, the host species of the bacteria in the marine
cluster likely play a role for the speciation process. P. atlantica and P. skyensis are the closest
relatives and both infect marine teleosts [35], whereas Ph. uteri isolated from a marine
mammal is classified slightly more distant [36]. The major setback in this case is the lack of
data in sequenced aquatic Pasteurellaceae, a fact that makes it quite precarious to formulate
any solid conclusions regarding the trait of virulence. However, the highly emerging
incidence and pathogenicity of Pasteurella in aquaculture has already brought [4,80] and
will definitely bring more genomic data to the scientific community.
4.2. Virulence Genes
The scarcity of aquatic Pasteurella genomes, particularly from the aquaculture envi-
ronment, highlights the significance of these P. atlantica genomes in exploring genomic
elements, including putative virulence factors, antimicrobial resistance genes, and their
potential implications for devising precaution strategies such as vaccine development
in aquaculture. The abundance of mobile elements such as GIs (11) and prophages (5)
in P. atlantica further enforces its high pathogenicity that has already been documented
in previous studies [4,6,28]. GIs and prophages are very often found in pathogenic bac-
teria and have consistently been reported as major contributors of virulence factors to
their bacterial hosts. Five out of the seventeen strongest candidate virulence factors of
P. atlantica are in GIs and/or prophages, which in total account for roughly 10% of the
genome. This finding is in line with the current literature, which supports the potential
of bacterial mobilomes to harbor significant pathogenicity traits. A recent comparative
genomic analysis of Vibrio anguillarum, a highly virulent aquaculture pathogen, revealed
that 64 GIs that belonged to the accessory genome of the species were present in six out of
nine of the most virulent strains [67]. In the same study, the role of prophages was also
quite prominent, while it was recently proven in another study that marine Vibrio harbors
a large number of prophage-encoded virulence factors [81]. In the pangenome analysis of
P. multocida, GIs were also characterized as one of the most important mobile components
not only as sources of virulence factors but also as facilitators of foreign genes acquisition.
Prophages were again highlighted as core elements of the mobilome, and it was speculated
that they may serve as precursors for the formation of GIs [69]. Additionally, facultative
intracellular pathogens, such as P. atlantica [6,28,82], usually demonstrate quite variable
genomes with a fourfold larger genomic content of mobile DNA such as transposable
elements and prophages, when compared to obligate intracellular bacteria [83].
Mobile elements are characterized by a high frequency of transfer in the environment
through the mechanism of horizontal gene transfer (HGT). HGT can be phage-mediated
and can facilitate the dissemination of virulence-associated GIs within and between micro-
bial communities [84], and the presence of a pathogenicity island can potentially define
virulence in bacterial pathogens [85]. Apart from sophisticated algorithms [60,61], sim-
pler methods that are based on the distinct GC content of horizontally transferred genes
compared to that of the bacterial chromosome have been suggested for the prediction of
GIs and prophages [86]. For instance, the pathogenicity islands in Salmonella typhimurium
(SPIs) have lower GC content than the rest of the bacterial genome [87]. According to the
in silico analysis of our study, the average GC content for GIs and prophages were 34.5%
and 35.6%, respectively, in both cases lower than 42.1%, which is the average GC content of
the P. atlantica genome.
Recent progress in in silico analysis tools allowed us to recognize and assess potential
virulence factors by exploring the novel genome of P. atlantica. Such methodologies consti-
tute fundamental principles of RV, which facilitate vaccine development, while turning
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extensive, time consuming, and generalized lab work into target-oriented functional analy-
sis and in vitro/in vivo trials. It was not until 2006 when the first standalone RV program
designated as NERVE [88] was published, whereas great progress as well as comparative
analysis have been achieved and performed in the RV field ever since [89]. The cornerstone
of virulence factor prediction has been the determination of subcellular localization of
bacterial proteins. Proteins that are extracellularly secreted or exposed on the bacterial
surface have good chances to play a role in bacterial virulence.
4.3. Adhesins
Adhesins, for instance, which can facilitate the colonization of pathogens to mucosal
or other biotic surfaces and which are essential for bacterial pathogenesis and survival may
be prominent virulence factors and suitable candidates for vaccine development [72,90].
Screening of the P. atlantica genome for gene targets that can be further functionally eval-
uated as virulence factors generated the 17 strongest candidate genes that may have
implications for bacterial virulence, based on subcellular localization and predicted adhe-
sion properties.
Previously published bath, cohabitation, and intramuscular and intraperitoneal chal-
lenge trials that included the current P. atlantica isolate (UiBP1-2013) illustrated high and
acute mortality rates, potentially indicating that extracellular proteins may have a substan-
tial role in the infection dynamics [28], an interim conclusion that is supported by present
findings. In our analysis, a putative uncharacterized protein ranked first as both a putative
virulence factor and a vaccine candidate.
According to the in silico analysis, the role of this protein was directly linked to major
adhesins YadA and Hia in Yersinia and H. influenzae, respectively, both of which are essential
for successful infection of their hosts via human epithelia tissues [73,74,91]. Although their
amino acid sequences were not identical, there was a clear connection based on query
coverage and confidence level, which in both cases were 100%.
Trimeric autotransporters (TAAs) are a family of non-fimbrial, homotrimeric bacterial
adhesins that are secreted by the Type 5c secretion system (T5cSS) and for which the
main function is the attachment of pathogenic Gram-negative bacteria to hosts and abiotic
surfaces. Yersinia adhesin A (YadA) is the most extensively studied member of this family,
while others include H. influenzae adhesin (Hia) and Neisseria adhesin A (NadA).
The type 5c secretion system is of great importance in the development of multivalent
recombinant and subunit vaccines, as it enables proteins to be exposed on the bacterial
outer membrane, making them potential vaccine targets [92]. This could then also be used
as the basis for further work to elucidate the structure of the Hia-like protein investigated
in the current study.
YadA showcases the invasive nature of Y. enterolitica and Y. pseudotuberculosis, which
colonize the intestine by adhering to the intestinal mucosa [93]. Immunologically, YadA
has been shown to be a highly immunogenic antigen. In fact, Tahir and Skurnik (2001) [93]
found that immunizing mice with live bacteria raised antibodies against only epitopes
located in the N-termini, whereas using inactivated bacteria raised antibodies against other
epitopes as well. In addition, a study [94] found that mice immunized using a recombi-
nant YadA vaccine had higher survival compared to those vaccinated with inactivated
Y. pseudotuberculosis.
Hia is an adhesin found in 25% of clinical non-typable strains of H. influenzae (NTHi).
It mediates adherence to host cells and causes various diseases in humans, including
respiratory tract infections and meningitis [95]. Hia differs slightly from other TAAs and
is thought to represent a new sub-family. It too is highly immunogenic, however, and
antibodies were strongly induced following natural infection observed in humans. Further-
more, opsonophagocytic antibodies were generated in serum in guinea pigs and mice [96].
However, due to its prevalence in so few strains and despite its high antigenicity, it cannot
be considered a vaccine target on its own but in combination with High Molecular Weight
adhesin 1 (HMW1), High Molecular Weight adhesin 2 (HMW2), and outer membrane
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vesicles (OMVs). In this way, a vaccine containing the three adhesins covers 95% of NTHi
and confers better protection [97].
The significantly higher expression levels of <hia> detected in the current study
following in vitro exposure to lumpsucker leucocytes after 9 and 12 h together with the
in silico results strengthen its candidacy as both a major virulence factor and a potential
target for subunit protein antigen, mRNA, or DNA vaccine development.
The expression of <hia> in the absence of a host correlates with previously observed
increases in bacterial growth rates [28] and indicates that the adhesin is typically expressed
during bacterial growth. In the exposure experiment, bacteria were harvested from the
growth medium at 18 h after inoculation when both bacterial growth and <hia> expression
were at peak levels and combined with HKL in cell culture medium, which does not favor
bacterial growth. The results from this experiment then demonstrate that the expression
of <hia> increases significantly in the presence of the host, following an initial period of
acclimation (up to 6 h, as seen in Figure 6). This implies that the presence of host leucocytes
serves as a trigger for the bacteria to significantly increase the expression of adhesins
(between 6 and 9 h after exposure) and shows that the increased expression is due to the
presence of the host and not an increase in bacterial cell numbers. Furthermore, it indicates
bacterial cell attachment to leucocytes as an initial step towards infection, as previously
suggested by Ellul et al. (2019) [6].
4.4. Vaccine Development
Vaccines targeting adhesins can confer protection by two major mechanisms, one
of which is by inducing neutralizing antibodies, which attach to adhesins and prevent
attachment and subsequent infection. The other involves inducing opsonizing antibodies,
which attach to adhesins and increase recognition of the pathogen by Fc receptors on
phagocytes, leading to phagocytosis, or by activation of the complement system [98], as
shown by Winter and Barenkamp [96] in their experiments with Hia.
Ellul et al. [6] recently assessed the efficacy of formalin-inactivated P. atlantica vaccine
in lumpsucker, and although immune response and antibody production were prominent,
the protection levels provided by the vaccine were relatively weak. Inactivated bacterin is
the most common and traditional type of vaccine used in aquaculture; however, alternatives
such as subunit recombinant, mRNA, or DNA vaccines may be the next step in solving
the problem [99]. This is especially the case with the recent advances in human mRNA
vaccines against SARS-CoV-2, which point to potential avenues for fish vaccines. These
vaccines can be developed using various techniques, including harvesting and purifying
the target directly from the pathogen, or using recombinant expression vectors, such as
E. coli [99]. Pending further work, the former method could be a possible step forward in
the case of P. atlantica as high expression rates were observed in bacteria in their exponential
growth stage.
Some of the most successful recombinant protein subunit vaccines in the aquaculture
industry include those against IPN (MSD Animal Health) and ISA in Chile (Centrovet).
DNA vaccines have also been produced for use in Atlantic salmon against IHN in Canada
and against SPD in Norway (Elanco). Subunit vaccines against the bacterial fish disease
furunculosis in Oncorhynchus mykiss [100] have been tested. All targets for the vaccine
development were identified in silico, employing the RV principles and found to be
protective. Recombinant protein production has already been used in order to protect
farmed fish against infections by V. anguillarum, Edwardsiella tarda, Aeromonas hydrophila,
and Francisella orientalis [101] in all cases leading to the suggestion of potential vaccine
candidates [102–104]. Following these lines, our study highlights the potential that in silico
analysis may have in the future formulation of a novel vaccine against pasteurellosis.
Commercial vaccines are available only for a few infectious diseases in aquaculture,
and given that the needs for fish and shellfish protein as well as the number of cultured
aquatic species are constantly increasing, novel vaccine development will be essential to
guarantee improved animal welfare and a safe, sustainable, and healthy product.
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5. Conclusions
In this study, we report the first fully sequenced genomes of P. atlantica, an emerg-
ing pathogen in Cyclopterus lumpus in Norwegian and Scottish aquaculture. The wide
phylogenetic distance from the closest bacterial relative, P. skyensis, and the very few
available Pasteurellaceae members of aquatic origin highlight the need for intensification
of sequencing efforts that should be focused on Pasteurella strains from the aquaculture
environment. In silico genomic analysis revealed numerous target genes that may be
responsible for the virulence of this species, and a major role was attributed to mobile
elements such as prophages and GIs. Functional analyses showed that the expression
levels of an uncharacterized protein increased significantly when P. atlantica was exposed
to leucocytes from lumpsuckers, complementing the in silico analysis by designating a
prospective virulence gene and by promising candidate for vaccine development. Further
assessment of virulence in larger scale as well as formulation of experimental vaccines will
shed more light on devising a precautionary strategy against a serious emerging disease
in aquaculture.
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